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Our  ever  increasing  knowledge  of  genetics  is  radically  changing  disciplines  in 
science  and  medicine.  Significantly,  the  study  of  gene  expression  and  protein 
synthesis within both healthy and abnormal cells has advanced understanding of the 
mechanism of disease at the molecular level. The future treatment of certain diseases 
may  benefit  from  new  classes  of  nucleic  acid  based  drugs  which  are  currently 
undergoing development and trialling. Concurrently, assays are being formulated to 
predict,  diagnose  and  monitor  medical  conditions.  This  more  detailed  patient 
analysis brings the option of moving away from traditional, textbook treatments and 
tailoring therapies to the individual, the field of personalised medicine. 
Current polynucleotide analysis platforms allow testing for genomic mutations and 
quantification of gene expression on a massively multiplexed scale with some arrays 
able  to  identify  more  than  a  million  unique  target  sequences  in  a  single  assay. 
However  much  development  is  required  to  take  this  analysis  technology  from 
laboratory based applications to the bedside. Reductions in assay costs and analysis 
time  are  particular  concerns.  The  4G  research  group,  based  at  the  University  of 
Southampton  has  developed  novel  encoded  microparticle  technology,  allowing 
individual particles to be identified in a mixture. The work herein documents the 
adaption of this technology for the multiplexed analysis of DNA samples in the form 
of  a  suspension/hybridisation  assay,  a  design  which  may  offer  advantages  over 
current  analysis  technologies  including  reduced  assay  time  and  increased  array 
flexibility. 
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1.0 Introduction 
 
Biological assays encompass methods used to detect and quantify the amount of a 
particular  constituent  from  a  biological  sample  or  to  determine  the  biological  or 
pharmacological potency of drug molecules. 
Deoxyribonucleic acid (DNA) contains the genetic information for the majority of 
known life forms; encoding for and regulating the expression of proteins within the 
cell. Analysis of a genome can provide a great deal of information ranging from 
identification and differentiation between individual organisms and between species 
to the state of their health, evolutionary relationships may be mapped and resistance 
to disease predicted. 
The macro structure of DNA, determined by Watson and Crick in 1953, is that of a 
highly ordered duplex of polymeric strands, wound in a right-handed double helix 
(Figure  1).  Each  strand  consists  of  a  phosphate-deoxyribose  backbone  with 
nucleobases  attached  to  the  sugar;  the  order  of  the  bases  constitutes  the  genetic 
information  store.  The  primary  objective  of  DNA  assays  is  to  determine  the 
sequence of these bases.  
Since the initial publication of the partial human genome in 2001 there has been an 
ever  increasing  demand  for  faster,  cheaper  and  more  reliable  genetic  analysis 
platforms.
1,2 Without these new technologies the wealth of data divulged from the 
Human Genome Project (HGP) cannot easily be translated into research and medical 
advances. To highlight (and attempt to close) the gap between the knowledge of the 
sequence  of  bases  which  encode  human  life  and  the  implementation  of  this 
knowledge a number of initiatives have been set up. These include the four year, 
European Commission funded REvolutionary Approaches and Devices for Nucleic 
acid Analysis (READNA) consortium and the altogether more glamorous Archon 
Genomics X Prize offering $10 million to those who develop a technology capable 
of sequencing 100 human genomes in 10 days.
3,4 
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Figure 1. The helical macromolecular structure of double-stranded DNA which consists of a sugar-phosphate 
backbone linked by phosphodiester bonds. Genetic information is represented by the sequence of the four 
DNA bases linked to sugar moieties; these bases pair up due to hydrogen bonding interactions which bridge 
the two strands of the duplex. 
 
An ideal sequencing technology would determine the order of bases in a DNA chain 
to a high fidelity whilst being economically viable and user friendly. An aim of 
research in this field is to develop technologies for use at the point of care; small, 
robust,  cheap  and  disposable  devices  which  can  be  operated  by  healthcare 
professionals (or patients) and which rapidly give results. Product design typically 
incorporates elements from the physical and life sciences most notably molecular 
biology, genetics, chemical biology, micro/nano engineering and bioinformatics. 1. Introduction 
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 1.1 Benefits of nucleic acid sequencing 
The first genome to be fully determined was that of the virus Bacteriophage MS2 in 
1976,
5 followed by the first “truly living” organism to be sequenced, the pathogenic 
bacterium Haemophilus influenzae in 1995;
6 since then over 180 organisms have had 
their  genetic  sequences  read.
7  Sequencing  of  the  human  genome  was  considered 
essentially complete in 2006, and at present over 95% of the genome has been read 
by the HGP.
8,9 The bulk of the missing sequence data is for highly repetitive non-
encoding regions such as chromosomal centromeres and telomeres and for regions 
which show variation amongst individuals.
10 As there is variation in the genomes 
between  individuals  of  the  same  species,  the  published  sequences  can  only  be 
considered a framework for the encoding of an organism and for this reason it is 
accepted that a species has been fully sequenced if ≥ 95% of its genome has been 
determined. 
The knowledge of the sequence of bases in a genome is of little use without an 
understanding of where genes are localised, what proteins they encode and what 
functions these proteins perform.
11 Work in the field of proteomics is progressing; 
however  the  determination  of  the  human  proteome  is  considered  a  greater 
undertaking than that achieved by the Human Genome Project.
12 It is estimated that 
less than 1.5% of the human genome encodes for protein production and these areas 
are currently the main focus of genomic research (the biological function of most of 
the remaining 98% is yet to be determined; though some is known to be important 
for the regulation of transcription and translation processes).
13   
There are a number of benefits that arise from genetic sequencing. Having a template 
of the human genome, for example, has led to an increased understanding of genetic 
disease. By comparing DNA from diseased individuals with the (healthy) template 
(using genome-wide association studies), mutations can be identified which either 
result in disease or can increase predisposition to disease.
14,15 The identification of 
common disease causing mutations has resulted in improvements in both diagnosis 
and  prognosis.
16,17  In  recent  years  technological  advances  have  resulted  in  the 
reduction of both sequencing time and cost which has lead to commercial screening 
services  being  widely  available.  The  deeper  understanding  of  the  mechanics  of 
individual diseases is also likely to aid development of improved therapeutics, with 1. Introduction 
14 
 
blanket screening of libraries of small (potential drug) molecules being replaced by a 
more targeted approach. 
Studies  of  evolution  are  also  benefitting  from  sequencing  information.  Where 
organisms  have  traditionally  been  classified  by  observations  of  their  physical 
characteristics leading to a mostly accurate but not highly detailed understanding of 
the evolutionary tree, they can now be classified using similarities between genomes, 
providing  a  more  informed  stance  as  to  the  evolutionary  relationship  between 
species.
18 
The use of genetic testing in forensic science has revolutionised law enforcement, 
with the sampling of an individual’s DNA now standard practice when thought to be 
on the wrong side of the law. This has aided the judicial process and lead to new 
convictions,  the  solving  of  cold-cases  and  the  quashing  of  previous  convictions 
where miscarriages of justice have been proven. 
 
1.1.1 Disease diagnosis and prognosis 
Genetic analysis can now used for the prediction, screening and diagnosis of many 
genetic diseases caused by mutations to the healthy genome. Mutations fall into two 
categories; hereditary and acquired.
19 Prior to the development of a new screen for a 
particular disease, the location of the affected gene must be identified. To narrow 
down  to  a  disease  causing  mutation  amongst  the  3.2  billion  bases  in  the  human 
genome, samples of DNA from people suffering from the illness are compared with 
the  standard  human  genome.  Historically  the  entire  genome  would  need  to  be 
analysed, for example the mutations responsible for Huntington’s disease and cystic 
fibrosis each took ten years to be identified.
20,21 More recently the localisation of 
problem base sequences has been aided by the publication of chromosome maps by 
the  HGP.
22,23  These  maps  document  genetic  landmarks  (specific  base  sequences) 
which  highlight  the  loci  of  genes  within  the  entire  genome,  assigning  them  an 
address along the sequence. Research to identify mutations and omissions from an 
individual’s genome can then be more targeted by looking at the known regions of 
interest. This research and the demand for testing has fuelled a steady growth in the 
market for genetic testing. Assays have been developed to screen for more than 2000 1. Introduction 
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different genetic diseases by way of identification of causative mutations (Figure 
2).
24 
 
Figure 2. The growth of genetic testing in recent years which is representative of the general trend of growth 
in  the  (commercial)  genomics  sector.  Though  few  new  companies  have  formed  since  the  turn  of  the 
millennium,  the  number  of  tests  for  genetic  diseases  continues  to  rise  with  over  2000  tests  currently 
available
24 
 
The  analysis  of  the  genome  as  a  diagnostic  tool  has  significant  advantages  over 
proteomic and cytomic assays, diseases may be identified prior to the onset of any 
symptoms  and  the  exact  cause  can  be  determined.  Early  or  pre-symptomatic 
diagnoses  can  allow  remedial  action  to  be  swiftly  taken,  including  therapeutic 
regimes and lifestyle changes which can lessen the extent of or fully negate later 
symptoms.  Often  the  presence  of  a  mutation  only  imparts  a  predisposition  to  a 
genetic  disorder  and  so  screening  can  be  used  to  estimate  the  risk  of  a  disease 
developing.
25 
The  passing  on  of  hereditary  diseases  to  offspring  can  also  be  screened  for. 
Screening is sometimes used in conjunction with in-vitro fertilisation when there is a 
high  risk  of  inherited  genetic  disease.
26,27  DNA  from  fertilised  zygotes  can  be 
screened  and  only  those  with  healthy  sequences  subsequently  implanted  in  the 
womb, avoiding disease inheritance leading to healthy offspring. 1. Introduction 
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Many diseases are symptomatic of multiple mutations; cystic fibrosis for example is 
caused  by  combinations  from  over  1400  mutations  of  the  cystic  fibrosis 
transmembrane  conductance  regulator  (CFTR)  gene.
21  Knowing  the  specific 
mutations  present  in  the  gene  alleles  gives  information  as  to  the  likelihood  and 
severity of symptoms, this more detailed diagnosis leaves scope for personalised 
medicine (theranostics) where a treatment can be tailored to the individual rather 
than to the average patient. Research into theranostics is at an early stage but is now 
being used clinically for the treatment of some cancers where markers for virulence 
and prevalence can be screened informing on the required intensity and duration of 
prescribed treatment regimes.
28,29 
 
1.1.2 Gene expression studies 
A useful tool for molecular biology is gene expression profiling where messenger 
ribonucleic  acid  (mRNA)  sequences  produced  by  transcription  within  the  cell 
nucleus are identified and quantified (or at least assayed relative to a standard).
30 As 
changes in the quantity of different mRNA sequences correspond to the activation or 
repression of specific genes, the cellular response to various environmental stimuli 
can be studied at a genomic level. The expression from thousands of genes can be 
assayed  in  parallel  with  specific  genes  being  turned  on  or  off  by  different 
environmental stimuli being identified. Major uses of expression profiling include 
drug discovery, disease prognosis and cellular research.
31,32 Fundamental studies of 
the  living  cell  using  expression  profiling  often  involve  exposing  cell  cultures  to 
different  conditions  (physical,  chemical  or  biological)  to  elicit  a  response  and 
comparing changes of mRNA levels.
33 This information can be complemented by 
proteomics and bioinformatics to better understand cell responses aiding research 
into  cell  signalling  pathways,  protein  function  and  identification  novel  drug 
targets.
34,35 For example, to aid development of novel cell culture medias, profiling 
has  been  used  to  identify  receptors  and  cell  signalling  factors  expressed  during 
growth.
36  Once  these  proteins  have  been  identified,  the  effects  of  various  small 
molecules and ligands on their corresponding gene expression were tested with the 
aim  of  promoting  protein  production  and  subsequent  maximisation  of  cellular 
growth. 1. Introduction 
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Theranostics  can  be  enhanced  by  combining  gene  expression  profiling  with 
commercial  screening  arrays  currently  available  for  the  screening  of  cancer 
biopsies.
37 Assaying the expression of various cancer mRNA biomarkers gives an 
indication as to the virulence of a patient’s specific cancer, dictating the treatment 
prescribed and giving an idea of the probability of remission.
38 
Expression profiling can be used throughout the drug discovery process from the 
identification of novel drug targets and the screening of potential drug molecules to 
the assaying of effects drug candidates have on expression across the entire genome 
and their toxicology to healthy tissue.
39,40 
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1.1.3 Species identification and forensics 
  
Figure  3.  The  current  map  of  the  phylogenetic  tree  displaying  the  genetic  relationship  between  (fully 
sequenced) organisms. The expanded region shows H. sapiens and some of our closest relatives. From the 
Interactive Tree Of Life (iTOL) project
41 
 
Due to the high fidelity of certain analytical techniques, changes of a single base can 
be  detected  allowing  discrimination  between  different  organisms.  Phylogenetic 
arrays  have  been  developed  for  the  identification  of  species  and  strains  with  a 
particular  focus  on  the  differentiation  of  microbial  taxa.
42  A  good  example  of  a 
phylogenetic  array  is  one  which  targets  regions  of  prokaryotic  ribosomal  RNA 
(rRNA) to classify different bacteria. These arrays specifically look at the nucleotide 
sequence  of  the  16S  rRNA  gene  as  it  has  both  highly  conserved  and  variable 
regions.
43,44  Analysis  of  the  variable  regions  provides  information  used  to 
discriminate closely related species and strains, whereas highly conserved regions 1. Introduction 
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vary  between  more  distantly  related  taxa.
45  Beyond  the  classification  of  life, 
phylogenetic ecology can be used to track the evolution of pathogens and is useful 
for  the  understanding  of  virulence  between  different  strains  of  the  same  disease 
causing microorganism.
46,47,48 Expanding on this genetic taxonomy by comparing the 
genomic data of all sequenced organisms it is possible to discern the evolutionary 
connections between species and online tools have been developed to disseminate 
this knowledge (Figure 3). 
Another use of sequencing technology is in forensic science where DNA profiling is 
used  to  identify  individuals,  establish  family  relationships  and  link  crime  to 
perpetrator. Identification is based on the assaying of short tandem repeats (STRs) in 
the genome, these are regions of consecutively repeating bases (1-6 nucleotides long) 
with the specific number of repetitions varying between individuals. Importantly, 
these regions are flanked by highly conserved sequences and can therefore be easily 
localised using complementary DNA (cDNA).
49,50 Most current forensic tests focus 
on 13 different STR loci, with the lengths of each STR in an individual’s genome 
being analysed, this results in 26 different repeats being measured (two copies of 
each allele) and gives an (almost) unique DNA “fingerprint”.
51 The chances of two 
randomly chosen individuals sharing the same STR profile has been calculated to be 
3 × 10
-13 (1 in 3 trillion), however the odds increase for related individuals.
52 
 
1.1.4 Ethical and legal discussion 
The ethical and legal issues surrounding genetic information are constantly evolving 
as  this  relatively  new  field  continues  to  advance,  often  with  moral  viewpoints 
clashing with big business ideology.
53 Solving these dilemmas is primarily a task for 
policy makers within government and the courts, but it is advantageous for scientists 
to be aware of moral issues affecting their field. 
One area for concern is the right of ownership over sections of, or whole, genomes. 
Patents have been being awarded for specific gene sequences since the early 1990’s 
both  in  the  U.S.  and  Europe  allowing  companies  or  individuals  to  control  their 
usage.
54  This  appears  to  contradict  historical  patenting  guidelines  where  natural 
materials cannot be covered.
55 Arguments against the patenting of natural sequences 1. Introduction 
20 
 
include  the  thought  that  it  hinders  the  advancement  of  genetic  research  and  the 
development  of  new  bioanalytical  technology.  Added  is  the  thought  that  a 
sequencing company actually holds ownership over part of the human genome. The 
counterargument in favour of intellectual property (I.P.) claims that the potential for 
commercial  gain  drives  new  research  and  rewards  success  in  the  field.  Recently 
established patents have been successfully challenged in court.
56 As the amount of 
information increases further problems may arise, for instance presently even short 
(incomplete)  sequences  of  an  individual  gene  can  be  protected,  when  the  whole 
sequence of that gene is determined it too can also be patented and the sequencing of 
the entire organism’s genome can be covered as well. This may lead to the same 
short base sequence being covered by three different patents; legal wrangling would 
likely then ensue. It seems inevitable that the way I.P. and genetic information are 
managed will need a radical overhaul in the not too distant future. 
Predictions of a future state of health using an individual’s genetic information also 
warrants discussion. Some genetic mutations cause disease or increase the likelihood 
of a disease manifesting and genetic screening can provide valuable information for 
diagnosis,  treatment  and/or  prevention.
33  However  regulation  has  yet  to  catch  up 
with  the  commercialisation  of  genetic  testing  allowing  unsubstantiated  claims  as 
providers (in the U.S.) do not yet come under the scrutiny of the Food and Drug 
Administration (FDA), the situation being similar elsewhere. These tests often give 
results  as  a  probability  of  disease  manifestation.  This  may  promote  a  change  in 
lifestyle to counterbalance an increased risk but it may too cause unnecessary worry 
about a problem which would not necessarily appear. At the very least there is an 
argument for a greater regulation of service providers and improved education of 
health professionals and the public.
57 
 
1.2 Technology overview 
DNA sequencing involves the determination of the order of nucleotides in a strand. 
This can include both the analysis of samples where none of the base order is known 
as in whole genome sequencing and the more focussed sequencing of regions of 
interest, for instance an area where the rough sequence is known but is a common 
loci for mutations.
58 Most sequencing consists of four steps; target amplification, 1. Introduction 
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purification,  analysis  and  identification.  Later,  this  chapter  will  focus  on  current 
methods of analysis. 
Often the amount of DNA within a biological sample is insufficient for sequencing 
and  therefore  requires  amplification;  generally  two  methods  are  used,  molecular 
cloning  or  the  polymerase  chain  reaction  (PCR).
59,60  The  degree  of  purification 
required is dependent upon the specificity and robustness of the techniques being 
used. Generally, purer DNA samples are needed for the sequencing of completely 
unknown  segments  (having  lengths  of  40  –  1000  bases  and  sequencing  utilises 
enzymatic pathways) than the more targeted sequencing of shorter regions of interest 
(involving very specific interactions with complementary probes). The purification 
techniques  employed  depend  upon  the  amplification  methods  used,  techniques 
include; precipitation, chromatography, centrifugation and affinity capture.
59 
Once  a sample has been analysed,  elucidation  of the base sequence may  require 
significant  computational  reconstruction.
61  For  example,  the  sequencing  of  an 
organism’s entire genome usually requires the whole strand to be cut into smaller, 
more manageable segments.
62 Once these shorter (overlapping) strands have been 
sequenced they then have to be reassembled in the correct order; for the human 
genome this requires the stitching together of 3.2 million shorter sequences, each 
approximately 1000 bases long, and achieving this reassembly would be extremely 
difficult without powerful computational methods.
63,64 
There  is  currently  great  interest  in the  advances  in  sequencing  technologies  as  a 
result of the publication of the human genome in 2003 and focus has now shifted to 
the more widespread use of this data. One of the main aims of this development 
drive are to reduce both the cost and the time required to analyse samples, with 
secondary aims of minimising sample and equipment size and reducing dependence 
on infrastructure/manual handling. In essence there is the desire to shift sequencing 
from large, dedicated laboratories to analytical laboratories, hospitals, GP’s surgeries 
and potentially the home, i.e. the point of care.
65,66 
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1.2.1 Sequencing of Medium and long DNA fragments 
The most common methods of sequencing make use of a PCR-based synthesis of the 
complementary  strand,  the  structure  of  which  is  then  elucidated.  Two  well 
established techniques are chain-terminating sequencing and pyrosequencing. 
Sequencing by chain termination was pioneered by Frederick Sanger in 1977 and 
resulted in the first practical (commercial) DNA sequencers.
67 The original method 
used  a  mixture  of  normal  deoxynucleotide  triphosphates  (dNTPs)  (some 
incorporating  a  radioactive  label, 
32P  which  emits  beta  particles)  and  modified 
dideoxynucleotide triphosphates (ddNTPs) (which lack a 3’ hydroxyl) during the 
DNA polymerase-catalysed synthesis of the oligonucleotide complementary to the 
target sequence (Figure 4). Upon incorporation of ddNTP, synthesis terminates. As 
the  incorporation  of  either  dNTP  or  ddNTP  is  statistical,  a  variety  of  different 
oligonucleotide lengths results. By only adding a single ddNTP to each polymerase 
reaction  and  separating  the  product  oligonucleotides  by  length  using  gel 
electrophoresis the sequence can be determined. 
PCR amplification will be discussed in more detail (Chapter 1.3.1). 1. Introduction 
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Figure 4. Chain termination (Sanger) sequencing. A. Target DNA is amplified in the presence of a single ddNTP 
which B. causes termination of polymerisation. C. Gels of the PCR mixtures each containing a single ddNTP 
can be run sorting the sequences by size and allowing reconstruction of the original base order. D - F. An 
improved sequencing setup using labelled ddNTPs to facilitate sequencing in a single gel lane. Running gels in 
multiplex utilising capillary electrophoresis has paved the way for higher throughput sequencing 
 
The method was improved by the use of labelled terminators in what is known as 
dye-terminator sequencing (Figure 4).
68,69 Using a different fluorophore for each of 
the four ddNTPs, only a single polymerase reaction is required as the identity of the 
terminal base in a sequence can be determined by the wavelength of light emitted. A 
further  advancement  was  the  development  of  capillary  electrophoresis  which  has 
superseded gel electrophoresis for the size separation of oligonucleotide sequences.
70 
Using these 100  m diameter silica columns for separation results in lower sample 
consumptions  and  a  decreased  read  times.
71  These  higher  throughput  techniques 
paved the way for automation and the development of commercial DNA sequencers 1. Introduction 
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(ABI  and  Amersham)  which  allow  analysis  in  parallel  (up  to  384  capillaries), 
technology  which  made  the  human  genome  project  viable.
72,73  Using  the  most 
developed Sanger methods combined with capillary electrophoresis would require 
approximately 10,000 instrument days and cost £15 million to sequence a human 
genome (3.2 billion bases).
74 
Pyrosequencing  allows  real-time  analysis  of  complementary  DNA  synthesis  by 
monitoring the incorporation of individual nucleotides.
75,76 In the presence of a DNA 
polymerase and the sample DNA, dNTPs are added sequentially, one at a time, and 
incorporation  is  monitored  by  the  indirect  quantification  of  pyrophosphate  (PPi) 
released.  Quantification  relies  on  an  enzymatic  pathway  where  PPi  is  initially 
converted to adenosine triphosphate (ATP) which is subsequently used to drive the 
oxidation of luciferin, this final step results in the release of photons, the intensity of 
light  emitted  being  proportional  to  the  amount  of  deoxynucleotide  initially 
incorporated (Figure 5). Any unincorporated dNTPs and remaining ATP is degraded 
by the enzyme apyrase. In summary; to a mixture of target DNA sequence, primers, 
enzymes, adenosine phosphosulfate (APS) and luciferin, a quantity of a single dNTP 
is added and the reaction monitored for light emission. After pausing to allow time 
for apyrase to degrade any remaining ATP and nucleotides, the reaction is continued 
by  the  addition  of  the  next  dNTP.  Repeated  cycling  through  of  the  four 
deoxynucleotide  triphosphates  allows  the  sequence  to  be  read  in  real-time  by 
detection of light emitted. 
 
Figure 5. The mechanism of pyrosequencing. The incorporation of a nucleotide into a growing DNA sequence 
initiates  a  reaction  cascade  which  results  in  emission  of  light.  The  reaction  is  self  propagating  as 
pyrophosphate  is both a reagent and a product  (highlighted  in blue), therefore after every addition the 
reaction  must  be  quenched  (by  the  enzyme  apyrase).  Bases  are  added  sequentially,  with  continuous 
monitoring of the intensity of light, a flash indicating incorporation 
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Pyrosequencing  has  a  number  of  advantages  over  Chain-termination  techniques 
including  removing  the  need  for  labelled  primers,  modified  nucleotides  or  gel 
electrophoresis, the monitoring of synthesis is in real-time and is carried out at room 
temperature and the sequencing is cost effective.
77 The technique does have some 
limitations, for example it is limited to read lengths of 400-500 bases as nucleotide 
incorporation is not 100% efficient, leading to an increase in background signal as 
the reaction progresses.
76 Furthermore the method cannot easily determine the length 
of regions where the same base is repeated many times (homopolymeric regions), 
this is because the increase in light intensity becomes (proportionally) less with each 
additional repeat, this effect becomes prominent after the incorporation of about ten 
identical  adjacent  nucleotides.
78  The  technology  has  been  commercialised,  most 
notably by 454 Life Sciences (Roche Applied Science) who, by immobilising the 
target  sequence  to  particles  and  arraying  in  microwells,  can  achieve  massively 
parallel  sequencing,  claiming  600  million  bases  read  in  10  hours  at  a  cost  of 
~£10,000.
79,80 
Solexa sequencing (Illumina) differs from pyrosequencing in that the extension of 
the growing complementary strand (immobilised on a surface) is monitored using 
fluorescently  labelled  nucleotides,  the  surface  being  imaged  after  nucleotide 
incorporation.  Following  imaging,  the  fluorescent  label  and  terminal  protecting 
groups are removed allowing the next nucleotide to be incorporated.
81 
The above sequencing methods can be used to elucidate the code of longer DNA 
chains by breaking the complete sequence down into more manageable chunks. One 
method is Shotgun sequencing, where target DNA is cut into fragments (often with 
the use of restriction enzymes), sequenced and then regions of overlap between reads 
are used to reassemble the original order of bases (Figure 6).
82 Another method is 
call primer walking, by this method primers are hybridised to a known region of the 
target  DNA  and  after  primer  extension  the  500  (unknown)  bases  beyond  the  3’ 
primer end are sequenced, now knowing the sequence further along the target DNA, 
new primers can be designed to hybridise further along the target strand and the 
process repeated.
83 1. Introduction 
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Figure 6. A summary of the shotgun sequencing of long DNA sequences. The target sequence is first amplified 
and broken into shorter chains with random breaks. Fragments are often inserted into plasmid DNA to be 
replicated in bacteria before being sequenced. Overlapping regions on the sequence fragments are used to 
elucidate the original base sequence. 
 
1.2.2 Sequencing of short DNA fragments 
Hybridisation assays can be used to detect and decode shorter target DNA sequences 
upon binding to their complementary strand (which acts as a probe, generally less 
than 100 bases long).
84,85,86 This methodology requires both a signal generation to 
indicate  when  a  hybridisation  event  has  occurred  and  a  way  of  identifying  the 
specific probe which has formed a duplex with complementary target. 1. Introduction 
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With  the  development  of  the  DNA  microarray,  it  became  possible  to  track  the 
positions of tens of thousands of oligonucleotide probes, and their application to 
whole genome sequence analysis was investigated.
85 Sequencing of the entire human 
genome by hybridisation has since been demonstrated to be impractical as probes 
cannot contain enough of a unique base sequence to permit sequencing.
87 A short 
oligonucleotide  sequence  may  be  repeated  within  a  genome  and  therefore  short 
probes will not distinguish between them, conversely, as probes increase in length, 
single  base-pair  mismatches  become  less  significant  (to  the  overall  strength  of 
hybridisation)  resulting  in  difficulty  distinguishing  between  similar  target 
sequences.
88  The  design  of  new  arrays  has  therefore  focussed  on  uses  such  as 
expression  profiling  and  single  nucleotide  polymorphism  (SNP)  detection.
89,90,91 
These are applications where the genome of a species has previously been (at least 
partially)  sequenced  and  using  this  information  arrays  can  be  designed  for  the 
detection  of  sequences  of  interest;  for  expression  profiling  this  relates  to  the 
quantification of specific mRNA strands and for SNP detection the discrimination 
between base variations at a specific site within a genome. 
The  technological  aims  are  to  develop  hybridisation  arrays  to  be  very  high 
throughput and multiplexed, cheap to produce and give a fast detection response 
whilst requiring little space, infrastructure or target sample.
92,93 
In summary, the technology is intended for use at the research laboratory/hospital 
level (at the point of care). Whole genome sequencing using chain termination or 
pyrosequencing is time consuming, costly and labour and infrastructure intensive. 
However this sequencing only needs to be carried out on a representative sample of 
individuals from within a species to generate the basic genome of that species and 
identify  its  common  positions  of  variation  (polymorphism).  On  the  other  hand, 
actually  using  this  knowledge  for  most  forms  of  scientific,  medical  or  forensic 
diagnostics  requires  sequencing  of  an  individual  target  (organism)  of  interest; 
therefore  there  is  a  need  for  cheap,  fast  and  more  portable  targeted  sequencing 
technology. 
DNA microarrays consist of many oligonucleotide probes immobilised on a planar 
surface, the location and sequence of each probe being known (Figure 7). As the area 
functionalised  with  each  probe  is  very  small  (less  than  250   m  diameter)  many 1. Introduction 
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thousands  can  be  fit  onto  a  chip  the  size  of  a  microscope  slide.
94  The  probe-
functionalised surface is exposed to a sample of target DNA and hybridisation to the 
specific complementary probe occurs. Binding events are commonly identified by an 
increase  in  fluorescence;  therefore  either  target  strands  carry  a  fluorophore 
modification  or  double-stranded  DNA-binding  fluorescent  intercalators  are 
added.
95,96 
 
Figure 7. Schematic representation of a DNA hybridisation microarray. A. Short oligonucleotide probes are 
ordered on a planar surface, probes are identified by their coordinates on an x,y grid. B. Upon exposure to a 
sample of labelled target DNA complementary sequences hybridise, C, and result in spots of fluorescence on 
the  array  surface.  Mapping  the  positions  of  fluorescent  signals  to  the  grid  coordinates  allows  sequence 
identification 
 
Label-free  detection  methods  are  the  focus  of  developmental  research,  with  the 
double  benefit  of  negating  target  modification  (with  fluorophore)  during  sample 
preparation  and  reducing  expensive  and  bulky  imaging  equipment.
97,98  One  area 
showing  promise  is  the  use  of  nanowires  (nanoelectrodes)  where  a  change  in 
potential caused by biomolecule binding can be detected at a surface.
99 For example, 
nanowires may be fabricated from silicon and functionalised with oligonucleotide 
probes in a manner similar to that used for microarrays, upon complementary target 
hybridisation the resistance of the wire is observed to change.
100,101,102 An array of 
wires, each with a unique probe sequence and an individual electrical connection 
may perform as a traditional microarray but on a much smaller scale. 
Multiplexing arrays where the probes are arranged on a planar surface suffer from 
some disadvantages including limitations to probe localisation (difficulty in printing 
probes in well-defined, small areas), an inflexibility of the probe library (where once 1. Introduction 
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an array is fabricated, the probes included may no longer be modified) and slow 
reaction kinetics (as reagents/target must diffuse onto the surface).
103,104 
An alternative is to immobilise biomolecular probes to the surface of particles to 
produce  a  suspension  array.
105,106  As  the  probes  are  now  attached  to  separate 
supports they can be moved independently allowing flexibility in the array design 
after  functionalisation.  Binding  rates  are  also  increased  as  the  particles  can  be 
suspended within the sample mixture which results in a decrease in the thickness of 
the diffusion zone close to the probe-functionalised surface.
107 This results in the 
binding kinetics being closer to that observed for solution-phase interactions, and 
this effect should be more pronounced when the concentration of target is low and 
the diffusion zone around a probe-functionalised surface would be likely to show 
target depletion.
108,109,110 
The theory behind multiplexed sequence analysis using suspension arrays is akin to 
microarray  technology,  but  modified  so  that  instead  of  spots  on  a  chip,  the 
fluorescence  of  individual  particles  increases  upon  complementary  target 
hybridisation  (Figure  8).  The  requirement  is  to  know  to  which  particles  each 
different probe is attached to and this can be achieved by designing particles to be 
easily  differentiated.  There  are  a  number  of  different  encoding  methodologies 
including spectral (incorporation of varying fluorophore levels to give a particle-
unique  emission  spectrum),  physical  (particles  of  differing  shape),  graphical 
(patterning of the particle surface) and holographic (where light is diffracted by the 
particle) allowing particles to be uniquely tagged.
111,112. The ability to control the 
probe-particle pairs by flow cytometry can be an additional benefit to suspension 
arrays (over microarrays) as particles can be analysed in a continuous flow. Other 
examples  also  exist  where  particles  have  been  fabricated  and  functionalised  in  a 
stream, which gives options for the continuous monitoring of biological samples.
113 1. Introduction 
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Figure 8. Schematic representation of a DNA hybridisation suspension array. A. Short oligonucleotide probes 
are immobilised on a particle surfaces, probes are identified by the encoding on each unique probe-particle 
conjugate. B. As with DNA microarrays, upon exposure to a sample of labelled target DNA complementary 
sequences  hybridise  which  results  in,  C.  particles  with  increased  fluorescence.  Decoding  the  particles 
displaying fluorescent signals allows sequence identification 
 
In recent years suspension array technology has been commercialised, most notably 
by  Luminex  Corporation  (U.S.)  which  use  microparticles  encoded  by  the 
impregnation of precise quantities of two fluorescent dyes, the ratio of the dyes being 
unique within each particle.
114 This technology has an encoding capacity of 100 (the 
number of different  codes available) and arrays have recently been developed to 
identify and genotype subtypes of the flu virus (H1N1).
115 
The  current  drawbacks  to  the  more  widespread  use  of  suspension  arrays  over 
microarrays appear to be the high cost of fabricating encoded particles in sufficient 
quantities, the requirement for great robustness of encoding and fidelity of decoding, 
and  the  difficulty  in  functionalising  different  particles  with  unique  probes  whilst 
tracking  the  immobilisation,  some  of  these  issues  are  discussed  in  more  detail 
below.
116 1. Introduction 
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1.3 Target and probe preparation for DNA hybridisation suspension arrays  
As previously noted, before the DNA in a biological sample can be analysed using a 
hybridisation array, the amount of target must usually be amplified. As these arrays 
are often designed to investigate specific genomic regions and detect the presence of 
known mutations this amplification may be focussed on replicating just the regions 
of  interest.  Furthermore,  the  target  or  the  probe  usually  requires  modification 
(labelling) so that any binding events may be detected.  
 
1.3.1 The polymerase chain reaction 
PCR is a routinely used laboratory technique for the exponential amplification of a 
region of interest on within a DNA sample exploiting naturally occurring cellular 
DNA and RNA repair and replication enzymes.
117 This makes it ideal for genetic 
testing such as SNP genotyping or disease diagnosis where although the exact base 
sequence in the variable (mutation) region is unknown and of interest, the sequence 
of bases in adjacent (non-variable) regions is known.
118,119,120 PCR is summarised in 
Figure  9.  Briefly;  a  mixture  of  sample  DNA,  two  primers  complementary  to 
sequences flanking the region of interest, all four dNTPs and a heat stable (e.g. Taq) 
DNA polymerase is placed in a thermal cycler.
60 The temperature is raised to 95 °C 
to denature the DNA duplex then cooled to 55 °C allowing annealing of the primers 
to the ss.DNA. Extension (polymerisation) is performed at 72 °C resulting in two 
ds.DNA  sequences,  with  the  rate  of  chain  extension  being  greater  than  60 
nucleotides  per  second.
121  By  cycling  the  temperature  the  three  steps  may  be 
repeated until the desired concentration of the target sequence has been reached or 
dNTP  has  been  depleted.  As  the  concentration  of  the  target  sequence  increases 
exponentially over 1 million copies can be made by temperature cycling less than 20 
times (in approximately 1 hour). 
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Figure 9. A graphical summary of PCR; A. PCR is used to amplify a region of interest on the sample DNA, 
primers can be designed to be complementary to regions flanking this variable region. B. Primer annealing is 
followed by chain extension with incorporation of dNTPs, extension is catalysed by thermally stable DNA 
polymerases such as Taq Polymerase. C. Products of the first three thermal cycles, each arrow represents a 
denaturing, annealing, extension cycle. Compare the linear increase in the concentration of the unwanted 
long chain sequence with the exponential increase in the desired short chain product (as denoted by *) 
 
1.3.2 Fluorescence labelling 
Most  hybridisation  assays  use  a  fluorescence  increase  as  an  indicator  of 
complementary  target  capture.  Conjugates  between  amplified  target  DNA  and  a 
fluorophore may be prepared pre, midst or post PCR. 1. Introduction 
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Fluorescently labelled PCR primers can be used in the amplification process which 
would  result  in  product  sequence  with  a  label  at  (or  near)  the  5’  terminus.
  68,122 
Primers  thus  used  are  often  expensive  and  primer  annealing  can  be  adversely 
affected.  Enzymatic  methods  include  the  use  of  fluorescently  modified  dNTPs 
during  the  chain  extension  which  are  incorporated  into  the  sequence.
123,124  The 
efficiency of modified  dNTP incorporation is dependent upon recognition by the 
DNA polymerase, for this enzymes displaying high fidelity are not always the best to 
use. 
Modified primers and dNTPs which include specific chemical functionalities can be 
exploited  for  labelling  after  PCR  amplification,  for  example  click  chemistry  has 
received interest due to the high yielding and specific nature of the reaction between 
two groups not normally found in biomolecules.
125 Post amplification labelling by 
enzymatic means can also be used, one example of this being the exchange of the 3’ 
terminal nucleotide for a fluorescent nucleotide in a reaction catalyzed by a sub-
fragment of DNA polymerase (Klenow fragment).
126,127,128 
For some hybridisation arrays it is not necessary to pre-label target sequences as an 
optical  signal  can  be  generated  upon  hybridisation  to  the  immobilised 
complementary probe. One example of this is primer extension where the 5’ overlap 
of a hybridised target sequence is utilised as a template for the 3’ extension of the 
tethered probe sequence.
129,130 Using a reverse transcriptase and labelled nucleotides, 
a fluorophore is incorporated onto the probe DNA only if the probe is hybridised. A 
disadvantage to this strategy is the difficulty in discriminating duplexes containing a 
single base mismatch from the complementary pairing, especially if the mismatch is 
distanced  from  the  probe’s  3’  end.
131  One  method  to  overcome  this  is  to  use  a 
nucleotide  degrading  enzyme  (e.g.  apyrase)  to  compete  with  the  reverse 
transcriptase.  This  works  because  extension  on  a  complementary  duplex  is  fast 
compared  with  on  a  mismatching  duplex,  therefore  less  labelled  nucleotide  is 
incorporated into the mismatching duplex in the limited time available before all free 
nucleotide is enzymatically degraded. Mismatching signal is thus reduced compared 
with that expected from complementary hybridisation. 
Another technique for target detection requiring no prior modification of target is the 
use of intercalators which become more fluorescent upon incorporation into double 1. Introduction 
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stranded DNA (dsDNA). These can be tethered to the probe sequence to be kept in 
close proximity of any formed duplex.
132,133 Molecular beacons can also be used to 
detect non-labelled targets, these are oligonucleotide probes which are modified with 
both  a  fluorophore  and  a  quencher  are  opposing  ends,  when  not  hybridised  to  a 
specific  target  sequence  partial  self-complementarities  result  in  a  hairpin  looped 
structure  bringing  these  two  modifications  into  close  proximity  (Figure  10).
134 
However, hybridisation to the complementary target is favoured, upon forming the 
duplex with target the probe becomes linear and a signal is observed. Molecular 
beacons have been immobilised to solid supports for use in hybridisation arrays.
135 
 
Figure 10. Molecular beacons are oligonucleotide probes complementary to a region of interest on a target 
sequence.  The  terminal  bases  (at  both  3’  and  5’  ends)  are  self  complementary  and  are  modified  with 
fluorophore  and  quencher  pairs.  In  the  absence  of  cDNA  the  beacon  has  a  hairpin  loop  conformation 
resulting  in  fluorophore  quenching,  however  hybridisation  to  cDNA  is  energetically  favoured,  when  this 
occurs the fluorophore is distanced from quencher and becomes active. 
 
The choice of labelling method used in hybridisation suspension arrays is situation 
dependant, multiple parameters need to be taken into account and so there is not one 
universal  technique  which  works  best.  Often  the  materials  (supports)  used,  the 
specific target sequences and the assay scale rule out the use of certain methods, 
whilst issues of time, cost and expertise as ever need to be taken into account. 
 
1.3.3 DNA synthesis 
The contemporary method for oligonucleotide synthesis is on the solid phase using 
phosphoramidite nucleosides.
136,137,138 This is a step-wise synthesis, adding one base 
at  a  time  to  a  sequence  growing  from  (and  immobilised  at)  the  3’  end.  As  the 
reaction  to  incorporate  these  building  blocks  is  not  100%  efficient  the  length  of 1. Introduction 
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sequence is limited to about 200 bases, however in most hybridisation arrays probe 
lengths of only 10 – 30 bases are required so this is not a problem.
139,140 
The  oligonucleotide  synthetic  cycle  involves  three  steps,  repeated  for  the 
incorporation of each additional nucleotide and ends with a final step to release the 
complete sequence from the support (Scheme 1).  
Step 1: Coupling. Synthesis exploits the reactivity of the 5’ hydroxyl group of a 
support-bound nucleotide towards the P
III centre of phosphoramidite reagents (1), 
forming  a  phosphite  linkage.  All  hydroxyl  groups  other  than  those  on  the  resin-
bound terminal nucleotide are protected hindering side reactions and uncontrolled 
polymerisation. 
Step 2: Oxidation. The phosphite centre (2), being chemically unstable, is required to 
be oxidised to a more stable phosphate (P
V) (3). 
Step 3: Deprotection. The acid labile dimethoxytrityl (DMTr) protecting group (25) 
of  the  new  5’  hydroxyl,  which  prevents  multiple  nucleotide  couplings  in  each 
synthetic cycle, is removed. 
These three steps are cycled, adding an extra nucleotide to the growing chain each 
time. 
Step  4:  Deprotection  and  Cleavage.  Once  the  oligonucleotide  (4)  is  complete  all 
protecting  groups  on  the  phosphate  centre  and  the  bases  are  removed  and  the 
sequence (5) is released from the support under basic conditions. 
Significantly  for  array  development  the  costs  and  labour  required  to  synthesise 
oligonucleotides  is  kept  low  by  automation,  with  the  first  automated  DNA 
synthesisers being produced by Applied Biosystems, Inc in 1983.
137,138 
Due  to  the  wide  range  of  phosphoramidite  reagents  available  DNA,  RNA  and 
unnatural  polynucleic  acids  can  all  be  synthesised,  furthermore  chemical 
functionality  can  also  be  incorporated  at  any  point  in  the  sequence.  The  use  of 
unnatural polynucleic acids is of particular interest in the design of hybridisation 
arrays as they often impart beneficial characteristics. For example phosphorothioate 
linkages are formed by the replacement of the oxidation step with sulfurisation; these 1. Introduction 
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are structurally similar to the natural phosphodiester backbone (with P-OH replaced 
by P-SH) but are resistant to hydrolysis by nucleases.
141 
 
Scheme 1. Solid phase oligonucleotide synthesis. Sequences can be synthesised by the sequential coupling of 
phosphoramidite nucleotides (1), followed by oxidation of the resulting phosphite linkage (2) to phosphate 
(3) and an acid deprotection of the terminal hydroxyl group of the growing tethered oligonucleotide (4). Once 
the oligonucleotides are fully formed, a basic deprotection and cleavage step separates the sequence (5) 
from the controlled pore glass (CPG) support. By using a non-labile linkage between the first nucleotide and 
the solid support, cleavage would not occur in the final step, allowing the immobilised oligonucleotides to act 
as immobilised probes useful for the design of hybridisation arrays 
 
Polyamide nucleic acid (PNA) is another unnatural DNA probe which uses an amide 
(rather than phosphodiester) backbone and therefore can be produced using peptide 
synthesis techniques.
142 As with phosphorothioate backbones, PNA show resistance 
towards  degradation  by  DNA  nucleases.
143  Furthermore,  as  the  backbone  is 
uncharged electrostatic repulsion is reduced in the PNA/DNA duplex compared with 
a  DNA/DNA  duplex  of  identical  base  sequence  making  hybridisation  more 1. Introduction 
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thermodynamically  favoured  leading  to  an  increase  in  the  melting  temperature 
(Tm).
144 This removal of charge density has also been shown to increase the rate of 
duplex  formation  to  immobilised  PNA  probes  (compared  with  the  equivalent 
immobilised DNA probe) as the target is not electrostatically repulsed when in close 
proximity to the surface.
144 
 
1.3.4 Large probe libraries 
Solid phase synthesis can be adapted to produce large libraries of nucleic acid (and 
other  types  of  oligomeric)  probes  using  relatively  few  coupling  cycles.  Standard 
synthesis uses the glass support, CPG, packed into columns amenable to automated 
systems. In a technique known as split and mix synthesis differently functionalised 
supports are mixed together after each coupling cycle and then split between separate 
vessels for the coupling of the next nucleotide.
145,146 In the case of oligonucleotide 
synthesis four reaction vessels would be used (Figure 11), one for the coupling of 
each base. After the first coupling cycle (coupling one nucleotide to the CPG in each 
vessel) the supports are mixed then split evenly between the vessels. As a result, 
each  separate  pot  has  examples  of  all  four  different  nucleotide-functionalised 
supports and after a second round of (four) coupling reactions, 16 unique probe-
particle pairs will have been synthesised. Upon mixing, splitting and a third round of 
coupling, 64 different probes would have been produced. This linear synthesis leads 
to an exponential growth in the number of different oligonucleotide sequences, with 
4
n unique probes produced where n is the number of coupling cycles completed. 
In the case of DNA suspension arrays, split and mix probe synthesis can be used to 
make  many  different  probe-particle  pairs.  Tracking  particles  by  reading  their 
encoding allows the location (i.e. reaction vessel) of each individual particle during 
each coupling cycle to be monitored, the oligonucleotide sequence of the probes and 
their encoded particle tethers can therefore be recorded.
147,148 In this way, thousands 
of different oligonucleotide probes can be made very quickly, but crucially both the 
base sequences and their locations are known. 1. Introduction 
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Figure  11.  Split  and  mix  synthesis  can  be  used  to  synthesise  large  numbers  of  different  particle-bound 
oligonucleotide  or  peptide  probes,  with  each  particle  surface  consisting  of  multiple  copies  of  a  single 
sequence.  The  above  example  represents  oligonucleotide  synthesis.  The  number  of  probe-particle  pairs 
increases exponentially with repeated coupling cycles 
 
1.4 Probe immobilisation 
A  well  designed  multiplex  DNA  hybridisation  array  affording  real-time  sample 
analysis requires many short probe sequences to be immobilised in known locations, 
whether they be to a planar surface in a grid-like pattern or to the surface of particles 
which have been encoded. This immobilisation has to be sufficiently stable to limit 
probe movement throughout the timescale of the assay as any probe mixing would 
render the array unreadable.
149 The choice of immobilisation technique used to attach 
probes therefore predominantly depends upon the robustness of the linkage formed. 
Other considerations when developing new array technology include the spacing, 
density  and  orientation  of  oligonucleotide  sequences  in  order  to  maximise 
hybridisation, the minimisation of DNA and other biomolecule nonspecific binding 
and (with the aim of being a commercial success) ease of manufacture and cost.
105 
The  relative  merits  and  disadvantages  of  commonly  encountered  immobilisation 
methods are discussed below. 1. Introduction 
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1.4.1 Adsorption 
Adsorption  relies  on  electrostatic,  hydrogen  bonding  or  Van  der  Waals  forces 
between  two  functionalities.  Often  in  the  case  of  oligonucleotide  probe 
immobilisation a positively charged surface would be required to interact with the 
negatively  charged  phosphate  backbone  of  the  probes.  An  example  of  the 
immobilisation  of  DNA  to  surfaces  via  electrostatic  interactions  is  in  the  use  of 
cationic microparticles as a drug delivery system. In this system DNA is adsorbed 
onto the particle surface and is slowly released over time (75% unbinding over the 
course of 14 days).
150 Another example is in hybridisation sensors where DNA has 
been adsorbed to the sensor tip of a quartz crystal microbalance (QCM).
151 Note that 
neither of these examples risk contact between different oligonucleotide sequences. 
Attachment by adsorption has multiple disadvantages which preclude its widespread 
use  in  suspension  and  microarray  technology.  Firstly,  immobilisation  is  not 
permanent  and  once  probes  start  migrating  across  or  between  surfaces  the  array 
would sooner or later become useless.
150,152 Any working array would not allow for 
much variation of pH range, ionic strength, temperature or probe length as alteration 
of these parameters could disrupt absorption.
153,154 Secondly, as probes are held to 
the  surface  via  electrostatic  attraction  via  backbone  phosphate  groups,  the 
oligonucleotide is relatively flat on the surface.
155 This orientation is less than ideal 
for hybridisation as the probe would be less accessible to cDNA in the bulk sample, 
the formation of the rigid duplex would be less favoured (energetically) too as any 
change  in  probe  orientation  must  weaken  interaction  with  the  surface.
156  A  final 
drawback of using this type of probe immobilisation is that a positively  charged 
surface (by nature of the design) is indiscriminate of the negatively charged species 
it  attracts,  therefore  significant  nonspecific  binding  of  target  DNA  and  acidic 
proteins would be expected. In summary, adsorption is not an ideal method for probe 
attachment  with  ease  of  manufacture  being  its  only  major  advantage  over  other 
methods; as probe and surface simply require mixing followed by washing steps 
assays can be set up without special knowledge. Adsorption is often used in arrays 
where probes are physically separated so mixing cannot occur, a common example 
being  in  enzyme-linked  immunosorbant  assays  (ELISAs)  performed  in  a  96-well 
plate format.
157 1. Introduction 
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1.4.2 Affinity capture 
The specific non-covalent interactions between proteins and their relevant ligands 
can be utilised for the immobilisation of biomolecular probes to surfaces. Generally 
surfaces are functionalised with a binding protein whilst the probes are modified 
with  the  corresponding  binding  ligand,  following  mixing  of  the  two  species,  the 
probe  becomes  immobilised  on  the  surface  via  a  relatively  strong  protein-ligand 
interaction.
158  The  suitability  of  a  protein-ligand  pair  for  use  in  affinity  capture 
mostly  depends  on  the  binding  equilibrium  dissociation  constant  (Kd)  and  rate 
constants (kon, koff) which give measures of the strength and speed of binding, the 
stability of the protein and the orientation upon immobilisation (where the binding 
site must be accessible to the ligand). Examples of affinity binding systems include 
using Penta-His antibody or Ni
2+ nitrilotriacetic acid (Ni-NTA) to bind His-tagged 
probes,
159,160  protein  A  to  bind  antibodies
161  and  avidin  or  streptavidin  to  bind 
biotin.
162,163 
The (strept)avidin biotin system is often used in the design of biological assays due 
to  having  the  strongest  ligand  binding  known,  other  attributes  contributing  to  its 
widespread  use  include  being  highly  stable  withstanding  a  wide  pH  range, 
denaturants and high temperatures (up to 100 °C when ligand is bound).
 164,165,166 As 
both proteins are tetrameric in structure, each binds four biotin ligands, this is useful 
as upon immobilisation on a surface binding sites may be sterically hindered but 
having multiple binding sites increases the chances of some sites being accessible. 
The orientation of immobilised proteins can sometimes be manipulated to optimise 
ligand accessibility, for instance by attaching through a specific amino acid residue 
on  the  opposing  face  to  the  binding  site.  ELISAs  often  make  use  of  the 
(strept)avidin-biotin system both for the immobilisation of probes and as a signalling 
molecule.
167,168 A good example of the system being used in a biosensor is in the 
immobilisation  of  DNA  probes  to  avidin-functionalised  quartz  crystal 
microbalances, used to study DNA hybridisation.
169 
Affinity immobilisation is used in commercial assay protocols as it can be very user 
friendly and flexible; surfaces can be pre-functionalised with the capture protein and 
different probe sets can be purchased linked to binding ligands. All the modifications 
requiring  operator-training  and  hazardous  chemicals  are  therefore  handled  by  the 1. Introduction 
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manufacturer, leaving the end user with the simple task of mixing ligand-probes with 
the functionalised surfaces in an aqueous buffer.
114 
Despite its incorporation in commercial bioassays, this type of probe immobilisation 
is  far  from  ideal  for  use  in  biological  sensing.  This  is  partly  due  to  frequently 
observed increases in non-specific binding, resulting in high background readings, 
false positives and a shortening of the array’s life-expectancy. Non-specific binding 
occurs because of the charged nature of the capture-protein, avidin for example has a 
pI  of  10  and  a  net  positive  charge  under  physiological  conditions,  thus  avidin-
functionalised surfaces have a tendency to attract negatively charged molecules. This 
unwanted attribute can be reduced by using engineered proteins, like NeutrAvidin 
and avidin-DN in which parts of the structure not essential for correct protein folding 
and  functionality  are  modified  to  alter  the  overall  charge  and  hydrophilicity.
170 
Another  limitation to affinity capture is the non-permanent nature of the linkage 
formed, most assays utilising affinity immobilisation will remain intact and usable 
for  a  few  weeks,  the  reported  half-life  of  the  avidin-biotin  complex  is 200  days 
making it potentially usable for long term assay setups, but this is an exceptionally 
strong capture system. 
 
1.4.3 Covalent bonding 
For many array designs a more stable probe immobilisation is required, whether for 
long-term storage, long-term data collection or to increase sensitivity and fidelity.
154 
Immobilisation  via  a  covalent  bond  is  desirable,  forming  a  permanent  linkage 
between  biosensor  surface  and  probe  moiety.
171  Chemical  modification  of  the 
surface  also  allows  a  finer  control  of  some  surface  properties;  this  can  be 
advantageous  as  important  design  considerations  including  probe  spacing,  probe 
loading levels, charge, hydrophilicity and non-specific binding may be manipulated. 
Due  to  the  scope  of  chemical  modification  available  probes  can  be  covalently 
immobilised on most materials desirable for use in biosensing, including glass, metal 
and polymeric surfaces.
172,173,174,175 A summary of some of the more widely used 
covalent linkages is given below (Table 1). 
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Table 1. Some common covalent chemistries for the conjugation of modified (oligonucleotide) probes to 
functionalised surfaces 
Linkage  Example reagents  Resultant crosslinking  Notes 
thioether 
   
Reagents unstable.
176 
 succinimidyl 
thioether 
   
Useful for site-specific 
coupling,
177,178 linkage 
susceptible to 
hydrolysis.
179,180 
ester 
   
Susceptible to 
hydrolysis.
181 
phosphate 
 
 
Used in 
oligonucleotide 
synthesis.
136,137,138 
thiourea 
 
 
Linkage unstable.
182 
imine 
 
 
Often reduced to 
amine, linkage not 
inert.
174,175 
sulfonamide 
   
Sulfonyl chloride 
reagent unstable,
183 
linkage formed very 
stable.
184 
amide 
   
Stable linkage, used in 
peptide synthesis.
174,175 
1,2,3-triazole 
   
Stable linkage, few 
side reactions.
185,186 
 
 
Covalent coupling can be used to maximise specific binding to immobilised probes 
by controlling probe distribution and orientation, the former by the use of blocking 
reagents to space out reactive groups on a surface to the desired loading density and 
the latter by selection of the correct coupling chemistry to react with the desired 
chemical group on the probe. Intelligent selection of spacer and blocking groups can 
also impart beneficial properties to an array (in addition to their use in optimising 
probe loading density). An example of this would be the use of polyethylene glycol 
(PEG) groups to increase the hydrophilicity of hydrophobic surfaces, as it has been 1. Introduction 
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shown  that  non-specific  binding  of  organic  (and  biologically  derived)  matter 
decreases with increased hydrophilicity.
187,188 PEG groups can be immobilised with a 
range of terminal functionalities making them ideal for use as linkers baring reactive 
groups. 
Covalent immobilisation of probe molecules is more involved than either adsorption 
or affinity capture as it can require the use of hazardous chemicals, fume-hoods and 
experienced technicians. Due to the permanent nature of covalent immobilisation it 
is ideal for preparing arrays well in advance of use, with suitable storage times in the 
range of months to years.
189,190 Covalent probe coupling is therefore routinely used 
in most commercial array formats where multiplexing kits are sold with probes pre-
arrayed. 
 
1.4.4 On-particle probe synthesis  
The immobilisation methods summarised so far have been examples of ‘top-down’ 
approaches where probes have been attached as a fully formed unit. An alternative to 
this is the ‘bottom-up’ synthesis of probes directly on the surface. Oligonucleotide 
and peptide synthesis is well established and is usually performed on the solid-phase 
with the final step in any synthesis being deprotection and cleavage from the support 
resin (Scheme 1), thus it is often possible to grow probes on a surface by modifying 
the established synthesis protocols and omitting the final resin cleavage step.
138,191 
Synthesis cycles generally require anhydrous conditions and the expertise of trained 
technicians but often they are automated to greatly reduce overall reaction times. 
Aptamer synthesis can be adapted to very quickly form an array of particle-bound 
probes  with  an  extremely  high  (multiplexing)  capacity  by  using  split  and  mix 
chemistry (Figure 11).
145,146 With the development of particle encoding and reading 
technologies it is conceivable that split and mix synthesis could be tracked for each 
individual particle, the location of all resulting probes would then be identifiable, 
however to date no examples of this have been published. 
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1.5 An overview of the 4G project 
The 4G project was so named as its main aim was to develop technology capable of 
sequencing  the  entire  human  genome  within  a  day;  at  the  time  of  the  project’s 
conception the human genome was overestimated to be 4 billion, or 4G bases long 
(the “3.2G” project, though more accurate, did not warrant a name change). 
This  ambitious  aim  was  to  be  accomplished  by  developing  novel  microparticle 
encoding technologies and by realising the potentials of combinatorial chemistry for 
the tracked split and mix synthesis of large libraries of short oligonucleotide probes. 
Assay  reading  was  to  make  use  of  a  custom  microfluidic  fluorescence 
detector/particle  decoder/particle  sorter  setup,  reading  “on  the  fly”.  Although  the 
original goal was ultimately to prove unachievable, advances were made, particularly 
within  the  fields  of  bioinformatics,  microparticle  encoding  and  microparticle 
functionalisation. 
Funding  came  in  the  form  of  a  five  year  research  grant  from  the  EPSRC  Basic 
Technology  Program.  This  multidisciplinary  project  was  initially  a  collaboration 
between two mostly autonomous groups based at the University of Southampton (M. 
Bradley) and the University of Cambridge (T. Bland), later the Southampton group 
split with the original principal investigator moving to the University of Edinburgh 
(to  be  replaced  in  Southampton  by  H.  Morgan).  The  Cambridge  group  had  a 
particular  focus on magnetic encoding technologies, whilst work at Southampton 
explored  optical  and  holographic  encoding,  assay  development  and  analysis.  The 
following  chapter  summarises  advances  made  by  others  in  the  4G  project  at  the 
University of Southampton to which the results in this thesis are complementary. 
 
1.5.1 Bioinformatics 
The modelling of short duplex hybridisation and melting within the bioinformatics 
group has lead to improved predictive models of probe and target interactions.
192 
These  in  turn  can  be  used  to  design  oligonucleotide  probe-sets  where  all 
complementary probes exhibit a similar duplex Tm, this allows the conditions under 1. Introduction 
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which multiplex assays are performed to be optimised to best distinguish between 
fully complementary sequences and those mismatch.
193 
 
Figure 12. The amount of an organism’s genome which can be ascertained by short read (hybridisation) 
sequencing using oligonucleotide probes of differing lengths (read lengths), A. λ-phage, B. E. coli, C. human. 
Incomplete sequencing is the result of repeated sequences of genome which cannot be detected using short 
probes. Dotted lines simulate the sequencing of a random genome of comparable length to the organisms’ 
selected
87 
 
Fundamental to the original project goal was the determination of the probe length 
required for an  accurate sequencing of the human genome.
87 By creating models 
incorporating total sequence length, sequence repeats and the length of probe used 
(read length), the total amount of an organisms genome that could be sequenced was 
determined. For organisms coded by very short genomes, for example the viral λ-
phage (GenBank accession no. NC_001416 size: 48 kb) almost complete sequencing 
could be achieved by analyzing the hybridization of probes just 13 bases long (13-
mer)  (Figure  12).  However  for  larger  genomes,  subsequence  repeats  result  in  a 
requirement for longer probes, for example sequencing 97% of the Escherichia coli 
(GenBank accession no. NC_000913 size: 4.6 Mb) genome needs probes 18 bases 
long. A further complication in the genomes from more complex organisms (like E. 
coli) are the presence of larger repeat sequences, including genes or intergenic repeat 
units  and  to  distinguish  between  these  very  long  oligonucleotide  probes  are 
required.
194 Therefore it was concluded that it is only practical to obtain a partial 
genome  of  organisms  more  complex  than  viruses  by  short  probe  hybridisation 
assays.  These  problems  are  greatly  multiplied  for  the  human  genome  where  the 
reading of 97% of the sequence would require probes 80 bases long (4
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probes!). The poor sensitivity of a hybridisation array using probes this long means it 
could  not  be  used  to  differentiate  between  complementary  sequences  and  those 
incorporating a single base mismatch, a level of accuracy which requires probes to 
be less than 30 nucleotides in length.
88 
Therefore the original project aim to sequence an entire human genome in a day 
using a hybridisation array was determined to be practically impossible due to the 
incompatibility of the technology to the task. However it had been shown that the 
assay principal could be used for the sequencing of very small (viral) genomes which 
would be of use, for example, for monitoring and identifying cold and flu viruses 
subtypes.
115  The  array  could  also  be  used  for  the  detection  of  specific  known 
sequences,  for  example,  for  forensic  uses  and  testing  for  pre-mapped  genetic 
diseases. 
 
1.5.2 Microfabrication of polymer particles 
Microparticles were fabricated by crosslinking monomeric SU-8 (6), an epoxy-based 
negative photo resist which can be used to fabricate structures with a high aspect 
ratio (Figure 13). SU-8 was considered ideal due to its already widespread use for 
fabrication  of  well  defined,  high  aspect  ratio  microstructures,  necessary  for  the 
particles’  coding  features.
195  The  particles  were  fabricated  on  silicon  wafers  in 
batches of 160,000 using the general methodology described (Figure 13).
196 For the 
purposes  of  encoding  it  was  important  to  control  polymerisation  by  selectively 
blocking UV transmission as only areas of the monomer exposed to light crosslink, 
the  shape  of  particles  can  therefore  be  controlled  by  placing  a  mask  between 
monomer  and  light  source  (photolithography).  An  additional  advantage  to  SU-8 
which our research exploited is the residual surface epoxide which remains from 
incomplete cross-linking. This could be used in subsequent steps as a handle for 
functionalisation. 
It should be noted that throughout the project the particles suffered from a lack of 
consistency after fabrication. Particles exhibited a range of surface epoxide loading 
densities,  changing  solvent  swelling  properties  and  a  varying  of  the  structural 1. Introduction 
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definition  regarding  encoding  features.  A  number  of  factors  contributed  to  this 
variation  including  the  method  of  production  (batch  processing,  months  between 
each batch, fresh and not so fresh reagents), a number of different researchers tasked 
with fabrication and changes to the fabrication facilities used (particles were firstly 
made on-site in the Mountbatten Building which was destroyed by fire, production 
was then shifted to the École Polytechnique Fédérale de Lausanne (EPFL), Lausanne 
before  returning  to  temporary  cleanrooms  constructed  at  Southampton).  On  the 
whole, these causes were unavoidable, but the problem of inconsistency affected all 
areas of the project. 
 
Figure 13. Structure of monomeric SU-8 (6) from which microparticles are fabricated. Particle fabrication uses 
silicon  as  a  substrate,  A,  onto  which  a  sacrificial  layer  of  aluminium  is  deposited,  B.  A  solution  of  SU-8 
monomer, photoacid initiator and solvent is spin coated to a thickness of 5 µm and heated to drive off 
solvent (soft bake), C. After cooling, the monomeric mixture is selectively exposed to UV radiation through a 
mask and heated in a post exposure bake (PEB), D, where areas exposed cross-link. Uncrosslinked SU-8 is 
then removed in a developer solution leaving particles mounted on the Al/Si substrate, E. When required, 
particles are released from the substrate  using a solution of 2% ammonium hydroxide to etch the aluminium 
sacrificial layer
196 
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1.5.3 Encoding technologies 
Developing novel encoding technology was a principle aim of the project with the 
team  based  in  Southampton  focussing  on  diffractive  encoding  methods.
111  By 
fabricating the particles to be tiny, one dimensional diffraction gratings the angle of 
any  intersecting  parallel  light  gets  bent,  the  magnitude  of  this  diffraction  is 
controlled by the distance between individual features on the particle which are a 
product  of  the  photolithographic  fabrication  process  (Figure  14).
197  Different 
particles  are  distinguished  by  the  degree  to  which  incident  light  is  diffracted, 
accomplished by intersecting the particle with a laser beam. 
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Figure 14. A. Principles of simple, 1 dimensional diffraction gratings (encoded microparticles) showing how 
the angle of diffraction decreases as the size of grating features increases. B. SEM images of 4 different SU-8 
microparticle diffraction gratings and their corresponding diffraction patterns as projected onto a screen. The 
code is determined by measuring the distance between 1
st order diffraction lines as indicated by the yellow 
arrows. The scale bar refers to the SEM particle images
197 
 
Figure 15. A. In order to increase the system’s encoding capacity (the number of unique diffraction gratings), 
two or more gratings may be superimposed, B. the diffraction resulting from parallel light intersecting these 
two superimposed gratings exhibits two angles of 1
st order diffraction. C. Superimposed diffraction gratings 
produced  by  nanoimprinting  into  SU-8  blocks,  this  technique  results  in  better  feature  definition  than 
photolithography.  D.  Diffraction  patterns  from  five  different  superimposed  diffraction  gratings.  E.  The 
encoding capacity as a function of grating length and degree of superimposition, more than 1 million unique 
codes can be fabricated using five times superimposed, 30 μm gratings
198 
 
 1. Introduction 
50 
 
It was observed that encoding capacity could be increased by overlaying multiple 
diffraction gratings to form individual superimposed gratings, this resulted in a more 
complex diffraction pattern and would allow millions of unique microparticles to be 
produced (Figure 15).
198 An extremely high encoding capacity procedure was also 
developed  using  holographic  encoding  to  produce  two  dimensional  diffraction 
gratings (Figure 16).
199 
 
Figure 16. A. Theoretical diffraction pattern produced from a two dimensional diffraction grating, the output 
being binary. Highlighted along the top and down  one side are alignment features. B. A real diffraction 
pattern as projected onto a screen from a 2D SU-8 diffraction grating. The encoding capacity of this particular 
example is 2
64 unique codes
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1.5.4 Biological assays 
With the realisation that human genome sequencing using short read oligonucleotide 
hybridisation  was  practically  impossible,  assay  development  was  shifted  towards 
more  realistic  targets.
87,88  The  detection  of  short  lengths  of  specific  genomic 
sequence  for  disease  diagnostics  and  genotyping  was  one  target,  this  required 
particle  functionalisation  with  oligonucleotide  probes  and  a  similar  hybridisation 
assay  format  proposed  for  sequencing.  Another  target  application  was  for  use  in 
multiplexed immunoassays, for the detection of human antibodies and cytokines as 
signallers of disease.
200,201 The development of these two array formats proceeded in 
parallel, with development of oligonucleotide arrays being the main focus of the 
work described herein. 
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1.5.5 Analysis technologies 
To  monitor  and  quantify  bioassay  results  a  range  of  analysis  technologies  were 
required. From the outset particles were analysed using a fluorescence activated cell 
sorter  (FACS)  and  by  fluorescence  microscopy.
202,203,204  The  FACS  worked  by 
forming  solution  micro-droplets  from  a  “cell”  (or  in  our  case  a  microparticle) 
suspension,  the  droplet  fluorescence  would  then  be  measured  at  a  number  of 
wavelengths.  Most  droplets  are  empty  and  give  no  signal,  however  droplets 
containing a single particle result in a change in fluorescence. The FACS was able to 
measure the fluorescence of large sample sizes very quickly (~500 particles min
-1) 
and  at  multiple  wavelengths  in  parallel.  Limitations  to  FACS  use  included  large 
standards deviations in the data output meaning the measurement of small sample 
sizes was prone to large errors and the inability to distinguish between differently 
encoded particles. The FACS was therefore generally used for assay development 
and optimisation where multiplexing capabilities were not required.  
Fluorescence  imaging  of  particles  using  microscopy  could  only  be  achieved  at  a 
much  lower  throughput  but  yielded  detailed  information  as  to  the  uniformity  of 
surface functionalisation, lower standard deviations for intensity measurements and 
enabled differently encoded particles to be distinguished. 
 
Figure 17. A schematic of the integrated particle fluorescence/code reading device which allowed almost 
concurrent measurements of fluorescence intensity (reflectance mode) and diffraction pattern (transmission 
mode) for individual encoded microparticles 1. Introduction 
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As  the  project  advanced  a  dedicated  integrated  particle  fluorescence  and  code 
reading device was constructed (Figure 17). Particles arrayed on a microscope slide 
could be aligned with an excitation source (mercury lamp) and the reflected light 
(fluorescence)  imaged.  Then  by  changing  the  light  source  to  a  green  laser  the 
diffraction  pattern  of  transmitted  light  imaged.  The  fluorescent  signal  and  the 
encoding could thus be ascertained for individual particles, useful for the analysis of 
multiplexed bioassays.                                                                            53 
                                                                    
2.0 Hybridisation suspension arrays utilising affinity immobilisation of 
oligonucleotide probes 
 
When developing encoded microparticle-based multiplexed suspension arrays one 
key consideration is the type of linkage used to attach probe to particle, this must be 
stable, easy to construct and have little influence on the probe binding kinetics. For 
this project, an affinity-based probe immobilisation method was developed utilising 
the exceptionally strong binding between the hen egg white protein avidin and its 
ligand vitamin H, also called biotin.
205,206 From reported dissociation data the avidin-
biotin complex has a half-life (t½) of over 200 days, which would allow different 
probe particle sets to be stored together for months without significant loss of probe 
from the surface.
162 
We chose a tetrameric form of avidin (designated avidin DN) which is isolated by 
affinity chromatography from hen egg white, it is claimed that this form of avidin 
exhibited  very  low  nonspecific  binding  to  nucleic  acids.
207  We  investigated  both 
affinity and covalent protein immobilisation methods and thoroughly characterised 
the strength of ligand binding to these functionalised particles. Avidin DN particles 
were  also  used  for  the  singleplexed  and  multiplexed  identification  of 
oligonucleotides using encoded microparticles. 
 
2.1 The protein functionalisation of SU-8 particles 
SU-8  microparticles  were  functionalised  with  avidin  DN  using  three  different 
methodologies. Two methods resulted in the covalent immobilisation of protein to 
carboxyl  functionalised  particle  by  use  of  carbodiimide  coupling  reagents;  either 
with  coupling  reagents  in  situ  (Type  I)  (10)  or  by  the  pre-activation  of  the  acid 
moiety using N-Hydroxysuccinimide (NHS) (Type II) (11) (Scheme 2). The third 
method  first  involved  the  functionalisation  of  the  particle  surface  with  biotin 
followed by immobilisation of avidin DN by affinity capture (Type III) (13). These 
immobilisations  of  avidin  followed  a  divergent  synthetic  route  where  the  native 
epoxide surface of the SU-8 particles (7) first underwent a nucleophilic ring opening 
with the bis-amine Jeffamine
® ED-900
® (14) yielding amine functionalised supports 2. Affinity probe immobilisation 
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(8) (amine was quantified by reaction with ninhydrin, surface loading density was 
found to be 5.3 ± 0.9 × 10
-9 mol cm
-2). Next, depending upon the desired protein 
immobilisation  strategy  the  amino  surface  was  acylated  using  either  succinic 
anhydride or biotin, resulting in carboxy (9) and biotin (12) functionalised surfaces 
respectively. Avidin DN was covalently coupled to the succinated particles using the 
coupling  reagent  N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide  hydrochloride 
(EDC) to activate the immobilised carboxylic acid moieties to nucleophilic attack by 
protein lysine residues. This coupling was performed both in a single step with EDC 
in situ (SU-8 Avidin DN Type I (10)) and in two steps where the acid was first 
reacted with EDC and NHS to form the activated but stable NHS ester, thus allowing 
for excess coupling reagents to be washed from the particles before the subsequent 
addition of protein  (SU-8 avidin DN Type II (11)). Avidin DN was immobilised by 
affinity capture to biotin modified particles simply by the incubation of the particles 
with the protein (SU-8 avidin DN Type III (13)). 
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Scheme 2. Three different routes to avidin-functionalised particles starting from amine functionalised particles (8). a) succinic anhydride, DMAP, DIPEA, DMF, b) avidin DN, EDC.HCl, 
imidazole buffer pH 7.0, c) i) EDC.HCl, sulfo-NHS, MES buffer pH 5.0, followed by avidin DN, PBS pH 7.4 d) biotin, DIC, DIPEA, DMF, DMSO, e) avidin DN, SSPE buffer pH 7.0 2. Affinity probe immobilisation 
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Immobilised  protein  was  quantified  using  the  bicinchoninic  acid  (BCA)  assay  (a 
colourimetric assay determining the reduction of Cu
II to Cu
I ions in the presence of  
peptide  bonds)  where  all  three  immobilisation  routes  resulted  in  higher  loading 
densities of avidin than predicted (i.e. formed surface multilayers).
208,209 The crystal 
structure of the avidin tetramer indicates dimensions of 5.6 × 5 × 4 nm.
210 Assuming 
avidin is close packed on the surface, each protein tetramer covers a minimum area 
of 2 × 10
-13 cm
2 (5 × 4 nm). The BCA assays performed on the avidin immobilised 
particles found an average protein tetramer loading density of 3.5 × 10
-11 mol cm
-2, 
which equated to a monolayer of  close packed avidin tetramers measuring 4.2 cm
2, 
therefore the particles had approximately four times more protein than would be 
expected if a monolayer were forming. After prolonged suspension (48 h) of the 
particles  in  wash  buffer  (SSPE  (5×),  0.02%  Tween-20
®)  buffer,  with  occasional 
replacement of buffer, BCA assay protein quantification was repeated and loadings 
were found to have decreased for all three particle types, with protein quantities now 
equivalent  to  monolayers  (Table  2).  Extended  suspension  in  buffer  (4  weeks) 
resulted in no further reduction in protein loading suggesting the linkage of avidin 
DN  to  SU-8  particles  was  strong.  Subsequent  immobilisations  of  protein  to 
microparticles were followed by a thorough wash step to remove all nonspecifically 
bound protein. 
The stability of protein immobilisation was further investigated by the attachment of 
a fluorescently labelled avidin DN by all three methodologies. Extended washing of 
the particles over the course of 4 weeks resulted in no loss of fluorescence intensity. 
Furthermore, the agitation of these labelled protein particles with both native epoxy 
SU-8  particles  and  (unlabelled)  avidin  DN  particles  showed  no  changes  to  the 
fluorescence signal of any particle type. These results reinforced the belief that the 
linkage between particle and protein was stable for all three immobilisation types 
and furthermore, the surface-bound avidin tetramer was stable with no breakdown 
into monomer subunits being observed. 
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Table 2. A summary of Avidin DN functionalised SU-8 particles with protein immobilised by three routes, 
showing protein loading densities and the maximum binding density (bmax) of the biotinylated and 
fluorescently labelled oligonucleotide FP1 
 
Though final protein loading was found to equate roughly to a monolayer by all three 
immobilisation strategies, Type I particles (with coupling reagent in situ) were found 
to have the highest avidin loading density. This may indicate a limited degree of 
protein to protein intermolecular coupling with cross linking occurring between the 
lysine  residues  found  on  the  surface  of  one  tetramer  and  aspartate  or  glutamate 
residues on a different tetramer. 
  
2.2 Proof of principle DNA hybridisation assays 
Type I avidin DN SU-8 particles (10) were used to test the principles of the DNA 
hybridisation  assay.  Two  biotinylated  oligonucleotide  probes,  PA  and  PB,  were 
incubated separately with samples of Type I particles, after 20 minutes the particles 
were washed to remove any excess probe which had not immobilised specifically. 
The  two  samples  of  probe  particles  were  each  split  3  ways  allowing  for 
hybridisations at 55 °C to three labelled target sequences, TA, TB & T2 (Scheme 3), 
samples of particles were washed and then analysed by flow cytometry (FACS) and 
fluorescence  microscopy.  The  three  targets  represented  complementary,  partially 
mismatching  and  completely  mismatching  sequences,  the  intensity  of  particle 
fluoresce acted as a measure of hybridisation. 
Avidin 
immobilisation 
method 
Avidin 
tetramer 
loading  
(mol cm
-2)  
(×10
-12) 
Avidin layers  FP1 bmax (mol cm
-2) (×10
-12) 
(SSPE (5×) buffer pH 7.0, 
0.02% tween-20
®) 
Avidin sites 
showing 
biotin 
affinity (%) 
specific  non-specific   
           
I (EDC in situ) 
(10) 
 
11.58 ± 4.36  1.39 ± 0.53  0.61 ± 0.02  0.95 ± 0.05  1.33 ± 0.33 
II (NHS ester) 
(11) 
 
6.69 ± 1.02  0.81 ± 0.12  1.73 ± 0.06  1.29 ± 0.06  6.48 ± 0.68 
III (affinity 
capture) (12) 
 
8.26 ± 2.25  0.99 ± 0.28  0.75 ± 0.02  0.36 ± 0.07  2.28 ± 0.43 2. Affinity probe immobilisation 
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Both complementary targets were found to have hybridised to the relevant probe 
particles as indicated by the high fluorescence signal  of 7300 a.u. (FACS, gain = 
500 V), whereas particles exposed to the completely mismatching sequence showed 
no fluorescence increase compared with blank SU-8 particles, 1000 a.u.. Though 
these  results  were  expected,  they  validated  the  principles  of  the  particle-based 
hybridisation  assay,  showing  the  successful  hybridisation  of  complementary 
sequences  and  the  discrimination  from  completely  mismatching  sequences.  This 
result also showed that the target DNA exhibits very little nonspecific interaction 
with the immobilised probe particles. 
Interestingly,  the  two  partially  mismatching  sequence  pairs  differed  in  behaviour 
with a duplex forming between PA and TB, 6500 a.u. whilst no hybridisation was 
detected for the oligonucleotides PB and TA, 1000 a.u.. The high thermal stability of 
the partially mismatching PA/TB duplex can be explained by the relatively strong 
non  Watson-Crick  base  pairs  formed;  studies  on  the  hybridisation  between  short 
DNA sequences containing single base mismatches have consistently found G·T and 
G·A mismatches to be the most stable, and three of these such interactions are likely 
in any PA/TB duplex formed.
211,212,213 Concerning the lack of hybridisation between 
the partially mismatched PB and TA sequences at 55 °C, the same studies also found 
A·C to be one of the most destabilising mismatches, with T·A and T·T interactions 
only displaying mediocre  stability. So the PA/TB duplex would be expected to have 
a greater thermal stability compared with the PB/TA duplex. It should be noted that 
the stabilities of non Watson-Crick base pairs are dependent upon multiple factors 
including  the  flanking  bases  (nearest  neighbour)  in  the  sequence,  the  order  of 
mismatch stabilities is therefore variable and dependent on the specific environment 
within each duplex.
214 These particles were also visualised using microscopy, white 
light  and  fluorescence  images  of  the  complementary  and  partially  mismatching 
immobilised-probe particles after mixing with the labelled target, TA, are shown 
(Figure 18).  2. Affinity probe immobilisation 
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Scheme 3. A diagram of the DNA hybridisation array proof of principle showing the hybridisation of different 
fluorescently labelled target oligonucleotides to immobilised-oligonucleotide probe SU-8 particles 
 
 
 2. Affinity probe immobilisation 
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Figure  18.  White  light  (top)  and  fluorescence  microscopy  images  of  labelled  oligonucleotide  target,  TA, 
exposure to a) complementary immobilised-probe, PA, particles and b) 4 base mismatching immobilised-
probe, PB, particles 
 
2.3 Probing the nature of the biotinylated-probe/avidin-particle interaction 
The  binding  of  biotinylated  probes  to  avidin  functionalised  particles  was  studied 
using the biotinylated and fluorescently labelled oligonucleotide, FP1. This 16 base 
long (16-mer) probe was labelled with cyanine-5 (Cy-5 (14)) fluorophore at the 5’ 
end and biotin at the 3’, FP1 was used as a standard throughout the studies detailed 
in  this  chapter.  Fluorescence  intensity  on  the  particles  was  measured  using  flow 
cytometry and by fluorescence microscopy. The intensity of particle fluorescence is 
proportional to the concentration of FP1 bound; using this observation the loading 
density of affinity captured FP1 could be measured. It should be noted that at higher 
concentrations in aqueous solution cyanine dyes have been shown to dimerise which 
leads to fluorescence quenching, therefore a very high density surface layer might 
also self-quench.
215 2. Affinity probe immobilisation 
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FP1 was captured on avidin coated particles by agitation in SSPE (5×) buffer with 
0.02 % Tween
®-20 ([FP1] ≤ 100 nM) followed by thorough washing in buffer. The 
observed increase in particle fluorescence (microscopy) indicated FP1 had bound to 
all three particle types. Type II avidin particles were found to have approximately 
twice  the  probe  loading  compared  with  the  other  two  particle  types,  which  both 
exhibited similar loading levels. 
Titrating  FP1  against  Type  I  avidin  particles  (10)  enabled  the  conversion  of 
measured fluorescence intensity to a calculated immobilised probe density and gave 
information  on  both  the  proportion  of  bound  to  free  probes  at  any  given  probe 
concentration (Kd) and the maximum probe binding (bmax) (Figure 19). 
 
Figure 19.The titration of the labelled biotinylated oligonucleotide FP1 against Type I avidin SU-8 particles (1 
mg mL
-1, 5.64 cm
2 mL
-1), inset: log plot 
 
The FP1 loading density upon saturation (bmax) was extrapolated as 1.03 ± 0.02 ×10
-
12 mol cm
-2. The Kd was found to be 1.2 ± 0.1 ×10
-9 M, a figure much greater than the 
reported value of binding between unmodified (wild-type) avidin and biotin (0.57 
×10
-15 M).
162 A number of theories were proposed to explain the binding being more 
than 6 orders of magnitude weaker than the wild-type system. Firstly the avidin DN 
and  biotin  are  extensively  modified;  the  protein  being  covalently  tethered  to  a 
support and the ligand (244 Da) being conjugated with a labelled oligonucleotide (~3 
kDa).  Secondly,  avidin  DN  is  one  specific,  affinity-isolated  form  of  the  protein; 2. Affinity probe immobilisation 
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reported  avidin  studies  have  mostly  worked  with  wild-type  avidin  containing  a 
mixture of all forms of the protein, not all forms may display identical affinity for 
biotin.
216 Thirdly, immobilisation to solid supports often leads to a reduction in the 
rate of any reactions/binding events due to poor bulk mixing at the surface and this 
may affect the position of the binding equilibrium.
217 Finally, the value obtained for 
the equilibrium dissociation constant may represent the mean binding of a rather 
complex system, that is to say there may be more than one type of binding event, 
with each type displaying different affinities. In an attempt to better understand the 
binding between FP1 and the SU-8 immobilised avidin DN, and to determine the 
suitability of affinity probe-capture for use in multiplexed DNA assays, a number of 
fundamental  kinetic  and  thermodynamic  studies  of  biotinylated  oligonucleotide 
probe binding to avidin DN were required. Initially the extent of nonspecific FP1 
binding to immobilised avidin particles was determined. 
 
2.3.1 The nonspecific binding of biotinylated oligonucleotides 
When avidin particles already saturated with FP1 were exposed to a concentrated 
biotin solution (1.25 mM), a drop in particle fluorescence over time was observed as 
the biotinylated FP1 dissociated from the immobilised avidin tetramer to be replaced 
by the excess of unlabelled biotin (Figure 20). However, rather unexpectedly this 
displacement appeared biphasic in nature with both a fast and a slow probe release. 
There are literature examples of biphasic avidin-biotin dissociation, however these 
involve the fast release of the fourth biotin from a saturated avidin tetramer followed 
by the slower release of the other three bound ligands.
218,219 This model did not fit 
our  system  where  it  was  improbable  that  all  four  binding  sites  on  the  surface-
immobilised protein would be accessible to biotinylated species. 2. Affinity probe immobilisation 
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Figure  20.  a)  FP1  dissociation  from  avidin  DN  SU-8  particles  in  an  excess  of  unlabelled  biotin  exhibiting 
biphasic dissociation, b) – d) integrated log plots for the three different protein immobilisation methods are 
displayed. Particle images are included to illustrate the conjectured degree and type of biotin binding at 
three points in the dissociation timecourse  
 
An  alternative  explanation  for  the  fast  initial  phase  of  probe  dissociation  was 
considered  which  was  dependant  on  the  electrostatic  interaction  between 
oligonucleotide  probes  and  avidin.  At  neutral  pH  the  phosphate  backbone  of  the 
probe is largely deprotonated and thus negatively charged whilst avidin, with an 
isoelectric point (IP) of 10, has a net positive charge.
162 For our studies, avidin DN 
had been selected due to the reported low nonspecific DNA binding, however this 
would prove not to be the case as further investigation would determine significant 
levels of nonspecific FP1 binding.
216 2. Affinity probe immobilisation 
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This nonspecific binding of FP1 was observed by a simple saturation experiment; a 
sample of Type I immobilised avidin DN particles was incubated in a solution of un-
labelled biotin (1  M) in order to saturate all of the (specific) biotin binding sites. 
After the washing of excess biotin, these particles were suspended in solution with 
FP1 (10 nM). The fluorescence from biotin pre-saturated particles was compared 
with that for avidin particles which had not previously been exposed to biotin but 
which  too  had  been  suspended  with  FP1.  Relative  binding  was  quantified  using 
fluorescence microscopy (Figure 21). Both samples were highly fluorescent, with the 
pre biotin-saturated particles (Figure 21b) showing a fluorescence intensity just 40% 
lower than the unblocked particles (Figure 21a). This experiment demonstrated that a 
high proportion (60%) of the fluorescence signal from FP1 bound avidin particles 
(Type  I)  was  due  to  the  nonspecific  binding  of  FP1  rather  than  the  specific 
interaction between the ligand and the protein active site. 
 
 
Figure 21. FP1 binding in SSPE (5×) buffer with 0.02% Tween-20
® to a) Type I avidin SU-8 particles and b) 
biotin  saturated  Type  I  avidin  SU-8  particles  showing  no  significant  difference  in  fluorescence  intensity 
indicating high levels of nonspecific FP1 binding 
 
2.3.2 Blocking of biotinylated oligonucleotide nonspecific binding 
Minimising  the  observed  nonspecific  interaction  was  important  for  the  accurate 
measurement  of  specific  binding  between  biotinylated  probes  and  immobilised 2. Affinity probe immobilisation 
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avidin DN, and to ensure the stability of immobilised oligonucleotide probes for later 
use in multiplexed DNA assays. 
The effects of different surfactants and blocking agents on the nonspecific binding of 
FP1 were investigated; once again the fluorescence of pre biotin-saturated avidin 
particles (representing nonspecific binding) was compared with that for unblocked 
particles (representing the total specific + nonspecific binding). No reduction in the 
level  of  nonspecific  binding  was  achieved  by  incubation  with  either  BSA  (1%), 
sodium  phosphate  (100  nM)  or  the  unlabelled  22-mer  oligonucleotide  (O2). 
However  surfactants  were  shown  to  have  an  effect  on  the  unwanted  nonspecific 
binding. Earlier studies had been carried out in aqueous buffer containing 0.02% 
(v/v) Tween-20
® to aid particle aggregation (pellet formation) upon centrifugation, 
as in the absence of any surfactant particles would interact (stick) with the inner wall 
of the Eppendorf
® tube. By increasing the Tween-20
® concentration to 1% the non-
specific binding of FP1 was found to be reduced to near the lower (fluorescence) 
detection limit, and thus this problem was negated. (Figure 22). 
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Figure 22. SU-8 autofluorescence (top) and Cy-5 fluorescence images of FP1 binding in SSPE (5×) buffer with 
1.0% Tween-20
® to a) Type I avidin SU-8 particles and b) biotin saturated Type I avidin SU-8 particles 
 
The  effects  of  varying  the  concentration  of  surfactant  on  both  nonspecific  and 
specific  binding  were  then  studied  further.  Measurements  were  taken  of  the 
fluorescence of pre biotin-saturated and unsaturated Type II avidin particles after 
exposure to FP1 in buffer solutions containing increasing concentrations of Tween-
20
® (0 to 2.0% v/v) (Figure 23a). Fluorescence of the saturated particles (nonspecific 
binding) was consistently lower than the unsaturated samples (total binding) at each 
Tween-20
® concentration. Fluorescence intensity was also observed to decrease with 
increasing  surfactant.  The  difference  in  fluorescence  intensity  between  the  two 
particle types represented specific binding, therefore subtracting the fluorescence of 
the saturated from the unsaturated particles allowed the plotting of relative levels of 
specific and nonspecific binding at each concentration (Figure 23b). As can be seen, 
nonspecific  binding  decreased  exponentially  with  increasing  Tween-20
®  whereas 
specific binding decreased linearly. The ratio of specific to nonspecific binding is 2. Affinity probe immobilisation 
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greatest  between  0.6  and  1.2%  (v/v)  Tween-20
®  with  nonspecific  binding  being 
negligible above 1%. 
 
Figure 23. a) The measured total binding and nonspecific binding of FP1 to Type II avidin SU-8 in SSPE (5×) 
buffer with increasing concentrations of Tween-20
® and b) the calculated specific binding of FP1 compared 
with nonspecific binding  
 
As Tween-20
® had been shown to also affect the specific binding of FP1, a sample 
of FP1 saturated Type II avidin particles in SSPE (5×) buffer with 1% Tween-20
® 
(v/v)  was  observed  over  a  period  of  4  days  (Figure  24).  Some  variation  in 
fluorescence  intensity  was  observed  due  to  the  small  sample  size  (N  =  20-30 
particles  per  measurement),  however,  the  overall  mean  fluorescence  intensity 
showed little change. This result implied that increased surfactant did not denature 
the immobilised protein (if the protein were being damaged one would expect to 
observe a decrease in fluorescence intensity, i.e. FP1 binding, over time) and that the 
previously  observed  decrease  in  fluorescence  upon  increasing  surfactant 
concentration was likely due to the binding sites being directly blocked by Tween-
20
® molecules (Figure 25). 2. Affinity probe immobilisation 
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Figure 24. Time course fluorescence measurements of a sample of FP1 saturated Type II avidin SU-8 particles 
in SSPE (5×) buffer with 1.0% (v/v) Tween-20
® 
 
 
Figure 25. A representation of the effects of increasing Tween-20
® surfactant, blocking of both nonspecific 
and specific FP1 binding to avidin DN SU-8 particles 
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The ionic surfactant Sodium dodecyl sulfate (SDS) was also shown to affect the 
binding  of  FP1  to  avidin  immobilised  particles,  with  0.2%  SDS  reducing  both 
specific and nonspecific binding by a similar amount to 2.0% Tween-20
®. However 
as SDS is commonly used as a protein denaturant and Tween-20
® had been shown to 
have  no  detrimental  effect  on  the  activity  of  immobilised  avidin  (Figure  24),  all 
future  studies  of  immobilised  avidin  particles  used  buffers  containing  1%  (v/v) 
Tween-20
®.  
Later studies of the kinetics of particle-immobilised complex dissociation under the 
new Tween-20
® conditions found the system to follow 1
st order exponential decay, 
showing no biphasic dissociation, with these results being discussed in detailed later 
in  the  chapter.  Further  analysis  of  the  biphasic  dissociation  results  (Figure  20) 
yielded information about the total amounts of specific and nonspecific FP1 binding 
to  each  particle  type  and  gave  some  kinetic  data  (Table  2).  Type  I    avidin  DN 
particles were found to have the highest FP1 nonspecific binding under low Tween-
20
® conditions (61% of the total FP1 binding) compared with Type II and Type III  
particles  (43%  and  32%  respectively).  The  cause  of  this  increased  nonspecific 
binding was unknown, however the distribution of protein on the surface may have 
had  an  effect.
220  Affinity  captured  avidin  (Type  III)  is  likely  to  form  the  most 
ordered  surface,  as  binding  to  covalently  immobilised  biotin  causes  all  avidin 
tetramers to adopt the same configuration, forming a close packed, flat monolayer. 
This ordered surface may help to minimise nonspecific binding by providing a lower 
surface area and reducing cavities within which molecules could become trapped. On 
the other hand, avidin immobilised with the EDC coupling reagent in situ (Type I) is 
likely to have some degree of protein-protein crosslinking (as evidenced by greater-
than-monolayer quantities of immobilised protein (Table 2), forming a disordered 
protein  layer  with  higher  surface  area,  congenial  to  greater  levels  of  nonspecific 
binding. Further evidence for a disordered surface on Type I particles may come 
from the kinetics of nonspecific binding dissociation (Figure 20, natural log plots), 
these particles exhibit the lowest rate of dissociation of nonspecificly bound FP1 (koff 
= 1.39 ± 0.22 × 10
-4 s
-1) compared with avidin immobilised by the Type II or Type 
III  routes (koff  = 3.20 ± 0.66 × 10
-4 s
-1 and 2.36 ± 0.44 × 10
-4 s
-1 respectively). 
Though the rate constant is not greatly lower, the smaller value may be indicative of 2. Affinity probe immobilisation 
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a reduced rate of FP1 diffusion from the particle due to the surface being disordered 
and having more cavities. 
The dissociation constant of FP1 specifically bound to immobilised avidin under low 
Tween-20
®  conditions  (0.02%  v/v)  was  also  calculated  from  the  data  for  each 
particle type (Figure 20). Again particles with avidin immobilised using EDC in situ 
(Type I) showed a difference compared to the avidin immobilised via other routes 
(koff = 4.84 ± 0.21 × 10
-6 s
-1 compared with 1.79 ± 0.52 × 10
-6 s
-1 for the NHS 
activated (Type II) and 1.52 ± 0.25 × 10
-6 s
-1 for the affinity captured (Type III) 
avidin DN particles). Though this data came from preliminary studies, it indicated a 
weakened complex was formed between immobilised avidin DN and FP1 compared 
with the complex between free avidin and biotin. Half-lives ranged between 1.7 and 
5.3 days. This had implications for the use of this system in particle based multiplex 
assays where different oligonucleotide probe particles are required to be kept mixed 
together for long periods of time, requiring probe immobilisation to be robust. The 
kinetics of specific probe binding and dissociation would therefore be studied in 
more detail. 
 
2.4 Biotinylated-probe/avidin DN solution-phase binding 
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Equation 1. 
The thermodynamic and kinetic parameters controlling the binding between FP1 and 
untethered avidin DN were studied (Equation 1). The determination of this data was 
important as it provided values to which ligand binding to immobilised avidin DN 
could  be  directly  compared.  Discrepancies  between  the  binding  kinetics  and  the 
position of the binding equilibrium compared with the well studied avidin biotin 
system could also be made. Having this data for FP1 binding to immobilised protein 2. Affinity probe immobilisation 
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and  untethered  protein  would  provide  information  as  to  the  effects  of  both  the 
protein  immobilisation  and  the  protein  and  ligand  modifications  on  the  binding 
equilibria. 
Fluorescence polarisation (FP) (aka fluorescence anisotropy) was used to measure 
the kinetic rate constants (kon and koff) and the equilibrium dissociation constant (Kd) 
of the protein-ligand complex in solution. Briefly; free FP1 being a (relatively) small 
molecule (3 kDa) has a high rotational diffusion (tumbles fast in space), therefore 
any  polarised  light  absorbed  by  the  fluorophore  is  re-emitted  at  both  a  longer 
wavelength and with reduced polarisation (due to the movement of the fluorophore 
between absorption and emission). Counter to this, avidin-complexed FP1 is a much 
larger species (71 - 80 kDa) with a much lower rate of rotational diffusion therefore 
emitted  light  is  released  retaining  a  greater  degree  of  polarisation.  By  exposing 
solutions of protein and FP1 to polarised light at the Cy-5 excitation wavelength 
(648 nm) and measuring the FP of emitted light (666 nm), we get a measure of the 
proportion of ligand which is complexed, where a higher FP value would indicate a 
larger percentage of the total amount of ligand being bound. 
 
2.4.1 Measuring the fluorescence polarisation of FP1 binding to Avidin 
To measure the binding between FP1 and avidin DN complex in solution, avidin DN 
was titrated against FP1 (12.5 nM), with the FP of the mixtures being measured after 
a position of equilibrium had established. A problem was apparent; when FP was 
plotted against increasing protein the expected ligand binding curve of a rise to a 
maximum was not obtained. Instead polarisation initially dropped as more avidin 
was added until reaching a minimum at a point where the ratio of protein tetramer to 
ligand was slightly greater than 1:4 i.e. when the total binding sites equalled the total 
amount of biotinylated probe. Increasing the amount of protein further resulted in an 
increase  in  the  measured  FP,  leading  to  a  maximum  (Figure  26).  Further 
investigation revealed that fluorescence intensity followed a similar trend (Figure 26, 
insert).  The  cause  of  this  apparent  reduction  in  fluorescence  was  likely  to  be 
quenching of the Cy-5  fluorophores as  cyanine dyes  are known to from dimeric 
complexes when in high concentrations in aqueous environments and this leads to a 2. Affinity probe immobilisation 
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decrease in fluorescence intensity (quenching).
215 FP1 free in solution is fluorescent, 
but when complexed with avidin, the close proximity to adjacent FP1 ligands in a 
saturated tetramer must result in a high (local) concentration of Cy-5. This could lead 
to Cy-5 dimer formation between adjacent ligands which would lead to fluorescence 
quenching. This would explain the observation that fluorescence was at a minimum 
when FP1 and avidin DN were in a 4:1 ratio and most avidin tetramers were fully 
saturated with ligand. As the quantity of available binding sites exceeds the amount 
of labelled biotin, binding occurs but the protein tetramers are no longer saturated 
resulting  in  less  quenching  and  an  increase  in  fluorescence  intensity.  This  alone 
should not affect our polarisation measurements as  FP compares the intensity of 
parallel to perpendicular light and both these light channels are affected equally by 
any dimming of fluorescence, however, the plate reader does not read both channels 
equally as the two cameras used have different gain values. Therefore any change in 
fluorescence intensity could affect parallel and perpendicular polarised light readings 
to different extents which would then alter the FP readout. 
 
Figure 26. The fluorescence polarisation and the fluorescence intensity (insert) of the titration of avidin DN 
with FP1 (12.5 nM) in solution, a 4:1 ratio of FP1 to protein tetramer is indicated by the dashed line 
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This problematic fluorescence quenching was minimised by the dilution of FP1 with 
a solution of (unlabelled) biotin to result in an FP1 to biotin ratio of 10:87. This 
lowered multiple FP1 bindings to the same protein tetramer whilst maintaining a 
sufficient amount of the labelled biotin as to be detectable by the plate reader under 
the low concentrations required by the experimental design. When a repeat of the 
protein to ligand titration was carried out using this diluted FP1 solution FP was seen 
to  increase  in  the  presence  of  more  avidin  DN,  fluorescence  intensity  was  not 
affected by the addition of avidin. 
The lower detection limit of the plate reader was measured, accurate FP could be 
made of solutions with Cy-5 concentrations as low as 1 nM. Using the FP1/biotin 
mixture to prevent quenching effects meant that the FP of ligand solutions could 
only  be  measured  down  to  10  nM  (~1  nM  FP1).  This  hindered  the  direct 
measurement of the equilibrium dissociation constant, Kd for the untethered avidin 
DN-FP1 complex as discussed later (2.5.4) but did allow the kinetic rate constants, 
kon and koff to be determined. 
 
2.4.2 Biotinylated-probe/avidin solution-phase association kinetics 
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Equation 2. 
The solution phase association kinetics of the avidin DN FP1 system was studied 
(Equation  2).  To  obtain  kon,  the  rate  of  binding  between  the  two  species  was 
monitored  by  measuring  increasing  FP  with  time.  A  10:87  FP1  to  biotin  ligand 
mixture (10 nM) was added to an equivalent amount of avidin DN binding sites (2.5 
nM tetramer) and the increasing polarisation as binding occurred was monitored. 
Binding was complete within ten minutes. The rate of binding could not be lowered 
to allow for a longer window of data collection as any further dilution of the ligand 
mixture  would  reduced  the  concentration  of  the  fluorescent  species  to  below  the 2. Affinity probe immobilisation 
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instrumentation  detection  limit.  FP  was  converted  into  a  measure  of  complex 
concentration to give a binding time course (Figure 27). 
 
Figure 27. A timecourse measurement of the rate of association of FP1 and biotin ligands (10 nM) to avidin 
DN (2.5 nM) in solution. Inset: integrated data 
 
The solution phase association rate constant was determined from the experimental 
data; kon = 1.22 ± 0.11 × 10
6 M
-1 s
-1, slower than that exhibited by the wild-type 
avidin  biotin  complex  (70  ×  10
6  M
-1  s
-1).
162  To  determine  whether  the  binding 
kinetics of the system were diffusion limited, and only slow compared with the wild-
type due to the increase in the size of the biotin ligand used, the collision frequency 
between  avidin  DN  and  FP1  was  estimated  using  the  Smoluchowski  equation 
(Equation  3),  where  NA  is  Avogadro’s  constant  (mol
-1),  Rαβ  the  sum  of  the 
(hydrodynamic) radii of avidin DN and the biotin probe (m) and Dαβ the sum of their 
diffusion coefficients (m
2 s
-1).
221 
 
 diff	   4  αβ	 αβ	 A	103 
Equation 3. 
This  gives  the  theoretical  maximum  association  rate  constant,  the  diffusion 
controlled rate constant (kdiff) for the reaction between two freely mobile substrates 
(α and β), dependant on the collision between the two binding species. If the kinetics 2. Affinity probe immobilisation 
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of the system studied are diffusion limited then we would expect kon to be a similar 
value to kdiff, if diffusion were not the limiting factor then kon << kdiff.  
The hydrodynamic radii (R) and the diffusion coefficients (D) are related by the 
Stokes-Einstein-Sutherland equation (Equation 4). 
 
  =	
 B	 
6   
 
Equation 4. 
Where kB is the Boltzmann constant (1.38065 × 10
-23 Pa m
3 K
-1) T is temperature 
(293.15 K) and viscosity of the medium is represented by η (1.098 × 10
-3 Pa s). 
Diffusion coefficients and hydrodynamic radii for the avidin DN and the biotinylated 
and  labelled  oligonucleotide  FP1  in  the  present  study  can  be  approximated  and 
calculated from similar values in the literature. 
Avidin  has  dimensions  5.6  ×  5  ×  4  nm  and  an  experimentally  determined 
hydrodynamic radius of 3.27 × 10
-9 m.
210,222 D is calculated as 5.98 × 10
-11 m
2 s
-1 
(Equation 4).
223 The avidin DN we have studied has a similar structure to the wild-
type avidin so it is reasonable to assume it has a similar rate of diffusion. 
The diffusion coefficient of an oligonucleotide (T1), which has a similar to structure 
to  FP1,  has  been  determined  by  others  using  fluorescence  cross  correlation 
spectroscopy as being 8.4 × 10
-11 m
2 s
-1.
224 This 13-mer sequence was labelled at the 
5’  terminus  with  Alexafluor  488  and  the  size  and  shape  is  comparable  to  our 
biotinylated and Cy-5 labelled oligonucleotide. The hydrodynamic radii of T1 was 
calculated as 2.33 × 10
-9 m (Equation 4). FP1 is slightly larger than T1 and therefore 
was expected to have a slightly larger hydrodynamic radius and thus a slightly lower 
diffusion coefficient, however the differences would be negligible due to the small 
increase in mass and the well ordered DNA structure. Thus it was assumed that the 
values calculated for T1 were reasonable estimates for the values of FP1. 
With estimates of the physical properties of avidin DN and FP1 we could calculate 
the expected diffusion controlled rate constants for protein ligand binding in solution 2. Affinity probe immobilisation 
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(Equation  3).  This  value  is  not  exact  due  to  the  equation  being  built  for  simple 
molecular  reactions  employing  collision  theory,  it  therefore  does  not  taking  into 
account that only a small proportion of the avidin surface is made up of the active 
site.
225 Thus the value for kdiff is the maximum possible rate. The diffusion controlled 
association rate constant for solution phase binding between avidin DN and FP1 was 
calculated as kdiff = 6.09 × 10
9 M
-1 s
-1. 
Comparing the calculated kdiff and determined kon, 6.09 × 10
9 M
-1 s
-1 and 1.22 ± 0.11 
× 10
6 M
-1 s
-1 respectively, the measured kon is significantly lower. This would imply 
that  the  rate  of  ligand  association  was  limited  by  a  factor  other  than  diffusion, 
however the difference in values may also be explained by the system’s low steric 
factor  (f)  (where  only  a  small  fraction  of  the  surfaces  of  avidin  and  biotin  are 
involved in binding, resulting in the probability of complex formation from any one 
collision being much less than 1).
226 The steric factor can be described as the ratio 
between the observed and diffusion limited rate constants and for the solution phase 
binding discussed herein is calculated as f = 0.0002. 
 
2.4.3 Biotinylated-probe/avidin solution-phase dissociation kinetics 
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Equation 5. 
The  dissociation  of  the  complex  between  avidin  DN  and  FP1  in  solution  was 
monitored  once  again  using  FP  (Equation  5).  As  with  previous  solution  binding 
studies, a mixture of unlabelled biotin and FP1 was used to limit the number of 
fluorescently  labelled  ligands  in  order  to  reduce  the  incidence  of  multiple 
fluorophores  bound  to  each  protein  tetramer  to  minimise  the  occurrence  of 
fluorescence  quenching.  Firstly  avidin  binding  sites  were  saturated  using  an 
equimolar amount of the ligand mixture of FP1 and biotin, resulting in a solution 
exhibiting a high FP due to the predominately complexed state of FP1. This was 
followed by the addition of a large excess of biotin. As FP1 dissociated from the 2. Affinity probe immobilisation 
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active  sites  on  the  tetramer,  the  vacant  binding  site  was  filled  by  biotin  which 
prevented any FP1 rebinding. This dissociation was evident by the decreasing FP 
over  time.  FP  measurements  were  converted  into  a  concentration  of  the  protein-
ligand complex which could be plotted as a dissociation time course (Figure 28). 
 
Figure 28. A timecourse measurement of the rate of FP1 dissociation from  Avidin DN in solution. Inset: 
integrated data 
 
FP1 dissociation from avidin DN in solution gave a kinetic value, koff = 7.28 ± 0.61 
× 10
-7 s
-1. This value is more than an order of magnitude larger than that reported for 
the  wild-type  system  (koff  =  0.4  ×  10
-7  s
-1)  and  has  implications  for  the 
immobilisation of probes by affinity with the intended use in assay systems due to 
the complex having a t½ of only eleven days. Though there are no literature values 
for the dissociation of biotinylated oligonucleotides from avidin some studies have 
made modifications to the structure of biotin to identify the chemical groups which 
interact with the protein active site and stabilise the complex. 
One study found the imidazolidone ring and to a lesser extent the thiophane ring of 
biotin as having the strongest interactions with the active-site of avidin and therefore 
essential for tight binding, modification of the terminal carboxylic acid was shown to 
have a much lesser detrimental effect on complex stability.
227  The labelled biotin 
used in our studies retained this double ring system. However, other studies have 
indicated that the terminal carboxylic group does interact directly with the protein 
active site. Crystal structures of the complex indicate the two carboxylate oxygens 2. Affinity probe immobilisation 
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form five hydrogen bonds, two to the polyamide backbone (R2N–H) of alanine (Ala-
39) and threonine (Thr-40) and three to the side chain groups (R–OH) of threonine 
(Thr-38) and serines (Ser-73 and -75) (Figure 29).
228 Studies quantifying the effects 
of  the  alteration  of  the  carboxylic  acid  moiety  of  desthiobiotin  have  also  been 
published.
165 Here it was found that modification of the acid to the corresponding 
methyl ester resulted in an eight-fold increase in the rate of complex dissociation.  
 
Figure 29. The crystal structure of the filled active site of avidin showing the favourable interactions between 
biotin and hydrophobic residues (left) and hydrophilic residues
228 
 
The biotin moiety of FP1 is conjugated to the oligonucleotide via an amide linkage, 
which replaces the terminal carboxylic acid. As the above literature reports suggest, 
a number of minor favourable interactions are lost between modified biotin and the 
active site of avidin, therefore the measured increase in the rate of FP1 dissociation 
from avidin DN compared with the unmodified biotin complex with avidin (wild-
type) could be explained. 
 
 
2.4.4 Biotinylated-probe/avidin DN solution-phase equilibrium thermodynamics 
Due to the lower detection limits of the plate reader, the most dilute FP1 biotin 
ligand mixture which could be studied was 10 nM, this was too concentrated for an 
accurate measurement of the equilibrium dissociation constant (Kd) of avidin DN 
binding  to  be  made.  At  nanomolar  concentrations  the  protein  and  ligand  are 
essentially  100%  complexed,  resulting  in  no  equilibrium  to  actually  measure.  A 2. Affinity probe immobilisation 
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value  for  the  Kd  can  though  be  calculated  from  the  experimentally  determined 
association and dissociation rate constants (kon and koff) (Equation 6). The calculated 
value (Kd = 6.0 × 10
-13 M) was 1000 times greater than that reported for wild type 
avidin biotin binding (Kd = 5.7 × 10
-16 M) indicating much weaker binding. This 
resulted from both the decrease in the association rate constant due to the increased 
size of the biotin species, and from the increase in the dissociation rate constant due 
to the loss of hydrogen bonding sites on the biotin resulting from its conjugation to 
oligonucleotide. 
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Equation 6. 
The measured kinetic and the calculated thermodynamic parameters of FP1 binding 
to avidin DN in solution are summarised (Table 3). 
 
Table 3. A summary of experimentally determined and calculated kinetic and thermodynamic parameters of 
avidin biotin binding in solution and of avidin DN FP1 binding both in solution and immobilised on SU-8. 
†measurements were made in SSPE (5 ×) buffer with 1% v/v Tween-20
® to eliminate nonspecific FP1 binding 
Complex  kon (M
-1 s
-1) 
(×10
6) 
koff (s
-1) 
(×10
-6) 
t½ 
(days) 
koff/kon (M) 
(×10
-12) 
Kd (M) 
(×10
-12) 
specific bmax  
(mol cm
-2) (×10
-12)
a 
 
             
avidin biotin sol
 162 
 
70  0.04  200  0.00057  -  - 
avidin DN  FP1 sol
† 
  
1.22 ± 0.11  0.73 ± 0.06  11.0  0.598  -  - 
Type I avidin SU-8 FP1
† 
 
0.54 ± 0.04  4.15 ± 0.29  1.9  7.726  10.03 ± 1.72  0.44 ± 0.02  
Type II avidin SU-8 FP1
† 
 
0.52 ± 0.03  1.57 ± 0.16  5.1  3.041  4.49 ± 0.85  1.38 ± 0.05 
Type III avidin SU-8 FP1
† 
 
0.52 ± 0.06  1.52 ± 0.08  5.3  2.910  4.05 ± 0.46  0.58 ± 0.01 
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2.5 Biotinylated-probe/avidin DN solid-phase binding  
The binding rates and interaction strength between biotin and particle-immobilised 
avidin were measured. This data could be compared with the previous measurements 
made  on  the  untethered  avidin  DN  and  would  show  how  detrimental  to  activity 
immobilisation  of  the  protein  was.  Samples  of  particles  were  analysed  using 
fluorescence  microscopy  to  give  a  measure  of  the  amount  of  FP1  bound  to  the 
support surface. Due to the relatively low proportion of working/accessible biotin 
binding  sites,  fluorescence  quenching  because  of  Cy-5  dimer  formation  had  not 
previously been observed on the particles, therefore dilution of the FP1 ligand in a 
solution containing biotin (as in the studies of untethered avidin DN) was no longer 
necessary.  
 
2.5.1 Fluorescence microscopy imaging of the supports and fluorophore stability 
When exposed to light of the correct wavelength, a fluorophore will absorb photons 
and enter an excited (high energy) state, some energy is lost (as heat) in vibrational 
relaxations  whilst  the  remaining  energy  is  released  as  a  photon  to  return  the 
fluorophore to the low energy ground state (Figure 30).
229 The photon released is of 
lower energy to the one absorbed (thus at a longer wavelength) due to the prior 
energy loss through vibrational relaxation. This fluorescence cycle is very rapid; Cy-
5 will emit a photon within 1 ns of absorption.
230 Being in the high energy state can 
lead  to  side  reactions  which  damage  the  fluorophore,  this  is  referred  to  as 
photobleaching.
231  Excited  state  oxygen  (singlet  oxygen, 
1O2)  produced  on  the 
photillumination  of  aqueous  media  has  also  been  found  to  degrade  ground  state 
cyanine dye; reaction occurs at the polymethine chain which links the two aromatic 
ring systems and results in the loss of extended conjugation.
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Figure 30. Jablonski diagram detailing the energy state of a fluorophore during photoillumination. Initially the 
fluorophore  in  is  a  ground  electronic  state  (S0).  A  photon  of  specific  energy  is  absorbed  (1.)  and  the 
fluorophore moves to an electronically excited state (S1). Vibrational relaxation reduces the molecule to the 
lowest energy level of the excited state (2.), with this energy being lost to the environment as heat. The 
molecule loses energy as a photon emission (fluorescence) and drops back to the ground electronic state (3.). 
As some energy had previously been lost due to vibrational relaxation (2.) the photon released is of lower 
energy than the photon originally absorbed, the released photon is therefore of a higher wavelength, this 
change in wavelength is referred to as the Stoke’s shift. An alternative pathway (3.’) can result from the 
molecule  being  in  a  high  energy  state  where  a  photoreaction  occurs,  changing  the  structure  of  the 
fluorophore (B), this is an example of photobleaching 
 
When the fluorescence intensities of the particles used in this work are measured by 
microscopy,  they  are  exposed  to  excitation  wavelength  light  for  a  number  of 
seconds; therefore it was important to know the stability of the Cy-5 molecule under 
our  experimental  conditions  to  make  sure  photobleaching  had  little  effect  on 
experimental results. The effects of photo illumination on Immunoglobin G (IgG) 
immobilised  particles  was  studied,  we  used  IgG  particles  as  the  binding  of  the 
corresponding Cy-5 labelled anti IgG resulted in much greater fluorescence intensity 
than the particles used for DNA hybridisations (this was due to there being multiple 
fluorophores per protein compared with only a single fluorophore conjugated to each 
oligonucleotide). 
Three particles with bound Cy-5 labelled anti IgG were continuously  exposed to 
excitation light whilst the fluorescence emitted was monitored (Figure 31, a). As 
expected the intensity of fluorescence decreased with continued excitation, as the 
cyanine  molecules  degraded.  Importantly,  this  degradation  took  place  over  the 2. Affinity probe immobilisation 
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course of minutes, a few seconds exposure does not have a marked effect on the 
emission  intensity.  Interestingly,  over  the  initial  100  seconds  of  excitation,  the 
fluorescence intensity actually increased with time. It is unknown why this should be 
the case, one explanation proposed that having multiple Cy-5 groups coupled to each 
antibody  (i.e.  in  close  proximity)  resulted  in  a  degree  of  fluorescence  quenching 
then, upon continuous illumination, fluorophores start to degrade. If one fluorophore 
is degraded any adjacent fluorophores may no longer be quenched which leads to the 
observed initial increase in the fluorescent signal. 
Figure 31. A) The fluorescence intensity of three Cy-5 functionalised particles under continuous excitation, 
displaying  fluorescence  quenching.  B)  Fluorescence  intensities  of  the  particles  in  four  different  encoded 
populations taken from an immunoassay multiplex, throughout sample analysis mean fluorescence intensity 
(as indicated by fitted curves) shows little change indicating fluorescence quenching has little effect on assay 
reading 
 
To confirm that the fluorescence of a population of particles changed little during 
analysis by microscopy a sample of the fluorescent antibody particles was mounted 
on a slide and the intensity of emitted light measured for 60 particles (Figure 31, b). 
Though  there  was  variation  in  the  signal  between  individual  particles,  the  mean 
signal did not vary as more particles were measured and the cumulative exposure to 
excitation light increased. This showed that though photobleaching did take place, 
the relatively long timescale over which it occurred meant that it did not affect on 
data collection, therefore the minimal effects of photobleaching on the experimental 
results can be suitably ignored. 
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2.5.2 Biotinylated-probe/avidin DN solid-phase association kinetics 
The association kinetics of FP1 binding to avidin DN immobilised on SU-8 particles 
were studied. The binding of FP1 in each of these particle assays is presented in 
terms of concentration for clear comparison with the untethered avidin DN studies. 
A particle suspension of 1 mg mL
-1 was used in all experiments, 1 mg of contains 
approximately 8.06 × 10
5 particles with a total surface area of 5.642 cm
2. Complexed 
FP1 loading density was measured in mol cm
-2.  
Avidin DN particles were suspended in SSPE (5 ×) buffer under the high Tween-20
® 
conditions (1% v/v) in order to block any nonspecific DNA binding. FP1 was added 
to these particle suspensions which were gently agitated. At intervals, samples were 
removed and any uncomplexed active sites quenched by the addition of an excess of 
biotin. The average particle fluorescence intensity was measured for each sample (N 
~ 30 particles per sample); this could then be converted to a measurement of the 
surface  loading  density  of  protein-ligand  complex  and  an  overall  concentration 
(Figure 32). 
Figure 32. A) Specific FP1 association to avidin DN functionalised particles showing a slower binding rate than 
that  to  non-immobilised  protein  (data  included  for  comparison),  different  immobilisation  methods  were 
found to not affect the rate of association. B) Integrated data 
 
The association rate constants for the specific binding of FP1 to avidin DN particles 
did not differ greatly between the different protein immobilisation routes; all three 
particle types gave a similar value, kon ≈ 5.3 × 10
5 M
-1 s
-1 (Table 3).  2. Affinity probe immobilisation 
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The  measured  association  rate  constants  were  compared  with  the  theoretical 
maximum rate constant as determined by collision theory. This diffusion controlled 
rate constant (kdiff) for the reaction between one freely mobile substrate (β) and one 
immobilised substrate (α) is described by a modified version of the Smoluchowski 
equation (Equation 7).
234,235 
 
 diff	 = 2  αβ	 β	 A	103 
Equation 7. 
Calculating the theoretical kdiff for ligand binding to a surface immobilised receptor 
using R and D values of avidin DN and FP1 results in kdiff =  1.78 × 10
9 M
-1 s
-1. 
Comparing this with the experimentally determined value of 5.3 × 10
5 M
-1 s
-1, once 
again as  found previously for solution-phase binding, the measured rate is much 
slower possibly due to the system’s low steric factor (f). 
Comparing  the  two  theoretical  maximum  association  rates  (solution  and 
immobilised) as calculated (Equations 3 & 7), solution-phase binding is predicted to 
be  3.4  times  faster.  From  the  experimental  results,  solution-phase  binding  was 
determined to be 2.3 times faster. The similarity between these two pairs of values 
indicates  that  the  measured  decrease  in  the  rate  of  association  upon  avidin 
immobilisation is wholly due to the limiting of the ligand’s vectors of approach (to 
the binding site, due to the particle surface), rather than any effects on the specific 
protein-ligand interaction itself. This also implies that in fact the binding is diffusion 
limited and backs up the previous calculation for f being 0.0002 (Chapter 2.4.2). 
The association rate constants obtained from this study of immobilised avidin DN 
can be compared with related systems reported by others. Two studies differ to the 
system  studied  herein  in  that  they  measured  the  binding  of  mobile  avidin  to  a 
biotinylated  surface,  the  two  groups  also  obtained  very  different  values  for  the 
association rate constant, kon = 1.2 × 10
5 M
-1 s
-1 and 1.9 × 10
8 M
-1 s
-1.
235,236 A single 
reported value can be found for the association between a biotinylated protein and 
avidin immobilised by adsorption on a surface, kon = 2.21 ×10
5 M
-1 s
-1.
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similar to the system reported here, with a slightly lower rate, as expected for a 
larger biotin species which would have a reduced rate of diffusion. 
 
2.5.3 Biotinylated-probe/avidin DN solid-phase dissociation kinetics 
The  dissociation  rate  constant  for  specific  FP1  uncomplexing  from  avidin  DN 
particles was determined by monitoring the loss of fluorescence over time of FP1 
saturated  avidin  particles  exposed  to  an  excess  of  unlabelled  biotin.  As  FP1 
dissociates  it  is  quickly  replaced  by  biotin,  thus  preventing  FP1  reattachment. 
Nonspecific binding was minimised by using SSPE (5×) buffer with 1% Tween-20
®. 
A 1
st order exponential complex dissociation was observed (Figure 33). Complexed 
avidin DN immobilised by the three routes was found in all cases to have a faster 
rate  of  dissociation  compared  with  that  previously  measured  for  the  untethered 
avidin DN (Table 3). The most unstable complex being between FP1 and Type I 
avidin DN particles (EDC in situ) (10), whilst the other two particle types showed 
similar rates of dissociation. The FP1 dissociation from Type I particles was six 
times faster than the solution based system and the resulting complex half-life was 
reduced to less than two days. 
 
Figure 33. A) Specific FP1 dissociation from avidin DN functionalised particles. Immobilisation resulted in a 
decrease in complex stability compared with the non-immobilised complex (data included for comparison), 
with Type I immobilisation forming the weakest complex. B) Integrated data 
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Upon biotin binding, conformational changes occur within the avidin structure which 
work to ‘lock’ the ligand within the protein structure, contributing to the normally 
very high stability of the complex. Some studies have shown evidence of cooperative 
binding, where the binding of a second and third biotin is stronger than the first (the 
forth biotin is held relatively weakly in comparison), though the immobilised avidin 
tetramers studied are unlikely to bind more than one FP1 molecule each and so will 
not benefit from cooperative binding.
228,238,239 Crystal structures of the avidin-biotin 
complex also indicate a structural rearrangement which blocks the entrance/exit to 
the  binding  pocket  upon  complex  formation.  It  is  postulated  that  the  covalent 
immobilisation  and  close-packing  of  avidin  may  restrict  any  conformational 
rearrangements which contribute to the high complex stability; this could explain the 
observed  reduction  in  the  complex  stability  for  all  three  immobilised  systems 
compared with the untethered system. Type I avidin DN particles are likely to have 
some  degree  of  cross-linking  between  protein  molecules  which  are  absent  in  the 
other two particle types, this could further constrict any rearrangements beneficial to 
the complex stability and explain the greater rate of dissociation determined for these 
particles. 
Two  related  studies  have  been  reported,  these  both  measured  avidin  dissociation 
from a biotinylated surface and published two widely different rate constants. The 
values reported were koff = 3.3 × 10
-7 s
-1 (t½ = 24 days) and koff = 3.8 × 10
-4 s
-1 (t½ = 
0.5  hours).
235,236 The  rate  constants  determined  by  the  studies  herein  lie  between 
these  prior  reported  values.  To  the  best  of  our  knowledge,  no  experimental 
determination  of  a  dissociation  rate  constant  for  an  immobilised  avidin  and  free 
biotin system has been reported. 
 
2.5.4 Biotinylated-probe/avidin DN solid-phase equilibrium thermodynamics 
By titrating FP1 against immobilised avidin the equilibrium dissociation constant 
(Kd)  can  be  experimentally  determined  and  the  specific  FP1  binding  (bmax) 
quantified. A direct measurement of the Kd could also be compared with the value 
calculated from the kinetic data previously obtained (Equation 6). Suspensions of 
avidin  particles  (SSPE  (5  ×)  buffer  with  1%  v/v  Tween-20
®)  were  exposed  to 
varying concentrations of FP1 and allowed to reach a binding equilibrium before 2. Affinity probe immobilisation 
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quantification of particle fluorescence and conversion into a measure of complex 
concentration (Figure 34). Kd and bmax values are given, the equilibrium dissociation 
constants were found to closely match the equivalent value as calculated from the 
rate constants (Table 3). This confirmed the weakened binding of the immobilised 
complex  compared  with  both  the  untethered  avidin  DN/FP1  and  the  wild  type 
avidin/biotin complexes. As expected, total specific FP1 binding (bmax) was 20-30% 
lower than found under low Tween-20
® conditions (0.02%) (Figure 23). 
 
Figure 34. FP1/particle-immobilised avidin DN titrations displayed as A) linear and B) log plots. Equilibrium 
dissociation  constants  obtained  closely  matched  predicted  values  as  calculated  from  the  experimentally 
determined kinetic data 
  
2.6 Analysis of the supports by flow cytometry 
Results from when the fluorescence of SU-8 particles has been analysed using the 
fluorescence  activated  cell  sorter  (FACS)  have  shown  very  broad  fluorescence 
populations.  Identically  treated  particles  often  give  intensity  readings  over  a  two 
order of magnitude range, whilst particles from the same sample, when analysed by 
fluorescence microscopy, display a very low intensity variation. This observation of 
particles by microscopy would suggest that the broad range of fluorescence observed 
by FACS analysis was due to error induced by the instrumentation or the analysis 
method rather than a real fluorescence variation. 
To confirm the cell sorter as the source of this fluorescence error the FACS machine 
was used to sort populations of particles which were then re-analysed in the same 2. Affinity probe immobilisation 
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machine.  The  idea  being  that  particles  collected  within  only  a  narrow  range  of 
fluorescence intensities from a population with a broad fluorescence range should 
show the same narrow fluorescence range when re-analysed by the cell sorter. If the 
sorted particles were to show a similar range of fluorescence intensities to the mother 
sample then the broad range of intensities would likely be an artefact of analysis by 
FACS. 
A mixture of particles exhibiting two distinct fluorescence populations between 30 
and 9000 a.u. was analysed, particles from between 200 – 800 (P2 in red) and 1000 – 
4000 a.u. (P1 in blue) were sorted and retained whilst all particles outside of these 
ranges were discarded (P3 in grey) (Figure 35). When these sorted particles were re-
analysed each sample only contained only a single fluorescence population which 
indicated that the original two populations had been successfully separated. Each 
population had a much greater range of fluorescence intensities compared with the 
stringent  gating  used  to  initially  sort  the  particles;  analysis  of  particles  collected 
between 200 and 800 a.u. showed fluorescence between 30 and 4000 a.u., likewise 
the  particles  collected  between  1000  and  4000  a.u.  now  exhibited  fluorescence 
between 200 and 9000 a.u. 2. Affinity probe immobilisation 
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Figure  35.  Two  representations  of  FACS  data  for  a  sample  of  SU-8  particles  containing  two  differently 
fluorescing  populations  a)  dot  plot  showing  fluorescence  of  individual  particles  at  575  nm  and  660  nm 
wavelengths and b) histogram showing the same results as a count of hits at varying fluorescence intensities 
in the 660 nm wavelength. Populations were gated based on their fluorescence intensity at 660 nm (the 
higher fluorescence population was designated P1 and coloured blue, the population with lower fluorescence 
was designated P2 and coloured red). P1 and P2 were sorted and the rest of the particles (P3) discarded. The 
sorted samples were re-analysed with c) showing a single low fluorescence population and d) a single high 
fluorescence population. Populations displayed a broad range of fluorescence intensities even after stringent 
sorting 
 
This error in the measurement of fluorescence of SU-8 particles could be due to the 
(random) orientation of the particle in relation to the detector. As the particles are 
cuboids different faces will emit different total fluorescence intensities and so the 
angle at which measurements are taken may affect the value obtained. In order to test 
this theory the orientation of SU-8 particles during cell sorter analysis would need to 
be  controlled  so  that  the  same  surface  could  be  measured  every  time.  This 
modification is beyond the scope of this project but perhaps could be achieved using 
hydrodynamic  focusing  or  by  electrode  deflection.
240,241,242,243  Measuring  GMA 
beads, which are spherical, did result in narrow fluorescence ranges of 0.2 orders of 
magnitude. 2. Affinity probe immobilisation 
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During the course of this work the FACS was  often used to analyse samples of 
particles even though this would result in a large standard deviation (s.d.) between 
individual particles. However this data was valid due to the very large numbers of 
particles analysed for each sample allowing errors to be quoted as standard errors 
(s.e.),  (s.d./√(number  of  readings).  The  large  standard  deviation  would  cause 
problems with the analysis of multiplexed assays where it could make two or more 
particle  populations  with  differing  fluorescence  intensities  indiscernible  (as  the 
different normal distributions overlap. One of the aims of the 4G project was to 
develop a working particle sorting device in order to automate the multiplex analysis 
of biological samples, it was thus considered desirable to continue using the FACS 
for analysis of DNA multiplex assays in the developmental stage as these results 
would be more akin to the end system. However, it became apparent that the in-
house designed cell sorter would not become a reality, leaving less emphasis on 
FACS  analysis.  Both  the  cell  sorter  and  microscopy  are  used  as  analytical  tools 
throughout  the  research  contained  herein  with  microscopy  (with  a  much  lower 
inherent error) becoming the analytical method of choice towards the latter stages of 
the work. 
 
2.7 Optimisation of hybridisation conditions 
The degree of hybridisation between two complementary DNA strands is affected by 
environmental  conditions;  most  notably  temperature,  salinity,  pH  and  the 
concentrations of the two strands.
244,245 Though DNA duplex formation has been 
studied extensively, the complexity of the many  environmental variables and the 
uniqueness of each DNA sequence make predictions of the optimal conditions for 
hybridisation  of  specific  sequences  difficult.  Calculations  for  the  melting 
temperature (Tm) of duplexes have been developed.
246 Predictions become further 
complicated by the inclusion of overhanging sections of DNA and in the presence of 
mismatching base pairs. Further to this, hybridisation to immobilised probe DNA has 
been  less  thoroughly  studied  and  is  likely  to  be  affected  by  the  immobilisation 
strategy  and  the  support  used.  For  these  reasons  a  number  of  experiments  were 
designed to investigate hybridisation to DNA probes immobilised on SU-8 particles 2. Affinity probe immobilisation 
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by  affinity  capture,  with  the  purpose  of  optimising  conditions  for  particle  based 
multiplex assays. 
 
2.7.1 Assays at elevated temperature 
The effect of increasing the temperature on particle-bound probe hybridisation was 
investigated. Increasing the temperature would reduce the amount of hybridisation as 
duplexes become less stable. The single base mismatching target, forming a less 
stable  duplex  with  the  probe  sequence,  would  be  expected  to  melt  at  a  lower 
temperature  than  the  complementary  target,  therefore  discrimination  between 
complementary  and  single  base  mismatching  targets  may  be  achieved  by 
hybridisation at elevated temperature. Immobilised probe-particles (PC and PD), in 
separate  vessels,  were  exposed  to  either  labelled  target,  TC  (11  nM)  which  was 
complementary or to PC which represented a single, mid sequence guanine:guanine 
(G:G) mismatch to PD. The Tm of the complementary duplex was calculated to be 48 
°C therefore these singleplex hybridisation suspensions in SSPE (5 ×) buffer, were 
heated to 60 °C then gently agitated at either  47, 49 or 51 °C overnight.
246 The 
particle  suspensions  were  washed  with  hybridisation  buffer  and  the  fluorescence 
intensity of the complementary and mismatching particles was compared using the 
FACS (Figure 36, no urea wash). Results indicated that complementary hybridisation 
had occurred at 47 and 49 °C, but was reduced at 51 °C. The single G:G mismatch 
hybridisation  followed  a  similar  pattern  but  the  total  amount  of  hybridisation 
(fluorescence  intensity)  was  lower  than  with  the  complementary  at  the  lower 
temperatures.  Focusing  on  the  lower  temperature  hybridisations  we  get  a 
complementary to mismatch signal ratio (c:m) of 12:10 and 15:10 (47 and 49 °C 
respectively),  the  particles  can  therefore  discriminate  between  different  target 
sequences (when not in multiplex). 2. Affinity probe immobilisation 
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Figure 36. The effects of hybridisation temperature and subsequent suspension in aqueous 2 M urea on 
target, TC, hybridisation to complementary probe, PC, particles (blue) and single G:G mismatch probe, PD, 
particles (red) 
 
A c:m ratio of 15:10, however, is not very large, if the two particle types were mixed 
and  analysed  using  the  FACS,  only  one  broad  population  of  particles  would  be 
observed  (due  to  the  inherently  high  instrumentation  error).  If  particles  could  be 
sorted based upon their encoding then the particles could be used to discriminate 
between the two target sequences in multiplex, however the technology at this point 
only allowed discrimination by fluorescence intensity.  
This  result  would  suggest  that  discrimination  by  varying  the  temperature  of 
hybridisation alone would not be sufficient. Fine temperature control was difficult 
with the experimental setup, which required placing an agitator (to keep particles 
well suspended) within an oven. Temperature was noted to vary by ± 2 °C and once 
the samples (within eppendorf
® tubes) were removed they started to quickly cool 
before washing. Further to these problems, the difference in Tm of a mismatching 
duplex compared with the complementary may  be smaller for immobilised DNA 
than  in  solution.  When  probes  are  immobilised  on  a  support,  the  localised 
concentration of ssDNA is very high, this can have the effect of increasing the Tm of 
any probe target duplex formed. This effect is not very prominent when most of the 
immobilised  probe  is  hybridised,  as  in  the  case  of  complementary  sequences. 
However, when more of the probes are single stranded the balance of equilibrium for 
any target in the close vicinity could be shifted to a hybridised state and lead to an 
increase in the mismatching duplex Tm and a broadening of the associated melting 
curve (Figure 37).
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Figure 37. The effects to Tm of the high localised concentration of probe DNA in immobilised probe systems 
 
A further complication with the use of temperature to obtain differentiation would be 
when large multiplex assays were developed (e.g. 100 different immobilised probe 
particles  discriminating  between  target  solutions),  each  immobilised  probe  would 
exhibit a different complementary duplex Tm, as each assay could only be done at a 
single temperature the conditions would never be optimal for all the complementary 
sequence  pairs.  Therefore,  attempts  were  made  to  increase  the  difference  in 
hybridisation between a complementary and a mismatching target sequence without 
the use of temperature control. 
 
2.7.2 Hybridised probe washing 
Washing in aqueous solutions of 2 M urea was found to improve complementary and 
mismatching sequence discrimination. Washing in 2 M urea resulted in a decrease in 
the  amount  duplex  for  both  types  of  hybridisation,  but  the  effect  was  more 
pronounced for the mismatching sequences. Prolonged exposure to urea eventually 
resulted  in  complete  loss  of  duplex  from  both  duplex  types,  implying  that 
discrimination was a kinetic process where the rate constant for the melting of a 
mismatching  duplex  was  greater  than  for  the  complementary  duplex.  For 
hybridisations carried out at 47 °C, the initial c:m is 12:10, after 1 minute exposure 
to 2 M urea the ratio has increased to 24:10 and with a second minutes exposure it is 
further increased to 38:10, subsequent exposure reduced the ratio (after 3 minutes 2. Affinity probe immobilisation 
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c:m = 35:10) as by now little mismatch duplex remained. An overlaid FACS image 
of the complementary (grey) and mismatched (red) particles after 2 minutes of 2 M 
urea  washing  shows  the  differentiation  between  the  two  populations  (note;  the 
fluorescence of particles in these two populations were measured independently, i.e. 
singleplexed) (Figure 38). 
 
Figure 38. Overlaid FACS histograms of target, TC hybridisation to complementary probe, PC particles (grey) 
and single G:G mismatch probe, PD particles (red) after 2 minutes exposure to 2 M aqueous urea 
 
2.8 Multiplex DNA assays using encoded-microparticle based affinity-captured 
probes 
2.8.1 Initial multiplex optimisation 
The hybridisation of a target oligonucleotide, TC to an immobilised complementary 
sequence,  PC  and  a  completely  mismatching  sequence,  PE  were  studied. 
Hybridisations were performed as singleplexes at room temperature, discrimination 
between the two targets was achieved using a 2 minute wash in 2 M aqueous urea. 
The two particle suspensions were analysed using the cell sorter (FACS) to measure 
the fluorescence intensity of individual particles (Figure 39, a – d). Probe particles 
which  were  complementary  to  the  target  sequence  showed  a  high  fluorescence 
intensity (25000 ± 1600 a.u., N = 890) compared with the non-complementary probe 
particles (540 ± 28 a.u., N =747). Overlaying fluorescence histograms (Figure 39, e) 
indicated that differentiation between the two populations would not be possible in a 
multiplex due to overlapping of the broad intensity range over which each population 
extended. If the two populations were mixed, one very broad peak would result from 2. Affinity probe immobilisation 
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histographic  display.  By  instead  displaying  the  fluorescence  data  as  a  dot-plot 
(Figure 39, f), where each particle was represented by a single point plotted against 
fluorescence  in  two  channels,  660  nm  (Cy-5  emission)  and  575  nm  (SU-8 
autofluorescence),  gave  a  much  clearer  differentiation  between  the  differently 
fluorescing particle populations. 
 
Figure 39. FACS data in the form of fluorescence histograms (left) and fluorescence dot-plots for labelled 
target, TC hybridisation to immobilised complementary, PC (a and b) and completely mismatching, PE (c and 
d) probes. Hybridisations were not in multiplex. Overlaid images are shown (e and f) showing more obvious 
population differentiation using the dot-plot representation 
 
The  same  probe  particles  were  used  to  differentiate  between  target  sequences  in 
multiplex.  This  time  TC  was  added  to  a  sample  containing  both  immobilised 
complementary probe PC particles and completely mismatching probe PE particles 2. Affinity probe immobilisation 
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in  suspension.  Conditions  of  this  multiplex  hybridisation  were  identical  to  the 
previous singleplexed experiments Once again a 2 minute wash in 2 M urea solution 
was  used  to  discriminate  between  complementary  and  mismatching  duplexes, 
however when the sample was analysed, discrimination was very poor (Figure 40) 
and two populations could barely be discerned. 
 
Figure  40.  FACS  dot-plot  of  a  multiplex  hybridisation  assay  showing  attempted  labelled  target  TC 
discrimination  using  particle  immobilised  complementary,  PC  and  mismatching,  PE  probes  in  a  mixed 
suspension. The assay had been left for 16 hours to reach equilibrium 
 
Next, separate samples of immobilised probes, PC and PE which had each been pre-
hybridised  with  the  labelled  target,  TE  and  washed,  were  combined.  The 
fluorescence intensity of these particles, now in a mixed suspension, were analysed 
using the FACS (Figure 41). A merging of the two particle populations was found to 
take place. Initially, two distinct fluorescence populations were easily distinguished, 
with one at a higher fluorescence intensity (660 nm), representing probe particles 
which were complementary to the target DNA. When the mixed suspension was re-
analysed 16 hours later, only one fluorescence population could be distinguished. 
The ability of probe-particle mixtures to discriminate between complementary and 
mismatching DNA appears to diminish with time. 
This represented a problem when carrying out hybridisation assays in multiplex. It 
was  likely  the  result  of  biotinylated  probe  oligonucleotide  dissociating  from  the 
avidin particles to which it had originally been attached and reassociating elsewhere. 
As has been determined, biotinylated oligonucleotide binding to immobilised avidin 
DN  is  much  weaker  than  the  binding  between  unmodified  biotin  and  avidin  in 
solution (Table 3). The half-life of the affinity binding in the immobilised system 2. Affinity probe immobilisation 
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was found to be a few days, however, probe dissociation appears to have a marked 
effect on the analysis of multiplex hybridisation assays within 16 hours. 
 
Figure 41. FACS data showing the homogenisation of immobilised probe particles. Labelled target, TC was 
pre-hybridised  to  immobilised  complementary,  PC  and  completely  mismatching,  PE  probe  particles  in 
separate vessels. a) Initially after the two particle samples were mixed, two fluorescent populations were 
easily  discernable,  b)  within  16  hours  probe  dissociation  resulted  in  a  homogenisation  of  the  different 
particles’ surfaces resulting in a single fluorescence population 
 
2.8.2 Homogenisation of heterogeneous probe-particle mixtures 
Further investigation of probe dissociation from the avidin DN particles was made. 
To a sample of Type II avidin DN particles was bound the labelled and biotinylated 
oligonucleotide FP1. These fluorescent particles were next mixed with a sample of 
Type II particles to which the unlabelled biotinylated oligonucleotide, PC had been 
bound. The fluorescence of particles in the mixed suspension was monitored (Figure 
42). The two populations were initially fluorescently distinct, however an obvious 
merger  of  the  two  fluorescence  intensity  populations  was  observed  within  three 
hours, by 19 hours two separate populations could no longer be differentiated. 
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Figure 42. a mixture containing both particles with a fluorescent probe (FP1) and particles with an unlabelled 
probe (PC) bound. Measurements were taken at t = 0, 143 and 1114 minutes (a), b) and c) respectively) and 
show the merging of the two populations as the biotinylated probes dissociate and reassociate between 
particle-immobilised  avidin  tetramers.  This  results  in  each  particle  eventually  having  a  similar  surface 
containing a mixture of all probe sequences  
 
This  instability  of  probe  binding  presents  a  problem  for  hybridisation  assays  in 
multiplex.  Most  obviously,  multiplex  hybridisations  have  to  be  performed  and 
analysed  quickly  to  achieve  the  best  differentiation  between  complementary  and 
mismatching sequences. This may not allow time for the system to reach equilibrium 
which would lead to a reduction in the total fluorescence intensity as hybridisation 
has not reached a maximum. The problem also means that different probe-particles 
may not be stored together; biotinylated probes may be immobilised in advance, 
however these particles need to be separated from any other particles with different 
probes bound. 
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2.8.3 An encoded microparticle based multiplex hybridisation assay to discriminate 
between complementary and completely mismatching DNA sequences 
Despite  the  problems  identified  with  the  use  of  the  biotin  avidin  system  for 
microparticle immobilisation of DNA probes, a number of multiplex assays were 
successfully  performed.  These  demonstrations  of  multiplexing  were  useful  for 
developing different particle handling techniques. Statistical tests were used to help 
determine the parameters of a working particle-based multiplex assay. 
The multiplex discrimination of complementary and mismatching target sequences 
was  attempted  using  probe  oligonucleotides  affinity  bound  to  encoded 
microparticles.  Biotinylated  oligonucleotide  probes  were  immobilised  to  particles 
with differing diffractive encoding (PE immobilised to particle type 2 and PC to 
particle  type  3).  After  washing,  samples  of  each  probe  particle  conjugate  were 
combined and exposed to a solution containing the labelled target oligonucleotide, 
TC (350 nM). Assays were allowed to equilibrate in suspension for just 40 minutes 
(to minimise loss of probe) this was followed with a wash in hybridisation buffer 
(SSPE (5 ×), further, more stringent urea washing was not found to be necessary to 
achieve sequence differentiation. Particles were imaged by fluorescence microscopy, 
where the two particle types displayed different fluorescence intensities (Figure 43). 
The assay mixture was then analysed using the fluorescence activated  cell sorter 
(FACS) where two clear fluorescence populations were once again visible (Figure 
44).  These  two  populations  were  gated  (FACS)  and  sorted  into  separate  vessels 
based upon their fluorescence intensity.  Finally, these high  and low fluorescence 
samples containing sorted particles were assessed by microscopy where the particles 
were decoded both visually (by the operator) and by using the in-house designed 
integrated particle fluorescence and code reading device (Figure 45) (which at this 
developmental  stage  could  not  be  used  to  quantify  fluorescence,  hence  the 
requirement for pre-sorting of the different particle-fluorescence populations using 
the FACS). The device combined imaging of the diffraction of light by individual 
particles and software to measure the angle of diffraction (the encoding) which was 
unique for each particle type. 2. Affinity probe immobilisation 
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This analysis method incorporating sorting by  fluorescence intensity followed by 
particle decoding was repeated for probe particle mixtures exposed to the second 
complementary target sequence (TE).  
 
Figure 43. White light (left), SU-8 autofluorescence and Cy-5 fluorescence images of the multiplex analysis of 
a sample containing (TC) using immobilised probe DNA. The complementary probe (PC) was bound to type 3 
particles (5 ridges visible) whilst the completely mismatching probe (PE) was bound to type 2 particles (4 
ridges visible). Note only type 3 particles (complementary) exhibit Cy-5 fluorescence 
 
 
Figure 44. FACS analysis of the complementary and completely mismatching DNA discrimination multiplex 
assay showing two clear fluorescence populations. The two populations were gated (the population with 
greater Cy-5 fluorescence emission, in blue, represented a high degree of hybridisation) and sorted according 
to fluorescence intensity 
 
A  summary  of  the  analysis  of  these  samples  is  shown  (Table  4).  Sorting  by 
fluorescence resulted in 100% accuracy. For the multiplex with the target sequence 
(TC),  100%  (50/50)  of  the  particles  in  the  higher  fluorescence  population  were 
identified  (visually)  as  being  particle  type  3  representing  complementary 
hybridisation. Likewise 100% (51/51) of the particles in the population with lower 
fluorescence  were  identified  as  being  type  2,  those  with  the  mismatching  probe 2. Affinity probe immobilisation 
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bound.  Using  the  code  reader  to  measure  the  angle  of  light  diffraction  correctly 
identified 98% (49/50) of the particles in the high fluorescence population with one 
particle  being  misread  as  having  a  different  encoding  which  corresponded  to  a 
particle type not present in the assay. Similarly 96% (49/51) of the particles in the 
population  with  lower  fluorescence  were  correctly  identified  as  type  2,  a  single 
particle was incorrectly read having type 3 encoding and another particle as being 
unidentifiable by the software due to structural damage. Analysis of the multiplex 
assay exposed to target oligonucleotide (TE) was equally robust. Once again all of 
the particles of the higher fluorescence population were visually identified as being 
those  with  the  complementary  probe  bound  whilst  all  the  particles  at  the  lower 
fluorescence  had  the  mismatching  probe.  The  software  identified  the  particles 
correctly in 94% of these reads. 
 
Figure  45.  Images  of  FACS  sorted  populations  of  fluorescent  particles  from  the  complementary  and 
completely  mismatching  DNA  discrimination  multiplex  assay.  Particles  from  the  higher  fluorescence 
population  (top)  represented  complementary  hybridisation  and  were  found  to  be  exclusively  of  type  3 
encoding, an image of the corresponding diffraction of light by the encircled particle (the encoding) is also 
shown. Likewise, particles from the population with lower fluorescence (bottom) were identified as being 
exclusively of type 2 encoding 
 2. Affinity probe immobilisation 
 
102 
 
Table 4. A summary of the fluorescence measurement and particle identification of differently fluorescing 
particle populations in the complementary and completely mismatching DNA discrimination multiplex assay. 
This is the analysis of particle samples after having been sorted (FACS) into two populations based upon 
fluorescence intensity  
Labelled target 
DNA 
Mean particle 
fluorescence (a.u.) 
Number of particles identified (visually/diffractively) for each 
encoding type 
 
1 
 
2 
 
3 
 
4 
 
unidentifiable 
             
(TC) 
 
5090 ± 61  0/0  0/0  50/49  0/1  0/0 
(TC) 
  
651 ± 6  51/49  0/0  0/1  0/0  0/1 
(TE) 
 
2865 ± 49  52/49  0/1  0/0  0/0  0/2  
(TE)  634 ± 6  0/0  0/0  52/49  0/1  0/2 
             
 
This experiment demonstrated the multiplex discrimination between complementary 
and  completely  mismatching  oligonucleotide  sequences  using  encoded  particles. 
Analysis was semi-automated and had a 96 % correct read percentage, which, with 
further  optimisation  of  the  read  software  could  be  improved.  Furthermore, 
complementary  and  mismatching  sequences  were  discriminated  with  a  100  % 
success rate, with all the particles observed in the higher fluorescence populations 
being visually identified as representing complementary hybridisation. This result 
suggested  that  the  major  problems  in  previous  experiments,  most  notably  the 
nonspecific binding of target DNA and the dissociation of probe molecules from the 
particle surface could be circumvented by the use of Tween
®-20 surfactant and by 
the decrease in the total time over which different particle types were mixed. 
 
2.8.4 An encoded microparticle based multiplex hybridisation assay to discriminate 
between complementary DNA and sequences containing a single base mismatch 
The multiplex hybridisation assay was used to differentiate between oligonucleotides 
differing  by  a  single  base.  Biotinylated  probes  were  bound  to  avidin  DN 
functionalised  encoded  particles,  with  probe  (PC)  attached  to  particle  type  3  (5 
ridges) and probe (PD) to particle type 2 (4 ridges). Both types of probe-immobilised 
encoded  particles  were  combined  and  the  mixed  suspension  was  exposed  to  the 
labelled target oligonucleotide (TC) (350 nM) for 40 minutes. This target sequence 
was  complementary  to  the  probe  (PC)  immobilised  on  particle  type  3  and 2. Affinity probe immobilisation 
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represented a single, mid-sequence G:G mismatch to the probe (PD) on particle type 
2. After washing in the hybridisation buffer (SSPE (5 ×)) the particles were washed 
for 2 minutes in a 2 M aqueous urea solution to aid in the differentiation between 
complementary  and  mismatching  hybridisation.  Particles  were  analysed  as 
previously where the particle mixture was first imaged by fluorescence microscopy 
(Figure 46), followed by FACS analysis (Figure 47) and sorting into two populations 
based on fluorescence intensity, the particles in these populations were then decoded 
both visually and using the automated setup, results of which are presented (Table 
5). 
 
Figure 46. White light (left), SU-8 autofluorescence and Cy-5 fluorescence images of the multiplex analysis of 
a sample containing (TC) using immobilised probe DNA. The complementary probe (PC) was bound to type 3 
particles (5 ridges visible) whilst the single base (G:G) mismatching probe (PD) was bound to type 2 particles 
(4 ridges visible). Note only type 3 particles (complementary) exhibit Cy-5 fluorescence 
 
 
Figure 47. FACS analysis of the complementary and single base mismatching DNA discrimination multiplex 
assay showing two clear fluorescence populations. The two populations were gated (the population with 
greater Cy-5 fluorescence emission, in blue, represented a high degree of hybridisation) and sorted according 
to fluorescence intensity 
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Table  5.  A  summary  of  the  fluorescence  measurement  and  particle  identification  of  sorted  fluorescence 
populations  from  the  complementary  and  single  base  mismatching  DNA  discrimination  multiplex  assay, 
target sequence (TC) was complementary to probe (PC) immobilised on type 3 encoded particles 
Mean fluorescence intensity (a.u.)  Particle identified (visually/diffractively) 
 
1 
 
2 
 
3 
 
4 
 
unidentifiable 
           
3054 ± 80 
 
2/3  0/0  48/42  0/5  0/0 
237 ± 6  48/44  0/0  2/5  0/0  0/1 
 
The  analysis  of  the  sorted  fluorescence  populations  indicated  that  96%  of  the 
particles found in the highly fluorescent population were of type 3, encoding for the 
complementary sequence, whilst 4% of the particles identified were of type 2. The 
reverse  was  found  for  the  population  with  lower  fluorescence,  with  96%  of  the 
particles  having  type  2  encoding.  The  encoded  microparticle  based  multiplex 
hybridisation  assay  had  been  shown  to  successfully  discriminate  between  a 
complementary and a mismatching sequence differing by a single base. 
 
2.9 Conclusions 
The kinetic and thermodynamic properties of the binding between a labelled and 
biotinylated oligonucleotide and avidin DN immobilised on polymer microparticles 
via  different  attachment  chemistries  have  been  thoroughly  investigated.  Rates  of 
association were found to be diffusion limited, as they are for the free avidin biotin 
system. However the rate was significantly reduced compared with the wild-type. 
One reason for this was because the rate of biotin diffusion was significantly lowered 
by conjugation to an oligonucleotide probe which made the ligand a much larger 
species.  Another  reason  was  the  steric  hindrance  which  came  from  being 
immobilised to a large surface, blocking the approach of biotin from one side and 
reducing the chances of a collision. Rates of dissociation were increased compared 
with  the  non-immobilised  avidin  system,  which  in  turn  displayed  rates  increased 
compared with those reported for the wild-type avidin biotin complex. These results 
indicated that both the modification of the carboxylic acid moiety of biotin and the 
immobilisation of avidin DN have significant effects on complex stability, leading to 
our system having a complex t½ of only five days. This increased dissociation rate 2. Affinity probe immobilisation 
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has  implications  for  the  use  of  avidin  affinity  as  the  immobilisation  method  in 
multiplexed  assays  when  probes  are  sharing  the  same  solution.  This  weakened 
complex was a very obvious problem as when different probes were immobilised on 
different particles and mixed in the same solution, probe swapping occurred resulting 
in the originally differently functionalised particles being indiscernible within a day. 
Our  kinetic  results  were  similar  to  the  incomplete  and  imprecise  data  for 
immobilised avidin which has previously been reported. When comparing with more 
comprehensive studies using immobilised biotin, we obtained a similar equilibrium 
dissociation constant but differing rate constants, with values between those of the 
two sets of reported data. 
Comparisons were made between the three different protein immobilisation methods 
investigated. Stable protein mono-layers were formed in each case, however having 
the coupling reagent (EDC) in-situ resulted in both the highest levels of non-specific 
biotinylated-probe  binding  and  the  lowest  levels  of  avidin  activity,  furthermore, 
complex  stability  was  reduced  with  a  t½  of  less  than  two  days.  The  NHS  pre-
activation and affinity capture methods lead to identical rate constants and similar 
degrees  of  non-specific  binding,  however  the  covalent  attachment  resulted  in  a 
significantly greater avidin activity, binding the most biotinylated probe. 
Despite the transient probe immobilisation, these encoded microparticles were used 
for  a  number  of  hybridisation  assays,  both  in  singleplexed  sample  analysis  for 
methodology development and in multiplexed analysis as a technology demonstrator. 
Multiplexes were made possible by only allowing probe-functionalised particles to 
be mixed for short lengths of time, complex dissociation was therefore minimal and 
probe migration between different particles not observed. 
Affinity capture was clearly not a good long-term strategy for probe immobilisation 
in  the  design  of  our  multiplexed  suspension  array,  a  more  permanent  tether  was 
required. 
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3.0 Particle-immobilisation of oligonucleotide probes by amide coupling 
 
The immobilisation of oligonucleotide probes via affinity binding had been found to 
be inappropriate for use in our particle based multiplexed DNA assays due to the 
increased rate of biotinylated DNA probe dissociation from the particle’s avidin-
functionalised surface (2.9.2). Transient probe immobilisation lead to particles which 
initially each had a single probe sequence bound, having a surface populated by all 
the different probes in a multiplex. Encoded particle multiplex assays make use of 
oligonucleotide probes immobilised on particles, these particles can be identified by 
a unique code and therefore each probe sequence can be localised. The link between 
the code and the probe needs to be stable to have a high degree of confidence in the 
identity of the probe once the code has been read. 
Covalent probe attachment has a number of benefits, most importantly for our assay 
systems a permanent bond would be formed eliminating problems of probe loss or 
swapping. In addition, it would be possible to develop a more flexible assay system 
as the linkage would be more stable to extremes of temperature and pH than any 
affinity binding. Furthermore, solid phase chemistry techniques are well established 
and permit an array of attachment chemistries, this allows the surface functionality to 
be  modified  giving  a  handle  for  the  control  of  various  physical  and  chemical 
properties. 
The covalent attachment of oligonucleotide probes to epoxy SU-8 microparticles was 
investigated.  The  aim  of  this  work  was  to  develop  stable  covalent  attachment 
chemistries which gave control of the density of probe molecules and the overall 
charge properties on the surface, allowing the optimisation of complementary target 
DNA hybridisation and the minimisation of nonspecific DNA binding to be achieved 
in tandem. 
 
3.1 SU-8 microparticles 
SU-8 particles (7) are fabricated by the acid catalysed polymerisation of epoxy SU-8 
monomer (6). Polymerisation is initiated by the activation of the photoacid under UV 3. Amide probe immobilisation 
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illumination  and  propagated  by  heat.  Microstructures  including  the  encoded 
microparticles used in this work can be patterned using a mask to selectively block 
exposure during illumination (Figure 13). After polymerisation, any  excess SU-8 
monomer is leaving particles with an epoxy surface functionality derived from the 
uncrosslinked sites along and at the termini of polymer chains (Figure 48). Epoxide 
functionality gives a handle for the chemical modification of SU-8. 
 
Figure 48. Two subunits of an SU-8 polymer chain. Two epoxide groups have been polymerised to form ether 
bridges  within  the  bulk  polymer,  any  uncrosslinked  epoxide  groups  are  retained  and  are  available  for 
chemical modification 
 
During  the  studies  of  the  covalent  attachment  of  avidin  to  the  particle  surface, 
polymerised epoxy SU-8 was modified with bis-amines and succinylating reagents to 
afford  an  amine  or  an  acid  surface  functionality  (Scheme  2).  Stable  protein 
attachment was attained by using carbodiimide coupling reagents with carboxylate 
SU-8 particles, resulting in attachment via an amide bond. These results indicated 
that polymerised SU-8 was amenable to standard coupling chemistry protocols and 
potentially solid phase synthesis.
191 
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3.1.1 The distribution of functional groups on the surface of SU-8 particles 
Covalently coupling avidin (Type II) previously resulted in a monolayer of protein as 
calculated from the quantity of protein attached and as observed from the uniform 
surface fluorescence obtained when labelled biotin species were bound (Table 2). 
However, a difference in the coverage between different sides of the particles was 
sometimes observed when studying protein particles complexed with labelled biotin. 
Here the two largest faces (top and bottom during fabrication) would often have a 
much lower fluorescence intensity compared with the four side faces, indicating a 
lower protein coverage on these faces. An example of this can be seen on avidin 
functionalised particles to which the labelled probe,  FP1, was specifically bound 
(Figure 22a). This indicated that not all sides of the SU-8 particles had an equal 
density of epoxide groups. 
Further  investigation  of  the  distribution  of  available  functionality  used  the  direct 
coupling of  carboxylate Cy-5 (14) to  amine modified SU-8 microparticles (8) in 
order to map the functional group distribution. Coupling was successfully achieved 
under  both  organic  and  aqueous  conditions  (HOBt/TBTU  in  DMF  and  EDC  in 
water),  with  both  methods  resulting  in  particles  (15)  with  similar  fluorescence 
intensities (Scheme 4). 
 
Scheme 4. The reaction of a bis-amine (Jeffamine
® ED-900
®) with epoxy SU-8 particles and the subsequent 
amide coupling of Cy-5. Coupling was successful under both organic and aqueous conditions. Coupling 
reagents consisted of either HOBt, TBTU, DIPEA, DMF (organic) or EDC, imidazole buffer pH 7.0 (aqueous) 3. Amide probe immobilisation 
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Imaging  under  the  fluorescence  microscope,  when  particles  were  observed 
perpendicular to the largest face a low fluorescence signal of 6 a.u. was recorded 
(Figure 49, a, b & d), whereas when observed perpendicular to the smaller faces an 
intense signal of 83 a.u. was detected (Figure 49, a, c & e). From a side-on viewpoint 
looking at the smaller faces (Figure 49, c & e), the distribution of fluorescence was 
more obvious where the observed face showed uniform signal (83 a.u.) increasing in 
intensity when approaching the edges connecting with the two other small faces (139 
a.u.).  This  increase  in  intensity  was  not  observed  along  the  long  edges  which 
connected with the largest of the particle’s faces. To rule out internal reflection as an 
explanation  for  this  uneven  fluorescence  signal  distribution  under  aqueous 
conditions, particles were observed suspended in glycerol as the refractive index (n) 
of glycerol is 1.47 (similar to that of the glass slide and cover slip) whereas for water 
n is 1.33. The fluorescence distribution was unchanged in glycerol, indicating the 
distribution  of  fluorescence  was  the  result  of  an  uneven  distribution  of  Cy-5 
fluorophore on the particle surface. From this result it was inferred that the four 
smaller faces of the SU-8 particles had a much greater loading density of epoxide 
available for functionalisation than the two largest faces. 
 
Figure 49. a) A fluorescence microscopy image of Cy-5 coupled SU-8 particles (15) with images highlighting b) 
a  view  perpendicular  to  the  particle’s  largest  face  and  c)  perpendicular  to  a  smaller  face.  Fluorescence 
intensity cross sections across d) the largest face and e) a smaller face 3. Amide probe immobilisation 
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It was unclear how the differences between surfaces of the same particle had been 
introduced.  This  was  a  batch  phenomenon  where  some  particle  production  runs 
would result in the uneven distribution of accessible epoxide whereas others would 
result in a uniform coverage with all six sides having similar loading. There was 
continuity within a production run where all the particles from the same batch would 
exhibit an identical distribution. Batches of particles were produced by apparently 
identical microfabrication protocols. 
As some batches did result in a high (and uniform) epoxide loading density on all six 
particle faces, there did not seem to be a fundamental problem with the fabrication 
process itself. The occasional variation problem was likely to be due to changes in 
baking and UV illumination times, as these were more variable (being controlled by 
an  operator).  Having  longer  illumination  and/or  baking  steps  and  higher 
temperatures  results  in  a  greater  degree  of  cross-linking  between  monomer  units 
which  would  lead  to  a  reduction  in  the  amount  of  residual  epoxy  functionality 
remaining.
249  The  fabrication  could  be  improved  by  the  use  of  automated 
illumination  and  heating  steps  to  achieve  a  greater  consistency  between  particle 
batches. Another cause of variation comes from the evaporation of solvent from the 
commercial SU-8 monomer preparation used. The same bottle of monomer/photo-
acid/solvent would be used for multiple batches of particles; however once a bottle 
was  opened,  solvent  evaporation  would  occur  which  would  result  in  a  higher 
concentration  of  monomer  and  lead  to  a  greater  degree  of  cross  linking.
251 
Automated exposure steps and the use of fresh SU-8 monomer preparation would 
have improved the reliability of particle fabrication, resulting in less epoxide loading 
density variation between different particle batches and more reproducible results. 
The surfaces of the particles were imaged under very high magnification using SEM 
which revealed structural differences between the top/bottom faces and the side faces 
(Figure 50).
250 The two large faces were revealed to be very smooth, whereas the 
smaller faces were far rougher with distinct pits and bumps (features with diameters 
of approximately 100 nm). This showed that the different environments the particle 
faces were exposed to during fabrication had an effect on the physical properties of 
those faces in addition to the chemical properties previously discussed. SEM and 
AFM  images  of  the  surface  of  polymerised  SU-8  layers  have  been  published, 
comparing the structures of these layers after having undergone different degrees of 3. Amide probe immobilisation 
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cross linking.
251 In the published work, the amount of cross linking was lowered by 
reducing the concentration of SU-8 monomer in the solvent during UV exposure. 
The SEM images published were in good agreement with the surfaces observed on 
our  particles  (Figure  50);    where  under  high  monomer  concentration/high  cross 
linking  conditions  a  smooth,  featureless  surface  was  achieved,  whereas 
polymerisation  at  lower  concentrations/reduced  cross  linking  resulted  in  a  rough 
surface with 10 – 20 nm features. 
During the fabrication of our particles it seems likely that the concentration of SU-8 
monomer  was  higher  near  the  surface  than  in  the  bulk  liquid  due  to  solvent 
evaporation. This may result in a higher degree of cross linking on the large top face 
than on the on the small side faces which were immersed in the solvent/monomer 
bulk. The bottom face (the other large face) is unlikely to be affected by solvent 
evaporation, however nor is it in contact with liquid monomer SU-8, therefore under 
high  cross  linking  conditions  (long  illumination  and/or  long  heating  cycles) 
polymerisation could still go to completion again leaving little residual epoxide. 
 
Figure 50. Scanning electron microscopy (SEM) images of SU-8 particles focused on a), a large face and b), a 
smaller (side) face 
 
It is possible to (re)generate surface functionality of polymerised SU-8 under harsh 
conditions,  possibly  by  acid  treatments  (discussed  later)  and  by  oxygen  plasma 
treatments.
252 These treatments are not ideal for the chemistries studied herein as a 3. Amide probe immobilisation 
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mixture of different functional groups are formed, for example, exposure to oxygen 
plasma oxidises the cross-linked SU-8 to form a mixed surface of ether, alcohol, 
aldehyde and carboxylic acid groups. Chemical oxidation could be used to convert 
these alcohol and aldehyde moieties to carboxylic acids (e.g. using Jones reagent, 
Cr
VI), however plasma etching also damages (etches) the polymer surface. 
As epoxide distribution varied between different batches of particles; those with no 
top/bottom face functionality were used for initial testing of various immobilisation 
chemistries whereas particles with more uniform distribution were used for assessing 
the probe loading levels, quantifying non specific binding and in actual multiplex 
assays. 
 
3.2 Probe immobilisation using amide chemistry 
Amide  coupling  between  amine  and  carboxylic  acid  modified  substituents  is  a 
commonly  used  method  for  covalent  linking.
253,254  There  are  many  examples  of 
oligonucleotide probes being immobilised in this way, often utilising the reaction 
between an amino oligonucleotide and a support with acid functionality.
255,256,257 The 
technique  is  widely  used  due  to  the  ease  of  both  oligonucleotide  and  surface 
modifications, the large range of available coupling reagents, the robustness of the 
reaction and the option of coupling under either organic or aqueous conditions. 
As a proof of principal, oligonucleotide probes were immobilised to SU-8 particles 
with a carboxy surface using carbodiimide-mediated amide coupling. Probes were 
purchased with a terminal amine modification and were coupled to acid particles 
which had previously been activated using EDC and sulfo-NHS to give a reactive 
NHS-ester surface (Scheme 5). One sample of carboxyl particles incorporated a 58 
atom Jeffamine
® ED-900
® (8) spacer, whilst another did not (17). Successful probe 
immobilisation  was  observed  by  the  immobilisation  of  Cy-5  labelled  amino 
oligonucleotide (FP2), whereupon the surface of the particles became blue and was 
highly fluorescent (60,000 a.u.). 3. Amide probe immobilisation 
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Scheme 5. The amide coupling of amino modified oligonucleotide probes to SU-8 particles without and with a 
58 atom Jeffamine
® ED-900
® spacer group 
 
Using particles with the amide coupled probe, P2, test hybridisations were carried 
out at room temperature using complementary, T2, and completely mismatching, T3, 
labelled target sequences. Complementary hybridisation occurred and gave a greater 
fluorescent signal compared with the non-complementary (10,000 compared with 
2000)  demonstrating  that  our  SU-8  particles  can  be  used  for  oligonucleotide 
identification after probes have been immobilised by amide coupling. Though this 
experiment  was  a  successful  proof  of  principal,  a  number  of  problems  were 
highlighted which would need addressing. Firstly, though the non-specific binding of 
labelled target sequences to probe particles was very low (as evident by the low 
signal from particles used for the non-complementary hybridisation assay), the non-
specific binging of target to carboxylic acid particles was high. This was unexpected 
as  both  the  target  sequence  and  the  particle  surface  have  the  same  net  charge. 
Furthermore, exposing carboxy particles to FP1 (without any carbodiimide reagents) 
resulted  in  a  high  fluorescence  intensity  showing  that  the  amine  modified  probe 
sequences also exhibit high levels of non-specific binding, likely due to electrostatic 
interactions between amine and acid moieties. This non-specific probe to surface 3. Amide probe immobilisation 
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interaction was found to be a lot more stable than the target to surface interaction, 
and could not be reduced by repeated washing steps. 
The second problem identified was the low hybridisation efficiency of the particles, 
where probe particles exposed to the labelled complementary target were much less 
fluorescent (10,000 a.u.) than particles with labelled probe directly coupled (60,000 
a.u.). A number of factors could affect the number of immobilised probes which are 
able to form complementary duplexes including probes being in a poor orientation 
making  hybridisation  unfavourable  and  the  surface  probe  density  being  too  high 
resulting in steric hindrance.
258 
 
3.3 Calculation of the optimal surface density of oligonucleotide probes 
The  DNA  duplex  has  a  much  larger  cross  sectional  diameter  than  monomeric 
sequences.  If  oligonucleotide  probes  are  immobilised  upon  a  support  to  the 
maximum surface coverage, complete hybridisation to the complementary sequence 
is  (thermodynamically)  disfavoured  due  to  steric  constraints.  An  increase  in  the 
amount  of  duplex  formed  can  be  achieved  by  sacrificing  a  proportion  of  the 
immobilised probes to give room for hybridisation to occur. 
The geometric cross sectional diameter of a DNA duplex is 2 nm, however this does 
not take into account the charge of the molecules, the effective diameter has been 
calculated  and  measured  as  2.7  nm  (in  1  M  Na
+
(aq)).
259,260  We  can  calculate  the 
maximum number of 2.7 nm diameter circles which can fit within 1 cm
2 by using 
hexagonal close packing models developed by Carl Friedrich Gauss (1777-1855) and 
László  Fejes  Tóth  (1915-1995),  which  equates  to  1.58  ×  10
13  circles  per  square 
cm.
261 Therefore the maximum possible surface density of DNA duplexes on a flat 
surface is 1.58 × 10
13 cm
-2. 
Experimental  determination  of  the  density  of  immobilised  DNA  monolayers  has 
been published. Most studies quote values between 0.9 and 1.2 × 10
13 units cm
-2 (1 
M Na
+ or K
+) for single strand immobilisation, whilst immobilising duplex DNA 
results  in  a  less  dense  surface  coverage  of  0.3  ×  10
13  units  cm
-2.
248,262,263  The 
achieved loading densities for single stranded DNA are very close to the theoretical 
maximum for hybridised DNA and they have been found to result in incomplete 3. Amide probe immobilisation 
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hybridisation, with hybridisation efficiency reduced to 10 – 30%.
248,262,263 Reducing 
the  probe  density  leads  to  greater  duplex  formation,  tending  towards  100%  of 
immobilised probes forming duplexes. In the three studies discussed, all probes were 
hybridised to the complementary target sequence once the surface density was below 
0.56, 0.4 and 0.2 × 10
13 units cm
-2.
248,262,263 
Under the assumption that the surface of our particles is flat, the loading density of 
amine is 5 nmol cm
-2 or 3 × 10
15 molecules cm
-2. The succinylation of amines goes 
to completion (resulting in a negative Kaiser test) and so we had a much greater 
surface density of reactive functional groups than should be necessary to achieve an 
efficiently hybridising probe monolayer. Therefore it was thought unsurprising that 
hybridisation on our particles was inefficient as the loading density of probe on the 
surface was likely too high. To achieve the same densities which literature studies 
found to give 100% hybridisation we only need to functionalise approximately 0.1% 
of the surface carboxylic acids with oligonucleotide probes. 
Reducing  the  density  of  probes  bound  may  solve  the  problem  of  probe 
overcrowding. The problem of non-specific target binding to SU-8 particles might be 
addressable using the 99.9% surplus of functional groups. Thus the requirements for 
the design of future particles included the need for control of both probe loading 
densities and of blocking groups designed to minimise non-specific binding. 
 
3.4 Phosphoramidite coupling chemistry 
In order to control surface functionality and properties, a versatile linker technology 
was required which would allow different chemistries to be incorporated and which 
was amenable to DNA chemistry. Phosphoramidite chemistry was seen as the logical 
choice as it is used for the solid phase synthesis of oligonucleotides and a wide 
variety  of  different  functionalities  could  be  incorporated  using  the  same  basic 
coupling reaction. This would allow the surface to be simultaneously modified with 
two different functional groups by coupling two different phosphoramidite reagents 
at the same time. Furthermore, each phosphoramidite coupling would incorporate a 
phosphodiester linkage, it was expected that this phosphate, with negative charge 
under neutral conditions, would reduce the non-specific binding of DNA. 3. Amide probe immobilisation 
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Figure 51. Phosphoramidites used to functionalise SU-8 particles for the immobilisation of oligonucleotide 
probes by amide coupling 
 
3.4.1 The amide coupling of oligonucleotide probes to SU-8 particles modified with 
a hexaethylene glycol phosphoramidite 
Before attempts were made to control the loading density and physical properties of 
the surface of particles by using combinations of different phosphoramidite reagents, 
the surface was functionalised with a single phosphoramidite. The dimethoxytrityl 
(DMTr)  protected  hexaethylene  glycol  (HEG)  phosphoramidite  (21)  was  used  to 
achieve HEG functionalised particles (26) (Scheme 6). The reaction between diol 
functionalised  SU-8  particles  (16)  and  the  HEG  phosphoramidite  (21),  could  be 
monitored  quantitatively  by  the  spectroscopic  analysis  of  the  deprotection 
supernatant.  The  DMTr  protecting  group  (25)  is  labile  under  acidic  conditions 
therefore deprotection with perchloric acid results in a HEG modified surface and the 
release  of  DMTr  cations  (DMTr
+)  into  solution.  These  cations  show  a  strong 
absorbance at 503 nm, which can be quantified and used to determine the surface 
loading density of HEG. This was found to be 8.86 ± 3.5 × 10
-9 mol cm
-2, a similar 
density as that found for Jeffamine
® ED-900
® functionalised SU-8 (8) (5.3 ± 0.9 × 
10
-9 mol cm
-2). HEG functionalised particles could then be further modified using 3. Amide probe immobilisation 
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succinic anhydride to achieve a carboxylate surface (27) to which amine modified 
oligonucleotides could be amide coupled (28). 
 
Scheme 6. The amide coupling of oligonucleotide probes to SU-8 particles modified with HEG 
phosphoramidite (21) 
 
The coupling of fluorescently labelled oligonucleotide probes was investigated under 
a range of conditions (Figure 52). The results indicated that the coupling of and/or 
non-specific binding of amine modified probes to HEG functionalised SU-8 particles 
(26) was minimal as indicated by the low fluorescence signal (~5000 a.u.) whereas 
the  coupling  between  probes  and  a  carboxylate  surface  (27)  had  been  achieved 
(54,000 a.u.). However, the exposure of carboxylate functionalised particles to amine 
modified oligonucleotide without the coupling mediators EDC and sulfo-NHS also 
resulted  in  a  high  fluorescence  signal  (36,000  a.u.)  indicating  significant  non-
covalent  binding.  The  exposure  of  the  carboxylate  particles  to  a  labelled  target 
oligonucleotide (without any amine modification) showed non-specific binding to be 
low (3500 a.u.) in this system. This suggested that the high levels of non-covalent 
binding observed were the result of charge interactions between the surface coupled 
carboxylate (negative at pH 7) and the probe coupled amine (positive). Extensive 3. Amide probe immobilisation 
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washing (48 hours) in SSPE (5×) buffer did result in a reduction in the fluorescence 
intensity of all the samples (excluding the blank), with the loss of non-covalently 
immobilised probe being greater than that for probe coupled in the presence of EDC 
and sulfo-NHS. These washing studies indicated that approximately 50% of the total 
immobilised probe was actually covalently coupled to the particles when EDC and 
sulfo-NHS  coupling  mediators  were  used,  the  other  50%  being  an  electrostatic 
interaction. 
 
Figure 52. The amide coupling of amino functionalised oligonucleotide probes to carboxyl SU-8 particles. FP2 
is  a  fluorescently  labelled  oligonucleotide  with  a  3’  amine  modification,  T2  is  a  similarly  labelled 
oligonucleotide lacking the amine modification. Negative controls showed coupling to be selective towards 
carboxyl (rather than hydroxyl) surfaces and that the non-specific binding of oligonucleotides was relatively 
minimal except in the case of amine modified sequences, this indicated a strong electrostatic interaction 
between the modified 3’ end of the oligonucleotide and the surface which would be oppositely charged at 
neutral pH 
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An unlabelled but amine modified oligonucleotide, P1, was covalently immobilised 
on the surface of carboxylate SU-8 particles (27), these particles were then used to 
assess  the  discrimination  between  labelled  target  oligonucleotides  with  differing 
sequences (Figure 53). 
 
Figure  53.  Hybridisations  to  oligonucleotide  probes  which  had  been  immobilised  by  amide  coupling  to 
carboxylate SU-8 particles (27), shown are the fluorescence signals of blank particles, a positive control of the 
coupling of a labelled probe, exposure to a labelled complementary target oligonucleotide and exposure to a 
labelled non-complementary target 
 
The  studies  showed  the  immobilised  probes  could  discriminate  between 
complementary  and  non-complementary  target  sequences,  giving  a  fluorescence 
ratio  of  6:1  after  no  optimisation  of  the  hybridisation  conditions.  However  the 
hybridisation efficiency was still observed to be poor, with only 9% of the probe 
sequences able to form the complementary duplex.  
As discussed previously, this poor hybridisation efficiency may have been the result 
of steric hindrance where the surface concentration of probes was too high impeding 
duplex formation (Chapter 3.3). This problem would be investigated in later studies 
with attempts to control the loading density of probe using mixtures of different 
phosphoramidites. 
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3.4.2 Stability and recycling of probe-functionalised SU-8 particles 
The  stability  of  the  amide  linkage  of  oligonucleotide  probe  functionalised  SU-8 
particles  (28)  was  investigated  under  different  environmental  conditions.  The 
fluorescently labelled probe, FP2, was coupled to the particles and a sample of these 
particles was heated to 70 °C for 20 minutes, whilst a second sample was suspended 
in 2 M urea solution for 2 minutes. These particle samples were then washed using 
SSPE (5×) buffer and then imaged by fluorescence microscopy. Heat treatment was 
found to result in only a small reduction of the fluorescent signal (5% drop compared 
with signal prior to heating). Suspension in urea resulted in a slightly greater loss 
(10%). These reductions in the fluorescent signal may have been a result of damage 
to the cyanine fluorophore rather than any loss of probes from the surface, however, 
for under the conditions examined, probe loss or damage was certainly minimal.
264 
To  assess  the  re-usability  of  probe  functionalised  particles  (28),  a  sample  was 
subjected to successive hybridisation and denaturation cycles with the fluorescent 
signal being measured at each stage (Figure 54). Two complementary hybridisation 
cycles  were  performed  where  probe  functionalised  particles  were  exposed  to  the 
labelled  complementary  sequence  and  the  fluorescence  measured,  followed  by 
heating to 70 °C for 20 minutes to denature any duplex formed. The same sample of 
particles  was  then  exposed  to  the  non-complementary  sequence,  followed  by  a 
further  heat  denaturation.  The  particles  were  then  hybridised  a  fourth  time,  once 
again  to  the  complementary  target.  The  results  showed  the  probe  functionalised 
particles to be stable to at least two hybridisation and heating cycles, suggesting that 
the same particles could be used for more than one hybridisation assay, reducing 
operating costs and materials used. It could also allow the perpetual monitoring of an 
environment,  a  type  of  continuous  monitoring.  This  particle  recycling  was  not 
possible when using the less robust affinity immobilisation, only covalent coupling 
results in a sufficiently stable linkage. 3. Amide probe immobilisation 
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Figure 54. Multiple hybridisation and duplex denaturation cycles on probe functionalised SU-8 particles (28). 
Probe, PF, was immobilised via amide bond formation to carboxylate functionalised SU-8 (27). The particles 
were then exposed sequentially to complementary, TC, and non-complementary, TH, target oligonucleotides 
sequentially, interspersed with heating steps. The results found the probe functionalised SU-8 particles to be 
stable to multiple assay repeats (at least three repeats) allowing the possible reuse of individual particles 
 
3.4.3 Control of functional group loading density using a methoxy triethylene glycol 
blocker group 
To improve the hybridisation efficiency of immobilised oligonucleotide probes we 
desired control of the loading density of the reactive HEG moiety, working under the 
premise that reducing the density of HEG groups would lead to a less crowded probe 
surface  making  duplex  formation  more  favourable.  The  synthetic  route  to  HEG 
coated SU-8 particles (26) was modified to include a methoxy triethylene glycol 
(TEG) phosphoramidite (22) to space out the HEG functionalisation. The resulting 
surface  was  expected  to  consist  of  a  mixture  of  reactive  HEG  and  blocking 
methoxyTEG moieties in the same proportion to that used in the reaction (Scheme 
7). 3. Amide probe immobilisation 
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Scheme 7. The amide coupling of oligonucleotide probes to SU-8 particles modified with a mixture of 
methoxyTEG phosphoramidite (22) and HEG phosphoramidite (21). The resultant probe loading is dependent 
upon the initial phosphoramidite ratios used 
 
By  reaction  with  varying  ratios  of  HEG  (21)  and  methoxyTEG  (22) 
phosphoramidites  the  loading  density  of  surface  hydroxyl  was  controllable. 
Quantification of trityl ion (DMTr
+) in the deprotection supernatant revealed that 
loading densities of 0.07, 0.19, 0.97 and 9.7 nmol cm
-2 were obtained. 
However, after the reactive HEG moiety had been converted to carboxylate (30), the 
amide  coupling  of  an  amine-modified  and  fluorescently  labelled  oligonucleotide 
giving (30) showed no dependence on the different particle loading densities (Figure 
55). Coupling of an unlabelled amine probe allowed hybridisation studies, these too 
showed no change between particles with differing hydroxyl loading densities with 
hybridisation efficiency remaining poor (~20%). 3. Amide probe immobilisation 
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Figure 55. The amide coupling of fluorescently labelled and un-labelled probes to carboxylate SU-8 particles 
(29) of differing HEG loading densities, the fluorescence of un-labelled probe particles (30) when exposed to 
labelled complementary and mismatching sequences is shown. The reduction of HEG loading density (from 
9.7 to 0.07 nmol cm
-2) had no effect on either the final loading density of FP1 or the hybridisation efficiency 
 
This result suggested that although control of the loading density of HEG on the 
particle surface had been achieved, this did not translate into control of the loading 
density of oligonucleotide probes subsequently immobilised. The immobilisation of 
amine modified probes via amide coupling resulted in a similar loading density for 
all samples. This loading density  was likely similar to HEG functionalised SU-8 
particles (26) (with no methoxyTEG blocking groups) discussed previously, as the 
fluorescence  intensities  upon  FP2  coupling  and  hybridisation  efficiencies  were 
similar (comparing Figure 53 with Figure 55) in both particle types. 
Subsequent studies would reveal a fundamental flaw to this coupling strategy which 
explained the apparent loss of loading control, these will be discussed towards the 
end of the chapter (3.5). 
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3.4.4 Altering surface functionality to reduce nonspecific oligonucleotide binding 
The hybridisation of a labelled target oligonucleotide to probe functionalised SU-8 
particles (31) (with control of HEG loading density) was studied. Different probe 
sequences had been coupled to the particles, which were then exposed (separately) to 
the  target  sequence,  TC.  The  immobilised  probes  represented  a  complementary 
sequence, PF, two non-complementary sequences, PH and PI, and one sequence 
representing  a  single,  mid-sequence,  base-pair  mismatch,  PG  (a  G:G  mismatch) 
(Figure  56).  Discrimination  between  the  complementary  and  the  two  non-
complementary pairings was achieved under mild washing protocols (a 2 minute 
aqueous  wash),  whilst  discrimination  between  the  complementary  and  the  single 
base mismatch pairings required a more stringent washing protocol (aqueous wash 
followed  by  suspension  in  2  M  urea  solution  for  2  minutes).  The  ratio  of  the 
fluorescence  of  particles  exposed  to  the  complementary  and  the  single  base 
mismatching targets was 6:1 after stringent washing. 
 
Figure  56.  The  exposure  of  SU-8  particles  (31)  functionalised  with  different  probes  to  a  labelled 
oligonucleotide target, TC. The loading density of HEG was measured as 0.01 nmol cm
-2, with methoxy TEG as 
a blocking group. The immobilised probes represented the complementary, a single G:G mismatch and two 
completely  non-complementary  sequences  for  the  target  oligonucleotide.  Urea  washing  resulted  in 
discrimination  between  the  complementary  and  the  single  base  mismatching  sequence  pairs  (6:1 
fluorescence ratio). 
 
To maximise the difference in signal between probes exposed to the corresponding 
complementary sequences and any mismatching target, non-specific binding has to 3. Amide probe immobilisation 
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be negligible. The non-specific binding of labelled DNA to differently functionalised 
SU-8  surfaces  were  investigated  (Figure  57).
265  Binding  was  measured  to  SU-8 
functionalised  with  diol  (-OH),  HEG  (-OH),  methoxy  (-OMe)  and  phosphate  (-
OPO3
-2) surfaces. Target DNA showed moderate to high levels of binding to diol, 
HEG and methoxy SU-8 whereas the phosphate surface significantly reduced non-
specific binding. This study showed the methoxyTEG phosphoramidite to be a poor 
choice for a blocking group, as non-specific DNA binding was high. Much better 
would  be  the  use  of  phosphate  as  a  blocking  moiety  to  improve  discrimination 
between complementary and mismatching target sequences. 
 
Figure 57. A study of non-specific binding of an antibody and an oligonucleotide to various SU-8 surface 
functionalities 
 
3.4.5 Control of functional group loading density using a phosphate blocking group 
A  biscyanoethyl  phosphoramidite  (23)  was  used  to  install  a  phosphate  blocking 
moiety on the SU-8 particle surface. Attempts were made to achieve a mixed HEG 
and phosphate surface using similar methods to those used previously for a mixed 
methoxyTEG/HEG  surface  (Scheme  7).  However,  control  of  the  HEG  loading 3. Amide probe immobilisation 
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density could never be achieved, with all samples having a similar (and high) HEG 
loading. This was different to the previous problems encountered, where control of 
HEG  loading  had  been  achieved  but  had  not  then  resulted  in  control  of  probe 
loading. NMR analysis of the biscyanoethyl phosphoramidite (23) showed it to have 
degraded to the oxidised phosphoramidate. 
 
Scheme 8. The amide coupling of oligonucleotide probes to SU-8 particles modified with a mixture of CPR 
phosphoramidite (24) and HEG phosphoramidite (21) 
 
A different phosphoramidite was used to act as a blocking moiety on the particle 
surface and still result in a predominantly phosphate functionality to reduce non-
specific target binding. The synthetic route to probe functionalised SU-8 particles 
using chemical phosphorylating reagent (CPR) phosphoramidite (24) as the blocking 
group  was  modified  from  that  used  previously  to  obtain  varying  HEG  and 
methoxyTEG surface densities (Scheme 8). Control of the HEG loading density was 
achieved  when  using  CPR  phosphoramidite  (24)  as  a  phosphate  blocking  group 
(Figure 58). 3. Amide probe immobilisation 
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Figure 58. Control of the loading density of HEG functionalised SU-8 particles (32) using CPR phosphoramidite 
(24) to impart a phosphate blocking group 
 
Though  varying  CPR  (24)  to  HEG  (21)  phosphoramidite  ratios  during  particle 
functionalisation did result in control of the HEG loading density, this once again did 
not  translate  into  control  over  the  density  of  immobilised  probes.  Particles 
functionalised  with  varying  HEG  loading  densities  were  reacted  with  succinic 
anhydride to form a carboxylate surface (33) to which the amine modified and Cy-5 
labelled  oligonucleotide,  FP2,  could  be  coupled  using  carbodiimide  chemistry. 
Though these particles (34) previously had defined loading densities as measured by 
trityl  ion  quantification,  all  particles  now  fluoresced  with  a  similar  intensity 
regardless of the expected probe loading density. Negative control particles which 
had an entirely phosphate surface (no reactive HEG groups) also fluoresced after the 
attempted amide coupling of labelled probe (Figure 59, a.), implying flaws in the use 
of phosphate blocking groups with an amide coupling strategy. 
 
3.5  The  incompatibility  of  phosphate-functionalised  SU-8  with  an  amide 
immobilisation strategy  
The nonspecific binding of both amino modified and unmodified, labelled DNA to 
phosphate functionalised SU-8 (35) was investigated. Amino modified and labelled 
oligonucleotide  showed  significant  binding  when  mixed  with  phosphate 
functionalised particles whereas labelled oligonucleotide lacking a terminal amine 3. Amide probe immobilisation 
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modification showed very little nonspecific binding (Figure 59, b. and d.). The amino 
modified and labelled oligonucleotide probe has a net negative charge at neutral pH, 
but is zwitterionic due to the terminal amine, thus there is likely an electrostatic 
attraction  between  the  positive  amine  and  the  negative  phosphate  surface  which 
could help to immobilised the probe. This interaction may result in a degree of order 
at  the  surface,  with  probes  being  immobilised  via  the  terminal  amine  and  thus 
available for hybridisation. This result showed the phosphate group used to control 
loading  levels  and  reduce  nonspecific  DNA  binding  is  incompatible  with  the 
coupling of amine modified probes as the charge interactions lead to nonspecific 
binding  to  the  phosphate  surface.  This  problem  might  have  been  mitigated  by 
changing the pH of the wash buffer to change the net charges of the surface or probe; 
however in the light of more serious problems being identified, the effect of the pH 
environment was never tested. 
A  labelled  oligonucleotide  without  a  terminal  amine  moiety,  TC,  was  shown  to 
couple to phosphate particles when EDC and sulfo-NHS coupling mediators were 
present  (Figure  59,  c.).  The  resulting  fluorescence  was  equal  to  the  coupling  of 
amino  modified  probes  and  showed  that  the  phosphate  group  reacted  with  DNA 
indiscriminately, coupling sequences with or without terminal amine modifications 
(36).  The  fluorescence  was  thought  to  arise  as  a  result  of  coupling  between  the 
phosphate  and  nucleophilic,  exocyclic  amines  in  the  oligonucleotide  to  form  a 
phosphoramidate  linkage  (Scheme  9).  Controlling  the  loading  density  using 
phosphate blocking groups was thus not compatible with the immobilisation of DNA 
via amide coupling chemistry as the probe couples to both the blocking phosphate 
groups  as  well  as  any  carboxylate  groups,  resulting  in  all  particles  having  an 
approximately equal probe loading density regardless of the initial phosphate to acid 
ratio. In fact, oligonucleotide probes have been reported to be immobilised via the 
phosphate  backbone,  coupling  to  amine-modified  sensor  surfaces.
266  Any  probes 
immobilised with attachment through the aromatic base amines would be arranged 
flat on the particle surface and likely not in an ideal configuration for hybridisation. 
It is perceivable that amine-modified probes could also be attached both through the 
terminal amine and the mid-sequence base amines. The poor probe orientation which 
would  likely  result  would  impede  duplex  formation,  helping  to  explain  the  poor 3. Amide probe immobilisation 
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hybridisation efficiency of our immobilised probes, where only approximately 15% 
of probes form a duplex with their labelled complementary target. 
 
Figure  59.  Phosphate  SU-8  with  a.)  aminoDNA,  EDC  and  NHS  (measuring  specific  probe  coupling),  b.) 
aminoDNA (electrostatic interaction, c.) DNA, EDC, NHS (coupling via DNA base amines) and d.) DNA (non-
specific binding) 
 
 
Scheme 9. The likely formation of a phosphoramidate bond between phosphate SU-8 particles and an amine 
modified oligonucleotide 
 
3.6 Conclusions 
Phosphoramidite coupling had been found to be a versatile method for the surface 
modification of SU-8 microparticles, allowing for a choice of various blocking and 
reactive functionalities, control of loading density and the inclusion of spacer groups. 
Oligonucleotide probes modified with a terminal amine had been covalently coupled 3. Amide probe immobilisation 
 
131 
 
to carboxyl functionalised particles and these particles were shown to discriminate 
between complementary and mismatching target sequences with minimal washing 
steps required. Discrimination of hybridisation between complementary sequences 
and those mismatching by a single base pair required a more stringent urea wash, the 
linkage immobilising DNA probe to the particle surface was demonstrated to be 
stable under washing and denaturing conditions. As the probe immobilisation was 
strong, probe functionalised particles were shown to be recyclable allowing future 
uses in continuous monitoring. 
Control of the loading density of surface functionality did not, however, translate 
into  control  of  oligonucleotide  probe  density.  This  was  because  the  phosphate 
blocking group had been found to be incompatible with amide coupling. This meant 
that either different blocking groups or a change of probe coupling chemistry were 
required to effect control over non-specific binding and hybridisation efficiency. The 
phosphate blocker had proven to significantly reduce non-specific oligonucleotide 
binding, was easy to couple and the loading of which could be easily monitored, 
therefore  the  decision  was  taken  to  focus  on  changing  the  probe  immobilisation 
chemistries used. 
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4.0 Hybridisation suspension arrays with probe immobilisation via the Cu
I 
catalysed Huisgen 1,3-dipolar alkyne-azide cycloaddition reaction 
 
Huisgen 1,3-dipolar cycloaddition reactions fuse alkyne and azide functionalities to 
form 5-membered hetrocycles (triazole).
185 Interest in this reaction was sparked by 
Sharpless, who highlighted it as an important component of his ‘click chemistry’ 
philosophy,  detailing  the  facile  synthesis  of  diverse  libraries  of  compounds 
exhibiting biological activity from simple reagents using a limited number of very 
efficient reactions.
267 The discovery of the catalysis by  copper  (I) of the  triazole 
forming reaction between alkyne and azide, allowing 1,3-dipolar cycloadditions to 
be performed at room temperature, opened up  further uses  for the reaction.
268,186 
These reactions were found to be highly chemoselective, only occurring between 
alkyne and azide, and regioselective, predominantly forming 1,4 (rather than 1,5) 
disubstituted triazoles (45) from substituted reagents. Since it works equally well 
under either organic or aqueous conditions and on solid supports the reaction has 
found  uses  beyond  synthesis  and  is  commonly  used  as  a  linking  reaction.  Two 
separate  molecules  may  be  linked  in  a  controlled  manner  if  one  contains  an 
accessible alkyne (38) and the other an azide (41). Though copper salts have been 
found to degrade oligonucleotides, tris-triazole ligands have been developed which 
serve  to  both  stabilise  the  Cu(I)  ion  under  aqueous  conditions  and  reduce 
degradation.
269,270 As both alkynyl and azido moieties are rarely found in nature the 
reaction is often utilized to link two biomolecules in a well defined manner after 
having artificially incorporated the reactive groups.
271 A proposed reaction scheme, 
incorporating the stabilising tris-triazole ligand is shown (Scheme 10).
274 
Though the term click chemistry as defined by Sharpless, encompasses a variety of 
important reactions, for the purposes of clarity and conciseness in this work, click 
chemistry and the click reaction refer specifically to the Cu(I) catalysed Huisgen 1,3-
dipolar cycloaddition. 4. Click probe immobilisation 
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Scheme 10. A proposed mechanism for the copper catalysed Huisgen 1,3-dipolar cycloaddition between 
alkynes and azides, with the Cu(I) stabilising tris-triazole ligand present 
 
4.1 Optimisation of the click reaction on the solid phase 
Due to the chemoselectivity and regioselectivity of the Cu(I) mediated 1,3-dipolar 
cycloaddition, the reaction was used to immobilise oligonucleotide probes to the SU-4. Click probe immobilisation 
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8  particle  supports.  By  functionalising  SU-8  particle  surface  with  alkyne  and 
terminally  modifying  oligonucleotide  probes  with  an  azido  moiety,  probes  were 
expected to attach to the surface ‘end-on’ and form a highly ordered monolayer with 
probes in an ideal orientation for efficient hybridisation. This strategy was expected 
to  be  compatible  with  the  phosphate  blocking  group  which  had  previously  been 
shown to reduce the nonspecific binding between DNA and SU-8, this would be in 
contrast to the amide coupling previously attempted (Chapter 3.0) which displayed 
poor  chemoselectivity  with  reaction  occurring  between  amine  and  both  acid  and 
phosphate groups. One aim was for the improved selectivity to be utilised to control 
probe loading density, giving further scope for optimisation. 
In  order  to  functionalise  amine-terminated  oligonucleotide  sequences  a  6-azido 
hexanoic acid NHS-ester (azide modifier) was synthesised, this could be coupled to 
amino-DNA with the final sequence having a terminal azide.
272 The azide modifier 
was also used to functionalise Cy-5 fluorophore, giving (47) for use as a standard 
and positive control. Cy-5 was considered a good control for DNA immobilisations 
due to both its use as a label in target sequences and its net negative charge under 
neutral aqueous conditions. The Cu(I) stabilising tris-triazole ligand (48) was also 
synthesised  in  high  yield.  Some  phosphoramidites  for  the  functionalisation  of 
particles with phosphate and alkyne were commercially available. 
 
4.1.1 Optimisation of the click reaction using GMA beads 
 
Scheme 11. The click coupling of azido Cy-5 to alkyne modified glycidyl methacrylate (GMA) beads 
 
Early studies set out to optimise the click reaction on the solid support with initial 
optimisation being carried out on GMA beads  as a large quantity  was available. 
Amino  GMA  beads  (amine  loading  at  ~1  nmol  cm
-2)  were  functionalised  with 4. Click probe immobilisation 
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pentynoic acid to afford an alkynyl surface (46). Azido Cy-5 (47) was coupled to the 
alkynyl particles using click chemistry (Scheme 11). Early  results indicated little 
coupling was taking place, but by increasing the reagent concentrations {azide (100 
 M), Cu (2 mM)} coupling was complete within four hours. The immobilisation of 
Cy-5  was  evident  by  the  blue  staining  of  the  previously  white  GMA  particles 
(negative control particles, being a combination of all the reagents with the exception 
of  the  Cu(I)  catalyst,  remained  white  (Figure  60).  Fluorescence  however  was 
extremely low. Measurements of the fluorescence of amino GMA particles using the 
FACS (gain set at 500 V) gave a value of ~100 a.u. whilst after Cy-5 coupling this 
rose  only  slightly  to  ~560  a.u..  Washing  with  dilute  NaOH(aq)  was  expected  to 
remove any unreacted azido Cy-5 which was non-specifically bound and decrease 
the  intensity  of  fluorescence,  however  upon  washing  an  increase  in  bead 
fluorescence was instead observed (~900 a.u. after 10 minutes wash). The intense 
blue  colour  of  the  beads  and  the  low  initial  fluorescence  which  increased  with 
washing suggested that coupling had been successful and had actually resulted in a 
very high density of fluorophore at the surface leading to the formation of cyanine 
dimers and subsequent fluorescence quenching.
215, 273 This result demonstrated that 
the click reaction could be used to functionalise supports similar to SU-8 and had 
established an initial protocol to use for click coupling. 
 
Figure  60.  Results  of  the  Huisgen  1,3-dipolar  cycloaddition  between  azide-modified  Cy-5  and  alkyne 
functionalised GMA. Pelleted beads are shown, with the right-hand tube containing all reagents and the left-
hand tube acting as a negative control containing all reagents minus the required copper catalyst 
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4.1.2 Optimisation of the click reaction on SU-8 microparticles 
 
Figure 61. The structures of phosphoramidites used for SU-8 functionalisation 
 
Following  optimisation  on  GMA,  the  click  coupling  was  attempted  on  SU-8 
particles.  Diol  particles  (16)  were  modified  using  mixtures  of  CPR  blocking 
phosphoramidite (24) (phosphate) and reactive alkynyl phosphoramidite (52) to yield 
particles (55) with a range of loading levels, measured by trityl ion analysis (Figure 
62). Azido Cy-5 (47) was then click coupled using the same conditions which had 
previously resulted in coupling to GMA beads. SU-8 particles did not change colour 
but did show an increase in fluorescence, the intensity of which appeared inversely 
proportional to the loading of surface phosphate (and therefore can be assumed to be 
directly  proportional  to  the  surface  loading  of  alkyne),  indicating  successful  and 
selective  click  coupling  (Figure  63).  Fluorescence  intensity  was  not  very  high 
{~18,000 a.u. (FACS gain set at 500 V), at 7.5 nmol cm
-2 alkyne loading}, this and 4. Click probe immobilisation 
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the lack of a colour change suggested the click coupling reaction had not gone to 
completion.  
 
Figure 62. SU-8 particles functionalised with alkyne (52) and phosphate (24) phosphoramidites, no spacer 
incorporation 
 
 
Figure  63.  Control  of  surface  alkyne  loading  density  using  a  mixture  of  alkynyl  (52)  and  blocking 
phosphoramidites (24), subsequent click coupling of azido Cy-5 confirmed that loading control had been 
maintained 
 
 
Figure 64; SU-8 particles functionalised with alkyne incorporating the 64-atom Jeffamine
® ED-900
® (14) spacer 
 4. Click probe immobilisation 
139 
 
SU-8 particles with an amino surface (Jeffamine
® ED-900
®) (8) are chemically more 
similar  to  GMA  beads  to  which  click  reactions  had  proven  to  be  high  yielding, 
therefore  these  particles  were  alkyne-functionalised  using  pentynoic  acid  (with 
product particles (56) testing negative for amine by ninhydrin quantification) (Figure 
64). Click chemistry was again used to link azido Cy-5 (47), this time particles were 
stained  intensely  blue  and  were  found  to  fluoresce  brightly.  The  fluorescence  of 
these particles incorporating a 64-atom spacer could not be directly compared with 
those  modified  previously  (using  the  9-atom  phosphoramidite  spacer)  due  to 
fluorescing above the FACS’s detection limit when measured under the previously 
used settings (F > 260,000 a.u. with gain set at 500 V). Changing the cell sorter 
instrumentation settings by lowering the gain to 300 V allowed precise measurement 
of particle fluorescence. Intensity was initially 42,000 a.u., upon thorough aqueous 
NaOH washing fluorescence dropped to 32,000 a.u. implying most of the signal was 
from  covalently  immobilised  fluorophore.  Though  the  reaction  worked  well  on 
alkyne modified particles incorporating a 64-atom Jeffamine
® ED-900
® spacer (14), 
these particles could not be a substitute for phosphoramidite modified particles due 
to  both  having  no  control  over  probe  loading  densities  and  the  amine  surface 
displaying relatively high DNA non-specific binding. 
 
4.1.3 Combining spacer groups and loading control for high yielding click reactions 
 
 
Figure 65. SU-8 particles functionalised with alkynyl (52) and phosphate (24) phosphoramidites incorporating 
the 29-atom HEG phosphoramidite (21) as a spacer 
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Phosphoramidite chemistry was adapted to incorporate spacers between the alkyne 
and  the  surface  which  would  allow  the  probe  loading  density  to  be  controlled. 
Particles were first functionalised with HEG phosphoramidite which was followed 
by a second round of phosphoramidite coupling, this time using a mixture of CPR 
(24) and alkynyl (52) phosphoramidites. This yielded particles (57) which once again 
had a mixed surface of reactive alkynyl and blocking phosphate groups but now all 
functionality was distanced from the surface by a 29-atom HEG spacer (Figure 65). 
One sample of the HEG particles was functionalised using equal measures of the 
CPR and alkynyl phosphoramidites, whilst a second (control) sample of particles 
was wholly functionalised with CPR phosphoramidite. The two particle types were 
found to have phosphate loading densities of 4.8 and 8.3 nmol cm
-2. Click coupling 
of azido Cy-5 to the 50% alkyne-functionalised particles was instantly recognisable 
by being stained blue, whereas particles containing no alkyne remained uncoloured. 
 
Figure 66. The fluorescence intensities of two particle surfaces (100% phosphate {–ve control} and 50:50 
alkyne:phosphate) after the attempted click coupling of azidoCy-5. Fluorescence of the alkyne surface is 2 
orders of magnitude more intense than to the blocked surface and is more stable to aqueous wash steps, 
indicating successful coupling 
 
Similar  to  when  click  coupling  fluorophore  to  alkyne  SU-8  incorporating  a 
Jeffamine
®  ED-900
®  spacer  (56),  the  fluorescence  when  having  coupled  to  50% 
alkyne HEG-particles (57) was too intense for quantitative analysis using the FACS 
set  to  previous  gain  settings.  Gain  was  reduced  to  300  V  and  fluorescence  was 4. Click probe immobilisation 
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measured  as  62,400  a.u.  compared  with  just  330  a.u.  for  the  blocked  phosphate 
particles (Figure 66). Further washing using SSPE(5×) buffer with 0.02% Tween-
20
® added and the subsequent suspension for 10 minutes in 1 M NaOH(aq) had no 
effect on the fluorescence of 50% particles whilst the level of non-specific binding to 
the blocked particles reduced resulting in the lower fluorescence intensity of 120 a.u. 
(giving a signal to noise ratio of 540:1). 
In  summary,  these  results  showed  the  aqueous  click  protocol  to  link  an  azide 
modified species to an alkyne functionalised surface to be efficient, experimentally 
simple and compatible with phosphate functionality. Loading control of alkyne had 
been maintained through the reaction and non-specific binding of the azido Cy-5 was 
found to be very low. 
The  experiments  did  highlight  the  importance  of  a  spacer  group  to  distance  the 
alkyne moiety from the particle surface. Coupling had been found to be poor to 
alkyne  particles  (55)  where  the  reactive  moiety  was  less  than  9  atoms  from  the 
polymer surface. However adding a spacer (29-atom HEG phosphoramidite (21) or 
64-atom Jeffamine
® ED-900
® (14)), led to efficient click coupling. This prominent 
spacer effect was likely the result of reduced steric hindrance during the reaction. 
Though the exact structure of the intermediate complex formed between the copper 
catalyst,  tris-triazole  ligand,  immobilised  alkyne  and  azido  Cy-5  has  not  been 
characterised,  it  is  certain  to  be  rather  large.
274,275  Expanding  on  literature 
speculation, one possible structure for this intermediate complex (42) is proposed 
(Figure 67), a large complex indeed when R represents a 1000  m
3 particle and R’ 
an  azido-fluorophore  with  a  molecular  weight  exceeding  700  Da.  Further  to  the 
steric factors discussed, poor reaction may also be accounted for by the effects of the 
diffusion layer, where reactions on surfaces are limited by mass transfer rather than 
bulk mixing effects, this is a result of the liquid in close contact with the surface 
(interphasic boundary) being shielded from bulk mixing forces.
276,277 The longer the 
spacer group, the closer the alkyne moiety is to the bulk liquid and any azide present, 
resulting in a faster rate of reaction. 4. Click probe immobilisation 
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Figure 67. A proposed intermediate/transition state complex formed during copper catalysed Huisgen 1,3-
dipolar cycloaddition 
 
4.2 Control of loading density through sequential phosphoramidite couplings 
With the necessity of spacer groups having been established, attention was turned 
towards the positioning of the phosphate group. This group was included to limit the 
nonspecific  binding  of  DNA  to  the  particle  surface  and  to  space-out  surface 
immobilised probe. The result of including phosphate should therefore lead to both a 
reduction in background signal (noise) and an increase in the efficiency of specific 
hybridisation in subsequent DNA assays. 
Previous iterations of particle functionalisation had added loading control during the 
final  phosphoramidite  coupling  and  resulted  in  good  regulation  of  alkyne  and 
phosphate loading densities. However by this sequence of coupling both reactive and 
blocking groups were tethered on the end of HEG spacers. The close proximity of 
the phosphate to any click-coupled oligonucleotide probes was a cause for concern 
as  it  was  feared  that  the  high  density  of  negative  charge  may  interfere  with  the 
specific hybridisation of any complementary DNA targets. 
The next design of alkynyl particle placed the phosphate much closer to the particle 
surface  and  thus  distanced  it  from  any  probe  coupling  (and  therefore  any 
hybridisation  events),  control  of  loading  density  was  now  achieved  in  the  initial 
phosphoramidite coupling rather than during the final coupling. 
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4.2.1 Spacing the reactive alkyne further from the blocking phosphate functionality 
 
Figure 68. SU-8 particles functionalised with alkynyl (52) and phosphate (24) phosphoramidites incorporating 
the 29-atom HEG phosphoramidite (21) spacer and employing loading control early in the synthetic route 
 
Particles were functionalised to compare yield of the click reaction and control of 
loading density when phosphate was  either on  the end of a 29-atom spacer (57) 
(Figure  65)  or  when  close  to  the  surface  (58)  (Figure  68).  Differing  alkyne  to 
phosphate ratios were coupled for both spacer arrangements yielding particles with 
100%  and  10%  alkyne  surfaces  or  surfaces  fully  blocked  with  phosphate  (as  a 
negative  control).  After  azido  Cy-5  had  been  coupled  and  the  particles  washed 
thoroughly, samples were analysed using fluorescence microscopy (Figure 69). 
 
 
Figure 69. Fluorescence microscopy images of functionalised SU-8 particles after the click coupling of azido 
Cy-5. Particles in images on the top row incorporated a HEG spacer for both phosphate and alkyne moieties 
and control of alkyne loading density was afforded by the final phosphoramidite coupling step (coupling to 
(57)). Particles in images on the bottom row incorporated a HEG spacer only for the alkyne moiety with 
phosphate  closer  to  the  surface,  here  control  of  alkyne  loading  density  was  afforded  by  the  initial 
phosphoramidite coupling step (coupling to (58)). Attempted phosphate : alkyne ratios are a) 10:0, b) 9:1 and 
c) 0:10 4. Click probe immobilisation 
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Little difference was observed in the yields of the click reaction with respect to the 
spacer layout, this was indicated by the similar fluorescence intensity of azido Cy-5 
coupling to both types of fully alkyne functionalised particles (Figure 69,c) and this 
indicated that the close proximity of spacer-coupled phosphate to the alkyne did not 
interfere with the click reaction. A difference was observed between the two spacer 
designs with regard to the control of loading density. As for previous couplings, 
good  loading  control  had  been  achieved  when  differing  ratios  of  the  two 
phosphoramidites  were  coupled  together  in  the  final  step  (Figure  69,  top  row), 
however  when  loading  control  was  attempted  in  the  initial  couplings  it  was  not 
carried through by later functionalisation steps (Figure 69, bottom). Coinciding with 
this disappearance of loading control, measurements of trityl ion after deprotection 
did correlate with the various phosphate and alkyne ratios indicating loading control 
had been achieved. 
In summary, attempts to control functional group loading density during the initial 
coupling of phosphoramidite mixtures had proved successful (as measured by trityl 
ion  analysis),  however  with  subsequent  rounds  of  phosphoramidite  coupling  this 
control  was  lost.  It  was  proposed  that  a  regeneration  of  surface  hydroxyl  had 
occurred at some point during functionalisation, negating the prior blocking. 
 
4.2.2 Acidic degradation of SU-8 
Coinciding with the discovery of the poor retention of loading control, degradation 
of polymerised SU-8 was noted upon prolonged immersion in acidic media.
272 The 
effect of acid on the surface of particles was further investigated using a range of 
acidic solutions and immersion times. Minor particle damage and surface etching 
(roughening)  was  observed  under  acidic  conditions  compared  with  suspension  in 
water  (Figure  58).  If  polymer  cross-linking  were  unstable  to  acid,  new  hydroxyl 
groups  could  be  formed  which  would  be  available  for  the  coupling  of 
phosphoramidite. 
During the trityl deprotection step of HEG phosphoramidite coupling to particles the 
polymer is exposed to perchloric acid, at which point control of hydroxyl loading 
could be lost (Scheme 12). This is not observed for either the deprotection of the 4. Click probe immobilisation 
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phosphate phosphoramidite (24) as this is achieved under basic conditions or when 
loading control is effected by the final phosphoramidite coupling step as the alkynyl 
phosphoramidite (52) for the same reason. Literature reports corroborate our results, 
with  cross-linked  SU-8  etching  rates  of  up  to  10   m  min
-1  under  more  extreme 
conditions (98 % H2SO4).
278 
 
 
 
Figure 70. Evidence of SU-8 etching after 36 h under various acidic conditions, clockwise from top left; water 
(control), 2% dichloroacetic acid in toluene, 60 % perchloric acid in methanol and 5 % trichloroacetic acid in 
toluene. Damage is indicated  
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Scheme 12. Phosphoramidite coupling highlighting issues with retaining loading control during trityl deprotection using perchloric acid. The use of acid has been observed to etch cross 
linked SU-8 possibly leading to the regeneration of surface hydroxyl. Note this had not been previously observed as niether CPR (24) nor alkynyl (52) phosphoramidites require 
deprotection under acidic conditions 4. Click probe immobilisation 
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4.2.3 Synthesis and use of a hexaethylene glycol spacer phosphoramidite with a base 
labile protecting group 
Knowing that particle hydroxy loading is unaffected under the basic conditions used 
for cyanoethyl deprotections, the acetyl-protected HEG phosphoramidite (51) was 
synthesised  from  mono-acetyl  HEG  and  2-Cyanoethoxy-N,N-
diisopropylaminochlorophosphine (chlorophosphitylating reagent) (50). Coupling of 
this  phosphoramidite  could  not  be  directly  quantified  therefore  surface  loading 
densities could only be inferred by measuring trityl ion concentrations resulting from 
deprotection of any phosphate blocking groups coupled. When analysing mixed CPR 
(24)  and  acetyl-HEG  (51)  phosphoramidite  coupled  particles  a  low  phosphate 
coverage (by trityl analysis) would imply a high HEG coverage and vice versa. 
The  acetyl  protected  HEG  phosphoramidite  was  used  in  conjunction  with  CPR 
phosphoramidite to obtain particles with varying hydroxyl loading; control of which 
it was hoped would be carried through subsequent coupling steps (Figure 71). 
 
Figure 71. The trityl analysis of SU-8 particles coupled with varying ratios of CPR (24) and acetyl-protected 
HEG (51) phosphoramidites. Measured trityl was found to be in a near linear relationship with the amount of 
the blocking phosphoramidite added, indicating both phosphoramidites react with a similar rate to surface 
hydroxyl. From the above data it was assumed that particles functionalised with a 100% acetyl-HEG surface 
would have a similar loading density to that measured for the phosphate surface (2.25 × nmol cm
-2) 
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Figure  72.  SU-8  particle  functionalised  with  alkynyl  (52)  and  CPR  (24)  phosphoramidites  including  two 
sequential couplings of the acetyl-protected HEG phosphoramidite (51) resulting in the incorporation of a 49-
atom spacer 
 
Subsequent  phosphoramidite  couplings  to  these  base-deprotected  HEG-
functionalised  particles  were  attempted,  hoping  to  retain  loading  control  whilst 
aiming for an alkyne functionalised surface. To one sample of particles at each HEG 
loading density  alkynyl  phosphoramidite (52) was coupled  (Figure 68), whilst to 
another sample a second acetyl protected HEG phosphoramidite (51) was coupled 
first before the eventual alkynyl addition (Figure 72). Alkyne groups would then be 
held on the ends of 29-atom (58) or 49-atom (62) spacers respectively. Upon click 
coupling  of  the  azido  Cy-5  standard  (47)  particle  fluorescence  were  measured 
(Figure 73, e) showing intensity to be proportional to the surface loading of reactive 
functional  group  (Figure  71).  This  matched  the  relationship  expected  if  loading 
control  had  been  retained  throughout  the  multiple  phosphoramidite  coupling  and 
deprotection steps. 
Though loading control had been retained under basic deprotection conditions, total 
fluorescence intensities were lower than for previous click couplings of the azido 
Cy-5  standard.  Comparing  particles  incorporating  the  29-atom  spacer  (58),  those 
with a purely alkyne surface (Figure 73, d) before fluorophore coupling exhibited 
less than three times the fluorescence intensity of those with a purely phosphate 
surface  (Figure  73,  a),  for  clarity  this  result  should  be  contrasted  with  similarly 
functionalised particles (Figure 69) which showed alkyne particles to fluoresce much 
more intensely than phosphate particles. This low fluorescence was indicative of a 
low yielding functionalisation route which could have been caused by either poor 
coupling efficiencies of the second and third phosphoramidite, poor efficiency of the 
acetyl-deprotection steps or poor coupling efficiency of the azido Cy-5 standard. The 
low  fluorescence  was  unlikely  to  be  caused  by  variation  between  SU-8  particle 
batches as the initial coupling of phosphoramidite had been monitored and loading 4. Click probe immobilisation 
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densities were found to be only slightly lower than normal (approximately 2.5 nmol 
cm
-2)  (Figure  71).  The  final  fluorescence  intensity  of  particles  incorporating  two 
acetyl-protected HEG phosphoramidite couplings (49-atom spacer) (62) was even 
lower than those having undergone only a single HEG inclusion, if phosphoramidite 
couplings were high yielding these two particle types would be expected to exhibit a 
similar intensity. This observation therefore suggested that low fluorescence was an 
effect of poor yielding phosphoramidite couplings. 
 
Figure 73. Fluorescence microscopy images of SU-8 particles initially functionalised with varying mixtures of 
CPR  (24)  and  acetyl-protected  HEG  (51)  phosphoramidites  followed  by  base  deprotection,  alkyne 
phosphoramidite (52) coupling and azido Cy-5 (47) click coupling. Initial attempted acetyl-HEG loadings were 
a) 0, b) 20, c) 50 and d) 100 %. Mean fluorescence intensities were compared and were found to correlate to 
attempted  acetyl-HEG  (and  subsequent  alkyne)  loading,  however  total  fluorescence  intensities  were  low 
indicating poor fluorophore loading levels 4. Click probe immobilisation 
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To  investigate  further,  samples  of  all  HEG  functionalised  particles  were  coupled 
with a cheap, DMTr protected deoxycytidine phosphoramidite (54) so that the yields 
of  multiple  phosphoramidite  couplings  could  be  directly  ascertained.  Trityl 
measurements  made  by  deprotecting  particles  coupled  with  the  protected 
deoxycytidine  showed  very  poor  coupling  efficiencies  for  all  particles  with  final 
cytidine loading densities of less than 0.1 nmol cm
-2 (a yield of less than 4% going 
by the loading density of the first phosphoramidite coupling being 2.25 nmol cm
-2). 
The poorest coupling was found to be between the cytidine phosphoramidite (54) 
and particles with two HEG spacers incorporated. From this can be concluded that 
the previously attempted stepwise couplings of acetyl-protected HEG and alkynyl 
phosphoramidite  were  also  likely  to  be  poor  yielding,  explaining  the  low 
fluorescences  observed  upon  fluorophore  conjugation.  Something  was  affecting 
subsequent phosphoramidite couplings which had not inhibited the initial coupling or 
deprotection steps. 
 
4.2.4 SU-8 porosity; swelling and the trapping of water 
Phosphoramidites  are  sensitive  to  water  and  will  react  violently  under  aqueous 
conditions, for this reason all coupling steps during oligonucleotide synthesis are 
carried  out  under  strictly  anhydrous  conditions.  Following  the  coupling  step  are 
capping,  oxidation  and  deprotection  steps  before  the  cycle  is  repeated  with  the 
addition of the next nucleotide. Oxidation takes place under aqueous conditions and 
the dehydration of the support after oxidation is therefore vital for high coupling 
efficiency during the following cycles. During oligonucleotide synthesis (Scheme 1) 
phosphoramidite coupling is usually high yielding as controlled pore glass (CPG), 
the support normally used does not swell and is easily dehydrated by washing in 
anhydrous solvent (acetonitrile).
279 
Water reacts stoichiometrically with phosphoramidites in a 1:1 ratio (Scheme 13) 
therefore  small  quantities  of  water  would  soon  be  removed  by  this  mechanism. 
However the products of reaction with water  can degrade further resulting in an 
acrylonitrile by-product (65). Acrylonitrile can react with phosphoramidite directly, 
the products of this degradation pathway being a cyanoethyl-phosphonoamidate (67) 
and another equivalent of the acrylonitrile (65), this therefore leads to the continuous 4. Click probe immobilisation 
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loss of phosphoramidite.
280 The slightest amount of water present can result in the 
eventual degradation of all phosphoramidite to the corresponding phosphonoamidate 
(67),  the  speed  of  this  degradation  being  dependent  upon  the  amount  of  water 
present. 
 
Scheme 13. Phosphoramidite degradation pathways. Phosphoramidite (51) is initially degraded in an acid 
catalysed  hydrolysis  to  cyanoethyl-H-phosphonate  (63)  and  diisopropylamine  (64).  The  presence  of 
diisopropylamine (base) leads to acrylonitrile (65) elimination and H-phosphonate (66). Acrylonitrile reacts 
with the original phosphoramidite to form the  cyanoethyl-phosphonoamidate  (67), acrylonitrile is also a 
product of this reaction and therefore degradation of the original phosphoramidite will be continuous, the 
rate being dependant on the concentration of acrylonitrile which itself is determined by the amount of water 
initially present 
 
During the course of this work SU-8 particles were observed to swell under various 
solvent conditions, with an obvious volume increase when in acetonitrile followed 
by  shrinking  back  to  the  original  dimensions  under  aqueous  conditions.  Work 
published in recent years has studied this behaviour in more detail.
281,282 By exposing 
200  m thick SU-8 layers to various solvent conditions and measuring the mass 
change  it  was  found  that  polar  aprotic  solvents  caused  the  greatest  mass  gain 
(swelling) with DMF, DCM and acetonitrile leading to mass gains of 61, 26, and 
15%  respectively.  Highly  porous  SU-8  structures  have  also  been  fabricated  by 
altering the ratio of solvent to monomer during SU-8 cross-linking.
283 Rhodamine 
and  glucose  were  both  observed  to  diffuse  through  the  manufactured  polymer 
membrane, moving through pores in the SU-8 structure. Pores are formed during 4. Click probe immobilisation 
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monomer cross-linking by the presence of solvent which is removed by evaporation 
during later (baking) steps in the polymer fabrication. Electron microscopy of the 
SU-8 particles used in our studies revealed rough, pitted surfaces (Figure 74), which 
appeared similar in structure to the reported porous SU-8 membranes. 
 
Figure 74. The surface of an SU-8 particle imaged by electron microscopy showing a pitted, porous surface. 
Scale bar represents 500 nm 
 
The SU-8 particles having a porous structure could explain why the coupling of a 
second phosphoramidite is generally much more poorly yielding than the coupling of 
the first. Initially, reaction of the first phosphoramidite with hydroxyl SU-8 particles 
(16) takes place in anhydrous acetonitrile where particles would swell, opening up 
the pores in the cross-linked matrix. After coupling is complete the particles are 
suspended in oxidiser (Iodine/THF/pyridine/water) where the pores are kept open 
(THF being polar aprotic) and water is permitted to enter the bulk structure. Particles 
are then  washed in anhydrous methanol (which leads to particle shrinking and  a 
closing of pores) followed by extensive drying in a heated vacuum centrifuge, water 
however, may remained trapped within the now closed SU-8 structure. During the 
coupling of any subsequent phosphoramidites, the particles are again suspended in 
acetonitrile,  at  which  point  swelling  will  occur  releasing  trapped  water  into  the 
presence  of  the  fresh  phosphoramidite  reagent  and  degrading  it.  If  a  sufficient 
quantity of water remains trapped by the SU-8 upon drying it could result in the 
failure of all but the initial phosphoramidite coupling. 4. Click probe immobilisation 
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Direct evidence for the trapping of small molecules within the polymerised SU-8 
matrix has been observed during the oxidation step; SU-8 particles have on occasion 
become stained brown due to the entrapment of iodine. The extent of staining was 
found to be reduced by soaking for extended periods (2 days) in an acetonitrile/water 
solution (80:20 v/v) however washing in distilled water (where pores are closed) was 
found to have no effect on the extent of staining. 
Previously we have demonstrated a variation in the surface epoxide loading density 
between batches, thought to be due to different levels of cross-linking during particle 
fabrication. A similar variation was also observed between particle batches as to the 
extent  of  iodine  staining,  with  some  batches  not  showing  any  visible  staining. 
Batches with increased cross-linking would be expected to have smaller pores and 
therefore swell to a lesser extent than batches with increased cross-linking.
251 This 
particle batch to batch variation in swelling properties also explained the variation 
seen in the successes of phosphoramidite couplings, occasionally the coupling of a 
second phosphoramidite had been found to proceed with high efficiency. 
 
4.3  Alkyne  loading  control  by  the  single  addition  of  a  well  designed 
phosphoramidite 
With both the unpredictable (batch-dependant) swelling of SU-8 particles and the 
subsequent  trapping  of  water  being  a  hindrance  to  sequential  phosphoramidite 
coupling it was logical to design a reagent which could achieve a controlled surface 
density of reactive groups and incorporate a spacer group in a single step. 
 
4.3.1 An alkyne-functionalised phosphoramidite incorporating a hexaethylene glycol 
spacer 
Requirements of the new reagent molecule were for; 
•  The resulting SU-8 functionalisation to require no acid deprotection steps and 
to  be  able  to  covalently  couple  probe  DNA  in  a  highly  chemoselective 
manner, therefore alkyne was retained as the functional group of choice for 
the click coupling of azide-modified probes. 4. Click probe immobilisation 
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•  The inclusion of a spacer group no less than 29 atoms in length which would 
be  inert  and  not  lead  to  an  increase  in  the  non-specific  binding  of 
biomolecules and so a hexaethylene glycol spacer was incorporated in the 
final reagent. 
•  A similar coupling rate compared to the (blocking) CPR phosphoramidite 
reagent  allowing  the  resulting  loading  density  to  be  controlled  by  the 
proportional addition of blocking and functionalising compounds. As results 
had  shown  the  acetyl-protected  HEG  phosphoramidite  (51)  synthesised 
previously to react at a similar rate to CPR phosphoramidite (24), the new 
reagent was also a phosphoramidite. 
The phosphoramidite synthesised was a combination of elements of the HEG and 
alkynyl phosphoramidites previously used, resulting in the HEG-linked propargyl 
phosphoramidite (53). This compound was synthesised in two reaction steps and was 
found to contain no significant impurities. 
Coupling of this new phosphoramidite and the control of its surface loading was 
assessed in the reaction between diol-functionalised SU-8 particles (16) and varying 
proportions  of  the  propargyl-HEG-phosphoramidite  (53)  and  the  trityl-protected 
CPR phosphoramidite (24). This resulted in SU-8 particles having a mixed surface of 
phosphate  and  alkynyl  moieties  (68)  (Figure  75).  Further  assessment  of  loading 
density  and  the  viability  for  the  alkynyl  group’s  use  as  a  handle  for  the 
immobilisation of oligonucleotide probes was tested by the click coupling of the 
azide-functionalised  Cy-5  standard  (Figure  76).  Finally  the  azide-modified  probe 
sequence, PL, was click coupled to these particles and the effects of loading density 
on the hybridisation of complementary, TI, and mismatching, TG, Cy-5 labelled 
target sequences investigated (Figure 77).  
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Figure  75.  SU-8  particle  functionalised  with  a  mixture  of  both  propargyl-HEG  (53)  and  CPR  (24) 
phosphoramidites.  This  surface  modification  incorporated  all  the  elements  which  were  expected  to  give 
particles suited to the click immobilisation of azide-functionalised oligonucleotide probes and their use in 
multiplexed DNA assays. This was a simplification of previous designs, aiming for particle functionalisation 
using a single phosphoramidite coupling step 
 
Overall, total loading was found to be quite low compared with previous batches of 
SU-8 particles; trityl deprotection and quantification indicated that particles coupled 
with  100%  CPR  phosphoramidite  (24)  had  a  loading  density  of  0.1  nmol  cm
-2 
(previous particle batches had been found to have loadings an order of magnitude 
more dense). This low loading density, whilst disappointing, was likely an effect of 
the variation in monomer cross-linking as a result of the batch-wise fabrication of the 
SU-8  particles,  it  did  not  imply  any  inherent  problems  to  the  phosphoramidite 
coupling  step.  Significantly,  the  particles  showed  trityl  loading  to  be  inversely 
proportional  to  the  amount  of  propargyl-HEG-phosphoramidite  and  the  resulting 
fluorescence  upon  the  click  coupling  of  azidoCy-5  was  found  to  be  directly 
proportional. These results demonstrated for the first time control of alkyne loading 
density, distanced from any blocking phosphate groups whilst retaining reactivity 
towards azides. 4. Click probe immobilisation 
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Figure  76.  SU-8  particles  were  functionalised  with  various  proportions  of  trityl-protected  CPR  (24)  and 
propargyl-HEG  (53)  phosphoramidites.  Alkyne  loading  was  assessed  by  quantifying  particle  fluorescence 
resulting  from  the  click  coupling  of  azidoCy-5.  Oligonucleotide  probes  were  also  click-coupled  to  alkyne 
particles and the hybridisations of Cy-5 labelled complementary (20 nM) and mismatching (100 nM) targets 
was also assessed using fluorescence quantification. 
 
Figure  77.  Cy-5  labelled  complementary  target  (20  nM)  hybridisation  to  probe-functionalised  phosphate-
blocked particles. The ratio of alkyne to phosphate surface functionality increases across the series from a) 
fully blocked, 0% alkyne to b) 0.1%, c) 1%, d) 10%, and e) 100% 
 
The room temperature hybridisation of mismatching target oligonucleotide, TG (100 
nM), was found to be inversely proportional to the density of phosphate blocking. 4. Click probe immobilisation 
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Although  fluorescence  was  highest  for  particles  with  no  phosphate  blocking,  the 
actual intensity was still found to be low, about one twentieth of the signal from 
azidoCy-5  coupled  particles.  This  result  would  indicate  a  good  coverage  of 
oligonucleotide probes (a high yielding click reaction) as the non-specific binding to 
a DNA-functionalised surface had previously been found to be low (Figure 76). 
Most encouraging was the hybridisation of complementary target oligonucleotide, TI 
(20 nM), to probe-functionalised particles at room temperature, the fluorescence of 
which was also shown to be proportional to the original surface loading of alkyne 
(Figure 77). The fluorescence intensity closely matched particles coupled with the 
azidoCy-5 standard, a result which indicated close to 100% hybridisation efficiency 
(saturation of immobilised probes) (Figure 76).  
It was perhaps surprising to achieve such high efficiency of hybridisation on the 
particles with the highest alkyne loading densities as literature reports and our own 
theoretical calculations indicated that hybridisation efficiency would be maximised 
at a probe density of 0.55 × 10
13 probes cm
-2 (9.13 × 10
-12 mol cm
-2). Above this 
loading complete hybridisation of all probes was expected to be hindered by steric 
factors.
262,263 As the surface loading density of our particles had been measured to be 
1 × 10
-10 mol cm
-2, particles with a probe to phosphate-blocker ratio of 1:9 might be 
expected to have resulted in the greatest capture of labelled target. This was clearly 
not the case with fluorescence increasing yet further with hybridisation to 20, 50 and 
100% probe-functionalised particles. 
A number of explanations for the apparent enhancement of hybridisation efficiency 
have been considered. Calculations of the reactive area of a particle are based upon 
the assumption that all surfaces are perfectly flat and we know this to not always be 
the case (Figure 74), the calculated surface area will therefore be an underestimate 
and likewise reported loading densities will thus be over estimated. It was thought 
unlikely that this simplification could account for (the entirety of) a ten-fold over 
estimate of loading densities, but it may make a significant contribution. 
Perhaps more significant is the swelling of SU-8 whilst suspended in acetonitrile 
during  phosphoramidite  coupling.  Following  coupling  are  oxidation  and  washing 
steps during which particles shrink, however it is not known if particles fully revert 
to their pre-swelled dimensions. If pores in the extended SU-8 cross-linking remain 4. Click probe immobilisation 
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partially  open,  then  a  much  greater  surface  area  may  be  available  for  the 
immobilisation of probe sequences and for the hybridisation of targets. This would 
also result in the measured probe loading density of 0.1 nmol cm
-2 being an over 
estimate. A ten-fold increase in surface area could well result from SU-8 having a 
porous structure. 
Swelling  could  also  result  in  an  over  calculation  of  amount  of  alkyne  actually 
available during the click reaction. If propargyl-HEG phosphoramidites and trityl-
protected CPR phosphoramidites could react within the open pores of SU-8, but the 
copper complex intermediate (42) (Figure 67) were too bulky to form there, not all 
of the alkyne would be available for probe coupling. The amount of available alkyne, 
as inferred from the measured total amount of phosphate would now be an over 
estimate, and therefore once again the loading density of probes would be an over 
estimate. 
A fourth factor to be considered is the presence of the flexible hexaethylene glycol 
spacer. Between the 5’ terminus of the oligonucleotide probe and the surface of the 
particle is a 33-atom (predominantly unsaturated) chain measuring approximately 50 
Å. The flexibility of this tether may reduce the steric effects of probe overcrowding, 
allowing  a  closely  packed  surface  with  a  lower  associated  energy  cost  than  that 
achieved by using a more rigid tether, or no spacer at all. This reduction of steric 
hindrance may result in more duplex forming than originally expected. 
It may be that the greater than predicted hybridisation efficiency experienced for 
these  particles  was  due  to  a  combination  of  a  number  of  the  above  proposed 
explanations, further investigation was beyond the scope of this work. 
 
4.3.2 Multiplexed hybridisation assays using the optimised encoded microparticle 
suspension array 
To test the performance of the loading-controlled propargyl particles for use in DNA 
hybridisation  arrays  a  number  of  multiplexing  experiments  were  attempted.  In  a 
similar manor to that used for previous technology demonstrations (Chapters 2.8.3 & 
2.8.4),  differing  oligonucleotide  probes  were  coupled  to  samples  of  uniquely 
encoded  particles  forming  probe-particle  pairs.  Covalently  coupling  the  probes 4. Click probe immobilisation 
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allowed more freedom with regards to hybridisation conditions whereas previously, 
immobilising  the  probes  by  an  affinity  interaction  (utilising  labile  avidin-biotin 
binding) forced the use of high concentrations of oligonucleotide target and stringent 
washing  steps  to  force  speedy  hybridisation.  The  present  assay  design  permitted 
longer  hybridisation  times,  allowing  equilibria  to  form  and  the  use  of  lower 
concentrations of target. These multiplex assays were run at elevated temperatures, 
just below the calculated melting temperatures of the complementary probe-target 
duplex.
246  This  was  found  to  have  afforded  good  discrimination  between 
complementary and mismatching sequences without needing to resort to stringent 
urea washing steps, indeed particle mixtures were simply washed twice using room-
temperature hybridisation buffer to remove unbound target. 
All four different particle codes were used in these assays,  after ring  opening,  a 
50:50 mixture of the propargyl-HEG-phosphoramidite (53) and the blocking CPR 
phosphoramidite (24) were coupled to each code then deprotected. AzidoCy-5 was 
coupled to samples of all particle types as a positive control, fluorescence intensities 
ranged between 580,000 and 1,300,000 a.u. (Figure 78). 
 
Figure 78. The fluorescence intensities of encoded SU-8 particles after the coupling of azidoCy-5 by click 
chemistry 
 
Azide-modified  oligonucleotide  probes  were  click  coupled  to  the  alkyne-
functionalised particles (Table 6) resulting in encoded microparticles with a 50:50 
surface of probes and phosphate (69) (Figure 79). 
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Table 6. Sequences of oligonucleotide probes covalently coupled to encoded SU-8 particles 
Name  Particle type (encoding)  Sequence (5’ to 3’) 
 
     
PJ  1  AAA AAG TTG GAT CC 
PK  2  CAA CCC CAG TTA ATA TTA TT 
PL  3  CAA CCC CAG GTA ATA TTA TT 
PM  4  GAG ATG CAC TCG AGT AAG TCA AGT CG 
     
 
 
Figure 79. Oligonucleotide probes immobilised to encoded SU-8 microparticles, sequence running from the 
triazole ring reads 3’ to 5’ 
 
Samples  of  each  probe-particle  pairing  were  mixed  and  used  for  the  multiplex 
detection and discrimination of labelled target sequences. For each 4-plex, 20 nM 
target was added and the mixtures of particles suspended for two hours, initially 
temperature was elevated to 70°C for 3 minutes to denature all duplex DNA, this 
was then dropped slightly below the Tm of the corresponding complementary duplex 
(between 45 and 54 °C depending on target) for the remainder of the assay. After 
washing twice, the individual encoding and fluorescence intensity of each particle in 
an assay were analysed and the mean fluorescence signal for each probe-particle pair 
calculated (Figure 80). 4. Click probe immobilisation 
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Figure 80. Multiplexed identification of labelled oligonucleotide target sequences (20 nM) using encoded 
microparticles functionalised with equal amounts of oligonucleotide probe and phosphate blocking moieties. 
Hybridisation  assays  were  able  to  distinguish  between  sequences  differing  by  a  single  base,  and  were 
performed  at  elevated  temperatures  to  minimise  mismatch  binding.  Mixtures  of  four  different  encoded 
microparticle-oligonucleotide probe pairs were exposed to 20 nM target a) (TG) 45°C, b) (TH) 54 °C and c) (TI) 
54°C. The data from particles functionalised with the probe complementary to the added target are coloured 
blue 
 
Three multiplex assays were performed. In each case discrimination was achieved 
between  complementary  and  mismatching  sequences,  even  when  the  probe  and 
target sequences contained only a single non-complementary base pairing (Figure 
80, b. and c.). Hybridisation to particles with type 2 encoding resulted in the lowest 
complementary signal (Figure 80, b.) which corresponded with the measurement of 4. Click probe immobilisation 
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probe loading; where the coupling of azidoCy-5 standard to these particles had also 
given the lowest signal (Figure 78). This lower probe loading to type 2 encoded 
particles  resulted  in  the  poorest  discrimination  in  a  single  multiplex  with  the 
complementary signal being only 1.7 times the intensity of that representing a single 
base-pair mismatch and 4.1 times the signal of complete mismatches. 
 
Figure 81. White light and fluorescence images of two encoded particle types (with all four types present in 
the assay). Three type 3 encoded particles functionalised with probe (PL) are visible on the left of the images 
along with a single type 2 encoded particle with probe (PK). Particles had been exposed to 20 nM labelled 
target  (TI)  at  54°C,  the  image  shows  the  discrimination  between  complementary  sequences  and  those 
mismatching by a single base-pair 
 
Improved discrimination between sequences differing by a single base was achieved 
in  the  final  multiplex  (Figure  80,  c.)  where  the  fluorescent  signal  from  particles 
functionalised with the complementary probe was greater than 13 times the intensity 
of particles functionalised with probe containing a single-base mismatch with respect 
to the target sequence (Figure 81). This complementary signal was also almost 20 
times  greater  than  that  of  particles  functionalised  with  completely  mismatching 
probe. An estimate of hybridisation efficiency could be gained by comparing the 4. Click probe immobilisation 
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fluorescent  signals  of  complementary  target  hybridisation  and  azidoCy-5  click 
coupling,  looking  at  type  3  encoded  particles  (Figure  80,  c  and  Figure  78 
respectively), hybridisation efficiency was calculated to be 86% (54°C), indicating 
that most of the immobilised probe sequences were in an orientation favourable for 
duplex formation. This was likely due to the controlled immobilisation via 5’ azide 
and the low surface loading density of probe. 
The  degree  of  discrimination  was  an  improvement  on  previous  multiplex  assays 
using affinity-immobilised probes (Chapters 2.8.3 & 2.8.4). Had the loading density 
of probe on particle been greater, complementary target hybridisation would likely 
have resulted in greater fluorescence intensities as well. In that scenario, nonspecific 
binding  and  mismatch  hybridisation  may  also  have  been  lower  due  to  a  higher 
loading density of phosphate. Neither had assay conditions, including hybridisation 
temperature, target concentration and the amount of particle washing been optimised. 
Therefore it was likely that the discrimination attained in these demonstrations of 
multiplexed  DNA  analysis  could  be  further  improved.  These  final  results  were 
hampered by  a shortage of time (to put into  assay  development)  and some poor 
batches of fabricated particles (which were overly cross-linked and thus had a low 
epoxide loading densities). 
The  new  methodology  of  probe  immobilisation  was  clearly  an  improvement  on 
previous systems including affinity-capture. The orientation of probes to maximise 
hybridisation  efficiency  and  the  incorporation  of  phosphate  groups  to  minimise 
nonspecific binding had been combined in an assay system which allowed control of 
parameters including assay time, temperature, salinity and probe loading density. In 
summary, the immobilisation scheme developed resulted in stable, oligonucleotide-
functionalised  encoded  microparticles  which  could  be  used  in  the  design  and 
optimisation of multiplexed DNA suspension arrays. 
 
4.4 Conclusions 
The aqueous Huisgen 1,3-dipolar cycloaddition reaction was found to be ideal for 
the  immobilisation  of  functionalised  oligonucleotide  probes  to  polymer 
microparticles.  The  chemistry  involved  was  robust  and  chemoselective,  only 4. Click probe immobilisation 
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occurring  between  azide-modified  sequences  and  alkyne-modified  surfaces  in  the 
presence  of  a  synthesised  tris-triazole  ligand  and  Cu
I.  The  surface  density  of 
fluorophore resulting from the click coupling of azide-functionalised Cy-5 to alkyne-
functionalised GMA beads was high enough to induce fluorescence quenching. The 
only requirement for an efficient coupling was the inclusion of a sufficiently long 
spacer group to distance the alkyne moiety from the surface of the support. For this 
purpose a 9-atom spacer was found to be of insufficient length, however spacers over 
28  atoms  long  resulted  in  a  high  yielding  reaction.  It  was  speculated  that  the 
formation of the intermediate copper complex may be affected by steric factors due 
to  its  large  size,  incorporating  the  copper-bound  ligand,  azide-modified 
oligonucleotide and the alkyne-modified particle. Moving the reaction further from 
the surface on the end of a flexible spacer resulted in a more favourable reaction 
environment. 
An azido-modifier was synthesised and subsequently used for the functionalisation 
of amino-terminated oligonucleotide probes. Functionalisation of the support surface 
to  control  both  alkyne  loading  density  and  nonspecific  DNA  binding  required 
significant development. Advancing on earlier work (Chapter 3) we continued to use 
phosphoramidite reagents for particle surface modification due to their compatibility 
with  established  oligonucleotide  synthesis,  the  variety  of  reagents  commercially 
available  and  the  idea  that  the  resulting  phosphate  bridges  should  reduce  the 
nonspecific binding of DNA. 
Control  of  loading  density  was  achieved  using  varying  ratios  of  different 
phosphoramidite  reagents,  forming  surfaces  with  a  mixture  of  both  blocking  and 
(trityl  protected)  reactive  functionalities.  However  it  was  found  that  upon 
deprotection  under  acidic  conditions  hydroxyl  loading  control  was  lost  and  all 
surfaces would present a similar hydroxyl loading density regardless of the amount 
of  blocking  phosphoramidite  initially  coupled.  Both  literature  and  experimental 
evidence indicated that polymerised SU-8 was vulnerable to damage (etching) under 
acidic conditions and in the case of our particles, the mildly acidic trityl deprotection 
employed  was  likely  etching  the  particle  surface  resulting  in  formation  of  new 
hydroxyl functionality. An acetyl-protected HEG phosphoramidite was synthesised 
so  deprotection  would  occur  under  basic  conditions  and  loading  control  was 
demonstrated using this reagent in conjunction with a blocking phosphoramidite. 4. Click probe immobilisation 
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The swelling properties of SU-8 in polar aprotic solvents was then found to be an 
issue, where the temporary entrapment of water molecules followed by their release 
in  the  presence  of  phosphoramidite  reagent  greatly  reduced  the  yield  of 
phosphoramidite  coupling  steps.  This  did  not  affect  the  coupling  of  initial 
phosphoramidites as before this step particles were not exposed to swelling solvents 
and  had  been  kept  under  anhydrous  conditions.  Subsequent  phosphoramidite 
coupling cycles after particles had swollen and been exposed to water, would show 
lower  yields.  Before  the  use  of  the  acetyl-protected  phosphoramidites  these  poor 
yields  had  been  hidden  by  the  regeneration  of  surface  hydroxyl  under  acidic 
deprotection conditions. As the swelling of particles in acetonitrile and the use of 
aqueous steps could not be avoided, and the thorough drying of particles between 
coupling cycles was found to be insufficient to avoid retardation of the coupling, a 
new design of phosphoramidite was proposed. This reagent incorporated a flexible, 
hydrophilic spacer with alkyne functionality requiring no deprotection and allowed 
control of alkyne loading density in a single coupling cycle. 
Following  the  click  immobilisation  of  azide-modified  oligonucleotide  probes  to 
particles with a controlled surface loading of alkyne, the hybridisation of DNA could 
be studied. Hybridisation to the SU-8 particles was found to be very efficient, as the 
fluorescence intensity of particles after the capture of a Cy-5 labelled complementary 
sequence was found to closely match that of particles with an azide-functionalised 
Cy-5  directly  coupled.  This  was  an  improvement  over  the  affinity  probe  capture 
system employed in preceding work (using immobilised avidin) where hybridisation 
efficiency had generally been found to be below 10%. 
Improved hybridisation efficiency when covalently coupling probes using the click-
based setup may have been due to a combination of factors resulting in the probe 
sequence adopting a conformation favourable to hybridisation. The use of a long, 
flexible spacer would allow the hybridised duplex further freedom of movement to 
form a stable conformation. In addition the targeted chemoselectivity of the click 
reaction guarantees the probe to be tethered through the terminal azide modification. 
Furthermore, the high density of negatively charged phosphate groups at the particle 
surface, which had been demonstrated to reduce DNA nonspecific binding, would, in 
a similar way, force the probe sequence to be held far from the surface therefore in 
an  ideal  position  for  interaction  with  target  sequences.  For  the  previously 4. Click probe immobilisation 
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investigated affinity captured probes, nonspecific binding of DNA to the protein-
coated  surface  was  found  to  be  an  issue,  it  is  conceivable  therefore  that  probe 
sequences may have also nonspecifically bound to this surface. If these probes were 
interacting  directly  with  the  surface  it  is  likely  they  were  in  a  less  favourable 
orientation for hybridisation, explaining the poor hybridisation efficiencies observed. 
The  high  efficiency,  click  coupled  probe-particles  were  used  for  the  multiplexed 
analysis of labelled target oligonucleotides. This demonstration suggested the array 
setup to be ideal for use in multiplexed DNA assays, with fluorescent ratios of 13:1 
and  20:1  resulting  between  complementary  :  single  base  mismatching  and 
complementary  :  completely  mismatching  sequences  respectively.  As  the  probe 
sequences were immobilised via covalent coupling, temperature could be increased 
to aid discrimination between similar target sequences.  In summary, the encoded 
microparticle suspension array resulting from the Huisgen 1,3-dipolar cycloaddition 
coupling  of  azide-modified  oligonucleotide  probes  to  well-designed  alkyne 
functionalised particles appeared to work as expected. Good discrimination between 
target  sequences  was  achieved  and  the  base  sequence  of  these  targets  could  be 
elucidated using the original microparticle encoding.  
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5.0 Conclusions and Future work 
 
5.1 Conclusions 
This  project  consisted  of  the  design,  development  and  implementation  of 
multiplexed  DNA  hybridisation  arrays,  utilising  encoded  microparticles  as 
oligonucleotide probe carriers. Assaying samples of short DNA sequences using this 
suspension array technology remains an emerging field with only a handful of kits 
commercially available, leaving scope for further development. 
Prior to this work the polymeric material SU-8, used as a support for both encoding 
and  probe  immobilisation,  had  been  extensively  used  for  the  microfabrication  of 
small structures and moulds, reports of the chemical modification of SU-8 are rare. 
Functionalisation  of  the  particle  surface  was  achievable  using  residual  surface 
epoxide groups which could be ring-opened with nucleophilic attack. This allowed 
for a number of different functionalities including alcohol, amine, acid, phosphate, 
ether and alkyne groups to be incorporated. From a chemist’s view point SU-8 is 
hardly an ideal material as throughout the project epoxide loading levels were found 
to vary between particles fabricated in differing batches. A combination of factors 
was  thought  to  affect  the  variation  in  monomer  crosslinking  which  caused 
fluctuating epoxide loading. Between batches the energy of exposure (mW) during 
photolithography would change (usually by ± 10%), this could be minimised by the 
regular  measurement  of  lamp  (light)  intensity  (and  the  subsequent  alteration  of 
substrate  exposure  time)  but  could  not  be  eliminated  as  the  lamp  had  a  natural 
variability. After exposure, SU-8 monomer crosslinks upon heating (PEB), as the 
baking times were controlled manually this added an element of human error into the 
fabrication process. Whilst perhaps the most significant variation was the amount of 
solvent in the pre-mixed monomer solution which would be reduced for batches 
fabricated from previously opened bottles of monomer compared with when using a 
new, fresh bottle. Changes to the amount of solvent have now been shown to affect 
the  amount  of  monomer  crosslinking  and  likely  therefore  the  resultant  surface 
epoxide loading levels.
283 Polymerised SU-8 was also found to swell in polar aprotic 
solvents like acetonitrile and the material was found to be incompatible with long 
term exposure to acidic conditions. 5. Conclusions & Future work 
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Despite these hindrances, protocols for the coupling of phosphoramidite moieties to 
the  particles  were  developed  which  lead  to  orthogonal  synthesis,  reactive  and 
blocking functionalities and various spacer lengths being incorporated. From this the 
loading density and distribution of chemistry could be controlled leading to different 
options regarding the modification of particles for use in DNA hybridisation assays. 
Throughout the array development there were two main issues to tackle; the stable, 
simple  and  controlled  immobilisation  of  oligonucleotide  to  the  particles  and  the 
minimisation of nonspecific interactions between target DNA and the SU-8 polymer. 
Utilising the specific affinity between the particle-immobilised protein avidin and its 
ligand biotin in the form of biotin-functionalised probes satisfied the requirements 
for a simple immobilisation method which resulted in the controlled orientation of 
probes, however the extensive modifications to both protein and ligand were found 
to weaken the normally very strong interaction. The half-life of the complex dropped 
from  200  days  (wild-type)  to  less  than  2  days  (on-particle).  This  transient 
immobilisation was not detectable until assaying in multiplex when the ability of 
probe-particle pairs to discriminate between complementary and mismatching target 
sequences  diminished  with  time  as  different  probe  sequences  were  migrating 
between particles. Amide coupling was also found to be unsuitable as coupling via 
nucleoside amines occurred in parallel with the intended coupling through terminal 
amine  modification.  The  use  of  amine  modified  probes  was  also  found  to  be 
incompatible  with  immobilised  phosphate  groups  which  were  used  as  blocking 
moieties, as the two functionalities were found to couple. 
As phosphate blocking and amide coupling could not be used in conjunction as they 
resulted in a loss of control of both probe loading density and probe orientation, 
more chemoselective reactive functionalities were required. The reaction between 
alkyne and azide groups to form functionalised triazole rings (Huisgen 1,3-dipolar 
cycloaddition, click coupling) did afford a stable covalent probe linkage. Due to the 
very  specific  nature  of  the  reaction  coupling  only  occurred  through  the  intended 
chemical  groups,  so  probe  loading  densities  could  now  be  controlled  and  the 
oligonucleotides  tethered  end-on  (through  a  terminal  azide  modification)  to 
maximise complementary target hybridisation. 5. Conclusions & Future work 
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Nonspecific DNA binding was found to be a problem which required attention so as 
not to interfere with detection of complementary sequences. Initially avidin DN was 
chosen as this form of the protein was reported to show reduced interaction with 
DNA,  however  biotinylated  probes  were  found  to  bind  both  specifically  and 
nonspecifically  to  protein-functionalised  particles.  Nonspecific  binding  could  be 
blocked by using high concentrations of surfactants (significantly Tween-20
®) but 
the move to covalent probe coupling increased the scope for surface optimisation to 
reduce this undesirable interaction. Surfaces could be functionalised with hydrophilic 
PEG  spacers  and  negatively  charged  phosphate  blocker  groups,  which  greatly 
limited binding between generic oligonucleotides and the microparticles. 
The final array design combined encoded microparticles with oligonucleotide probes 
orientated  towards  and  accessible  to  target  DNA.  The  use  of  phosphate  groups 
minimised  the  nonspecific  binding  of  completely  mismatching  target,  whilst  the 
stable  click  linkage  allowed  heating  of  assay  suspensions  in  order  to  maximise 
discrimination  between  complementary  sequences  and  those  mismatching  by  a 
single base. This covalent probe immobilisation also allowed different probe-particle 
pairs to be stored in suspension together and for particles to be recycled by the heat 
denaturation of formed duplex. 
The  array  was  used  for  the  successful  multiplexed  analysis  of  oligonucleotide 
solutions  containing  four  labelled  target  sequences,  hybridisation  efficiency  of 
immobilised  probes  was  found  to  be  greater  than  85%  and  a  complementary  to 
mismatch signal to noise ratio of 20:1 was attained. 
 
5.2 Future work 
The array was optimised for the detection and identification of synthetic nucleotide 
sequences  and  it  would  be  interesting  to  see  how  well  the  particles  discriminate 
between sequences derived from biological samples. Any real samples would likely 
contain  amplified  target  in  a  mixture  with  unamplified  DNA  and  possibly  PCR 
enzymes,  dNTPs,  labelling  reagents  and  other  contaminants  depending  upon  the 
stringency  of  purification  employed.  It  may  be  found  that  increased  sample 5. Conclusions & Future work 
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complexity interferes with the accuracy of any assay developed, the conditions of 
which would require further optimisation. 
Once  optimised,  it  should  be  possible  to  use  the  array  not  simply  for  sequence 
detection but for quantification too. For this the microparticle fluorescence intensity 
after the capture of labelled target would be quantified and compared with a standard 
curve. The standard curve would have been already obtained from probe-particle 
titration with standard solutions of target. 
Quantitative  results  could  be  obtained  by  kinetic  measurements  of  the  rate  of 
fluorescence increase (rate of hybridisation). This rate would be proportional to the 
concentration  of  target.  The  system’s  association  rate  constant  could  be 
predetermined therefore there would be no need to wait for oligonucleotides to reach 
a binding equilibrium, only the initial rate of fluorescence increase would need to be 
measured sequencing and quantifying in minutes.. 
There is scope for expansion in the chemistry of polymerised SU-8. In this work 
surface modifications were focussed on minimising the nonspecific binding of DNA 
eventually settling on a negatively charged phosphate surface. This is not a universal 
blocking group, indeed interactions with positively charged molecules would likely 
be greatly enhanced compared with unmodified surfaces. In subsequent studies of 
the  chemical  functionalisation  of  SU-8  we  have  focussed  on  using  PEG-based 
blocking and reactive spacers to minimise nonspecific protein binding. To date we 
have  achieved  control  of  functional  group  loading  density  by  the  radical 
polymerisation  of  PEG  methacrylamide  monomers  to  SU-8  surfaces  pre-
functionalised  with  radical  initiators.  Work  is  also  ongoing  to  achieve  initial 
epoxide/diol  loading  levels  which  are  independent  of  fabrication/polymerisation 
protocols used to crosslink SU-8 monomer. Polymer etchants are being investigated 
which may negate the particle variation inherent with a batch fabrication process; 
these  work  by  refreshing  the  SU-8  surface  regardless  of  the  initial  level  of 
crosslinking.  In  general  SU-8  has  been  shown  to  be  a  useful,  if  sometimes 
temperamental, substrate for chemical modification and this may lead to the future 
functionalisation of interesting, well defined lithographic microstructures. 
To date the split and mix synthesis of oligonucleotide or peptide probes has not been 
attempted using encoded microparticles. Synthesis on SU-8 has been accomplished 5. Conclusions & Future work 
171 
 
by our group and recently by others, but this has never been applied using either split 
and mix techniques or particle tracking by reading encoding.
191,284 This would help 
realise  the  potential  of  encoded  microparticles  for  the  formation  of  very  large 
immobilised  probe  libraries  and  their  subsequent  use  in  highly  multiplexed 
biological assays. 
As  may  be  expected  from  an  interdisciplinary  basic  technology  project,  we  only 
achieved  the  groundwork  required  to  develop  a  working  multiplexed  DNA 
hybridisation array. It is hoped that in the not too distant future large scale encoded 
microparticle suspension arrays may be able to detect and quantify both proteins and 
oligonucleotide  sequences  in  parallel,  making  fast  and  accurate  point  of  care 
diagnostics a reality and ushering in a world of personalised medicine. 
   5. Conclusions & Future work 
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6.0 Experimental 
 
6.1 Materials and apparatus used 
6.1.1 Reagents and suppliers 
Oligonucleotide  sequences  (both  modified  and  unmodified)  were  obtained  from 
either Sigma-Genosys (UK) or ATDBio (Southampton, UK) or were synthesised in-
house using a MerMade 192 well DNA/RNA synthesiser, with reagents purchased 
from Link Technologies (UK) and Glen research (Virginia, USA). 
Monomeric  SU-8-5,  EC  solvent  (polypropylene  glycol  methylether  acetate, 
PGMEA)  and  Microposit  MF-319  developer  solution  (tetramethylammonium 
hydroxide, 2.2% w/v solution in water) were purchased from Chestech Ltd, (Rugby, 
UK). Avidin DN was purchased from Vector laboratories (California, USA). BCA 
Assay  Kit  was  obtained  from  Pierce  Biotechnology  (Illinois,  USA).  All  other 
reagents and solvents were obtained from Sigma-Aldrich (UK), Fluka (UK), Acros 
(UK), Alfa Aesar (UK) and Fisher (UK). 
 
6.1.2 Apparatus and equipment 
Microparticle fabrication made use of an EVG 620 mask aligner with photomask 
(Compugraphic, UK). Accuspin
TM Micro centrifuges (Fisher Scientific, UK) (r = 8.5 
cm)  were  used  for  particle  sedimentation.  Fluorescence  intensity,  fluorescence 
anisotropy and absorption measurements of solutions was measured using a SafireII 
microplate reader (Tecan, Switzerland). Particles were analysed under a fluorescence 
microscope (Carl Zeiss AG, Germany) or using a FACSaria flow cytometer (BD 
Biosciences, USA). Kinetic and thermodynamic constants were calculated by fitting 
data using commercially available software (SigmaPlot 11.0, Systat Inc, USA and 
Origin 8.1, OriginLab Corporation, USA). 
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6.2 General analytical methods 
6.2.1 Amine quantification – Kaiser test 
The Kaiser test was used to quantify on-particle amine loading density; ninhydrin 
reacts with particle-tethered primary amine to form the cleaved chromophore.
285 
286 
Kaiser  solution  A:  phenol  (4  g)  was  dissolved  in  ethanol  (1  mL)  and  potassium 
cyanide (0.13 mg) was dissolved in water (200  L). The aqueous potassium cyanide 
solution was diluted in pyridine  (9.8 mL)  and  combined with the phenol/ethanol 
solution. 
Kaiser solution B: ninhydrin (500 mg) was dissolved in ethanol (10 mL). 
To a known quantity of SU-8 microparticles (~ 50  g) were added Kaiser solutions 
A (60  L) and B (60  L), the particle suspension was then heated at 100 °C for five 
minutes with occasional agitation. Suspensions were allowed to cool and particles 
separated by centrifugation (1 min, 10,000 rpm, 9503 g). Supernatant (100  L) was 
decanted and absorbance (570 nm) was measured using a microplate reader (Costar, 
transparent,  flat-bottomed  96-well  UV  star  plate).  After  subtraction  of  the 
absorbance  from  a  blank  sample,  concentration  of  primary  amine  was  calculated 
using the Beer-Lambert law, ε = 15700 M
-1 cm
-1, l = 0.28979 cm (100  L in well). 
 
6.2.2 Protein quantification – Bicinchoninic acid (BCA) assay 
The  bicinchoninic  acid  (BCA)  assay  was  used  to  quantify  particle-immobilised 
protein.
208 Green Cu
II salts are reduced to Cu
I by peptide bonds, two molecules of 
bicinchoninic acid complex with the Cu
I ion and result in a purple colouration.
209 
A  known  quantity  of  protein-functionalised  SU-8  microparticles  (~  20   g)  were 
suspended in BCA reagent (100  L) (BCA, sodium bicarbonate, sodium carbonate, 
sodium tartrate, copper sulphate, water, pH 11.3). BCA reagent (100  L) was also 
added to protein standards (0 – 4  g avidin DN). All samples were heated at 60 °C 
for  thirty  minutes  with  occasional  agitation.  Samples  were  allowed  to  cool  and 
particles separated by centrifugation (1 min, 10,000 rpm, 9503 g). The absorbance 
(562 nm) of supernatants (75  L) and standard solutions (75  L) were measured 6. Experimental 
 
175 
 
using a microplate reader (Costar, transparent, flat-bottomed 96-well UV star plate). 
Absorbance measurements for protein standards were used to plot a standard curve 
to which supernatants from particle samples could be fitted. 
 
6.3 Epoxy SU-8 microparticle fabrication (7) 
 
Particles were fabricated from photoactive epoxy SU-8-5 monomer. The commercial 
resist (a mixture of monomer and PGMEA) was spin coated as a 20  m layer onto 
primed silicon wafers (525 ± 25 µm thick) onto which a thin layer of Al had been 
evaporated. The SU-8 layer was soft baked (65 °C, 4.5 min then 95 °C, 9 min), 
exposed to UV through a photomask and post exposure baked (65 °C, 2 min then 95 
°C,  4  min).  After  allowing  to  relax  for  24  hours,  uncrosslinked  monomer  was 
removed by development in EC solvent (PGMEA) for 4 min with agitation. The 
wafers  were  thoroughly  rinsed  with  isopropyl  alcohol  and  blow  dried.  The  Al 
sacrificial  layer  was  removed  by  sonicating  the  wafers  in  Microposit  MF-319  at 
room  temperature  for  20  min.  Released  microparticles  were  collected  by 
centrifugation  (1  min,  10,000  rpm,  9503  g),  washed  in  water  (4  ×  1  mL)  then 
methanol (4 × 1 mL) and dried under vacuum at room temperature for 4 h. Particles 
fabricated had dimensions 5 × 10 × 20  m. 
 
6.4 Preparation of amino functionalised SU-8 microparticles (Jeffamine
® ED-
900
® spacer) (8) 
 
Dry  epoxy  SU-8  particles  (5  mg)  were  suspended  in  MeCN  and  pelleted  by 
centrifugation  (1  min,  9503  g).  A  solution  of  O,O'-Bis(2-aminopropyl) 6. Experimental 
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polypropylene  glycol-block-polyethylene  glycol-block-polypropylene  glycol  800 
(Jeffamine
® ED-900
®) (600 µl) in MeCN (600 µl) was added and the particles re-
suspended. The reaction was agitated for 18 hours at 50 ºC. After centrifugation the 
supernatant was decanted and the SU-8 pellet washed in MeCN (6 × 1 mL) followed 
by MeOH (3 × 1 mL). The amino functionalised SU-8 was then dried by vacuum 
centrifugation (4 h). 
Amino  particles  tested  positive  for  a  primary  amine  by  Kaiser  test,  whereas 
unfunctionalised  epoxy  particles  gave  a  negative  result.  Loading  levels  were 
typically in the range between 25 – 35 µmol g
-1 (4.4 – 6.2 nmol cm
-2).  
 
6.5 Preparation of carboxyl functionalised SU-8 microparticles (Jeffamine
® ED-
900
® spacer) (9) 
 
To  a  suspension  of  amino  microparticles  (5  mg,  125-175  nmol  based  on  amino 
groups, suspended in dry DMF, 100  L) was added a solution of succinic anhydride 
(10 mg, 100  mol), DMAP (11 mg, 90  mol) and DIPEA (5.5 mg, 7.5  L, 42.7 
 mol) in dry DMF (1.6 mL).  The suspension was agitated at room temperature for 1 
h.  The suspension was centrifuged (1 min, 9503 g), the supernatant discarded and 
the reaction repeated with fresh reagents for a further 1 h. The microparticles were 
washed  with  DMF  (4  ×  1  mL)  and  MeOH  (4  ×  1  mL),  and  dried  by  vacuum 
centrifugation to afford carboxyl functionalised SU-8. The reaction was monitored 
by the ninhydrin test, which was negative on completion. 
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6.6 Preparation of biotin functionalised SU-8 microparticles (12) 
 
Biotin (24 mg, 98.1  mol), DIC (12 mg, 95.1  mol), DMAP (12 mg, 98.1  mol) and 
DIPEA (8.9 mg, 12  L, 63  mol) were dissolved in a solution of 50% DMF in 
DMSO  (1.6  mL).  This  solution  was  mixed  for  10  minutes  allowing  reagents  to 
dissolve. Amino functionalised SU-8 particles (5 mg, 125-175 nmol based on amino 
groups) were added to the biotin solution and the suspension agitated for 1 hour. The 
supernatant  was  decanted  and  fresh  biotin  coupling  solution  was  added  to  the 
particles which were agitated in suspension for a further hour. Particles were washed 
in 50% DMF/DMSO (4 × 1 mL) and MeOH (4 × 1 mL), then dried by vacuum 
centrifugation  to  afford  biotin-functionalised  SU-8.  The  reaction  was  monitored 
using the Kaiser test, which was negative on completion.  
 
6.7  Avidin  DN  functionalised  SU-8  microparticles  (coupling  reagents  in-situ) 
(avidin DN SU-8 Type I) (10) 
 
To carboxyl-functionalised SU-8 (5 mg, 125-175 nmol based on carboxyl groups) 
suspended in imidazole buffer (2 mL) were added; EDC.HCl (7.8 mg, 40.5  mol) 
and avidin DN (200  g, 2.94 nmol). The reaction mixture was agitated gently at 50 
°C for 3 hours. The microparticles were washed with SSPE (5×) buffer (0.75 M 
NaCl, 50 mM sodium phosphate, 5 mM EDTA, 0.02% Tween-20
®, adjusted to pH 
7.0, 4 × 1 mL) and the supernatant separated by centrifugation (2 min, 2000 rpm, 
380 g) to afford avidin DN-immobilised SU-8. Particles were washed again (2 × 1 6. Experimental 
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mL)  after  overnight  suspension  and  the  amount  of  immobilised  protein  was 
determined  by  BCA  assay  to  be  reproducibly  in  the  range  7.2  –  16.0  mol  cm
-2. 
Particles were stored as a 1 mg mL
-1 suspension in SSPE (5×) buffer with 0.02% 
Tween-20
® and 0.01% sodium azide. 
 
6.8  Avidin  DN  functionalised  SU-8  microparticles  (carboxyl  pre-activation) 
(avidin DN SU-8 Type II) (11) 
 
To carboxyl-functionalised SU-8 (5 mg, 125-175 nmol based on carboxyl groups) 
suspended in MES  buffer (0.1 M MES, 0.5 M NaCl, 0.02% Tween-20, adjusted to 
pH 5.0, 2 mL) were added; EDC.HCl (7.8 mg, 40.5  mol) and sulfo-NHS (2.9 mg, 
25  mol). Particles were agitated for 10 minutes after which the supernatant was 
decanted and the particles washed with deionised water (0.02 %Tween-20) (3 × 1 
mL). Avidin DN (200  g, 2.94 nmol) in PBS (0.14 M NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4 adjusted to pH 7.4, 2 mL) was added to the particles and 
the suspension agitated gently for 2 hours. The microparticles were washed with 
SSPE  (5×)  buffer  (0.02  %  Tween-20
®,  adjusted  to  pH  7.0,  4  ×  1  mL)  and  the 
supernatant  separated  by  centrifugation  (2  min,  380  g)  to  afford  avidin  DN-
immobilised  SU-8.  Particles  were  washed  again  (2  ×  1  mL)  after  overnight 
suspension and the amount of immobilised protein was determined by BCA assay to 
be reproducibly in the range 5.7 – 7.7 mol cm
-2. Particles were stored as a 1 mg mL
-1 
suspension in SSPE (5×) buffer with 0.02% Tween-20
® and 0.01% sodium azide. 
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6.9 Avidin DN functionalised SU-8 microparticles (affinity capture) (avidin DN 
SU-8 Type III) (13) 
 
To biotin-functionalised SU-8 (5 mg, 125-175 nmol based on carboxyl groups) was 
added a solution of avidin DN (200  g, 2.94 nmol) in SSPE (5×) buffer (0.02% 
Tween-20, adjusted to pH 7.0, 1.6 mL). Particles were agitated gently for 1 hour 
before the supernatant was decanted and the microparticles were washed with SSPE 
(5×) buffer (0.02% Tween-20, adjusted to pH 7.0, 4 × 1 mL) and the supernatant 
separated by centrifugation (2 min, 380 g) to afford avidin DN-immobilised SU-8. 
Particles were stored as a 1 mg mL
-1 suspension in SSPE (5×) buffer with 0.02% 
Tween-20
® and 0.01% sodium azide. Particles were washed again (2 × 1 mL) after 
overnight  suspension  and  the  amount  of  immobilised  protein  was  determined  by 
BCA assay to be reproducibly in the range 6.0 – 10.5 mol cm
-2. Particles were stored 
as a 1 mg mL
-1 suspension in SSPE (5×) buffer with 0.02% Tween-20
® and 0.01% 
sodium azide. 
 
6.10 Covalent Cy-5 coupling to amino SU-8 under aqueous conditions (15) 
 
Cyanine-5 (Cy-5) dye (carboxyl functionality) (0.2 mg, 0.3  mol) was dissolved in 
imidazole  buffer  (100   L,  pH  7.0)  with  EDC.HCl  (0.5  mg,  2.6   mol).  Amino 
functionalised SU-8 particles (0.3 mg, 7.5-10.5 nmol based on amino groups) were 6. Experimental 
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added  to  this  solution  and  the  suspension  agitated  for  40  minutes  at  room 
temperature. Particles were washed using SSPE (5×) buffer with 0.02% Tween-20
® 
(5 × 1 mL). The particles were visibly blue. 
 
6.11 Covalent Cy-5 coupling to amino SU-8 under organic conditions (55) 
 
Cy-5 (0.2 mg, 0.3  mol) was pre-activated using a solution of HOBt (0.1 mg, 0.74 
 mol), TBTU (0.2 mg, 0.62  mol), and DIPEA (0.13  L, 0.1 mg, 0.77  mol) in 
DMF (100  L). After 30 minutes, amino functionalised SU-8 particles (0.3 mg, 7.5-
10.5 nmol based on amino groups) were added to the Cy-5 activated-ester solution 
and agitated for 40 minutes at room temperature. Particles were washed using DMF 
(3 × 1 mL) followed by SSPE (5×) buffer with 0.02% Tween-20
® (2 × 1 mL). The 
particles were visibly blue. 
 
6.12 Preparation of vic diol functionalised SU-8 microparticles (16) 
 
Un-functionalised  (epoxide)  SU-8  particles  were  suspended  in  hydrochloric  acid 
solution (2 M) for 2 minutes then washed with NaOH(aq) (2 M) followed by water to 
afford vic diol functionalised SU-8 particles. 
 
 
 6. Experimental 
 
181 
 
 
6.13 Preparation of carboxyl functionalised SU-8 microparticles (no spacer) (17) 
 
Vic diol functionalised SU-8 particles (1 mg) were suspended in DMF (200  L) and 
a solution of succinic anhydride (2 mg, 20  mol), DMAP (2.2 mg, 18  mol) and 
DIPEA (1.1 mg, 1.5  L, 8.54  mol) in DMF (320  L) was added. The suspension 
was agitated at room temperature for 1 hour.  The suspension was centrifuged (1 
min, 9503 g) and the supernatant discarded, the reaction was then repeated with fresh 
reagents for a further hour. Microparticles were washed with DMF (4 × 1 mL) and 
MeOH  (4  ×  1  mL),  and  dried  by  vacuum  centrifugation  to  afford  carboxyl 
functionalised SU-8. 
 
6.14 Covalent DNA probe coupling to SU-8 microparticles (no spacer, amide 
coupling) (18) 
 
EDC.HCl (1.3 mg, 6.8  mol) and sulfo-NHS (0.5 mg, 4.2  mol) were added to a 
suspension of carboxyl functionalised SU-8 particles (20  g) in MES buffer (0.1 M 
MES, 0.5 M NaCl, 0.02% Tween-20, adjusted to pH 5.0, 100  L). Particles were 
agitated for 10 minutes after which the supernatant was decanted and the particles 
washed  with  deionised  water  (0.02%  Tween-20)  (3  ×  200   L).  Amine  modified 
oligonucleotide  probe  (10  nmol)  in  PBS  (0.14  M  NaCl,  2.7  mM  KCl,  10  mM 
Na2HPO4, 2 mM  KH2PO4 adjusted to pH 7.4, 100  L) was added to the particles 6. Experimental 
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and the suspension agitated gently for 2 hours. The DNA probe functionalised SU-8 
particles were washed with SSPE (5×) buffer (0.02% Tween-20
®, adjusted to pH 7.0, 
4 × 200 L) and stored in the wash buffer with 0.01% sodium azide added. 
 
6.15 Covalent DNA probe coupling to SU-8 microparticles (Jeffamine
® ED-900
® 
spacer, amide coupling) (20) 
 
Amine  modified  DNA  probes  were  coupled  to  carboxyl  functionalised  SU-8 
particles which had a Jeffamine
® spacer group. Coupling was achieved by the same 
technique used to couple to carboxyl functionalised particles lacking the spacer, as 
previously outlined (6.14). 
 
6.16 General procedure for the coupling of phosphoramidites to hydroxyl SU-8 
 
Hydroxyl functionalised SU-8 particles (400  g) were dried thoroughly for 24 hours 
under vacuum at 50 °C. Phosphoramite(s) were dissolved in anhydrous MeCN (to a 
final concentration of 0.1 M). Phosphoramidite solution (200  L) was mixed with a 
solution  of  5-Ethylthio-1H-tetrazole  (ETT)  in  MeCN  (0.25  M,  320   L)  and  this 
activated phosphoramidite solution added to the hydroxyl functionalised SU-8. This 
particle  suspension  was  agitated  under  nitrogen  for  30  minutes,  after  which  the 6. Experimental 
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supernatant  was  removed  and  discarded  and  the  particles  suspended  in  a  second 
aliquot of activated phosphoramidite solution for a further 30 minutes. 
These phosphite functionalised particles were next washed using anhydrous MeCN 
(3 × 500  L) and oxidised using iodine (0.02 M) in THF/pyridine/water (7:2:1) (1 
mL). Following this, the now phosphate functionalised particles were washed using 
MeOH (2 × 500  L) and water (2 × 500  L).  
Cyanoethyl and sulphate (CPR phosphoramidite (24)) protecting groups were labile 
under  basic  conditions  and  were  removed  by  the  suspension  of  particles  in 
concentrated aqueous ammonia (30% w/w, 17.6 M, 500  L) at 60 °C for 1 hour, 
after which particles were washed with water (4 × 500  L) and dried thoroughly. 
DMTr protecting groups were labile under acidic conditions and were removed by 
the suspension of particles in perchloric acid. 
 
6.17 Preparation of carboxyl functionalised SU-8 microparticles (HEG spacer) 
(72) 
 
HEG phosphate functionalised SU-8 particles (1 mg) were suspended in DMF (200 
 L) and a solution of succinic anhydride (2 mg, 20  mol), DMAP (2.2 mg, 18  mol) 
and  DIPEA  (1.1  mg,  1.5   L,  8.54   mol)  in  DMF  (320   L)  was  added.  The 
suspension was agitated at room temperature for 1 hour after which particles were 
concentrated by centrifugation (1 min, 9503 g), the supernatant discarded and the 
reaction repeated  with fresh reagents for a further hour. The microparticles were 
washed  with  DMF  (4  ×  1  mL)  and  MeOH  (4  ×  1  mL),  and  dried  by  vacuum 
centrifugation to afford carboxyl functionalised SU-8. 
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6.18 Preparation of DNA probe functionalised SU-8 microparticles by amide 
coupling (HEG spacer) (73) 
 
Amine  modified  DNA  probes  were  coupled  to  carboxyl  functionalised  SU-8 
particles which had a HEG phosphate spacer group. Coupling was achieved using 
the technique previously outlined (6.14). 
 
6.19 Synthesis of 6-azidohexanoic acid ethyl ester (75) 
 
6-Bromohexanoic acid ethyl ester (2 mL, 2.516 g, 11 mmol) was mixed with DMF 
(25 mL). Sodium azide (1.466 g, 22.6 mmol) and potassium carbonate (2.338 g, 16.9 
mmol) were added and the suspension stirred at 50°C, overnight under nitrogen. The 
reaction  was  monitored  by  TLC.  The  suspension  was  allowed  to  cool  and  was 
filtered (celite). The residue was washed with toluene (8 mL), supernatants were 
combined and solvent removed in vacuo. The crude product was purified by column 
chromatography  (eluent; EtOAc/hexane 1/20) to  yield 6-azidohexanoic acid ethyl 
ester (1.621 g, 8.8 mmol, 80%). 
Physical state: colourless oil; 
Rf = 0.30 (silica gel, 1:20 EtOAc:hexane); 
MS (m/z): calcd for C8H15N3O2, 208.11 [M+Na]
+; found, 208; 6. Experimental 
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1H NMR (300 MHz, CDCl3): δ 4.14 (q, 2H), 3.27 (t, 2H), 2.32 (t, 2H), 1.65 (m, 
4H), 1.42 (dt, 2H), 1.25 (t, 3H). 
13C NMR (75 MHz, CDCl3): δ 173.4, 60.3, 51.2, 34.1, 28.6, 26.2, 24.5, 14.2. 
Assignment 
1H NMR: δ 4.14 (CH3CH2OR), 3.27 (CH2N3), 2.32 (CH2CO2), 1.65 
(CH2), 1.42 (CH2), 1.25 (CH3). 
Assignment 
13C NMR: δ 173.4 (RCO2R’), 60.3 (CH3CH2OR), 51.2 (CH2N3), 34.1 
(CH2CO2), 28.6, 26.2 & 24.5 (CH2), 14.2 (CH3). 
 
6.20 Synthesis of 6-azidohexanoic acid (76) 
 
Sodium hydroxide (0.928 g, 23 mmol) was added to a solution of 6-azidohexanoic 
acid  ethyl  ether  (1.074  g,  5.8  mmol)  in  water/dioxane  (1:2,  11.6  mL).  After  30 
minutes the reaction mixture was passed down a dowex pyridinium column with 
water/MeOH  (1:1)  as  eluent.  Solvent  was  removed  in  vacuo.  Product  retained  a 
NaOH  impurity  and  was  therefore  partitioned  between  chloroform  (10  mL)  and 
water (10 mL). The aqueous phase was washed using chloroform (10 mL) and the 
organic  fractions  were  combined,  dried  (anhydrous  magnesium  sulphate)  and  the 
solvent removed in vacuo to yield 6-azidohexanoic acid (0.609 g, 3.9 mmol, 67%). 
Physical state: colourless oil; 
MS (m/z): calcd for C6H11N3O2, 156.08 [M-H]
-; found, 156; 
1H NMR (300 MHz, CDCl3): δ 3.20 (t, 2H), 2.25 (t, 2H), 1.55 (m, 4H), 1.40 (m, 
2H). 
13C NMR (75 MHz, CDCl3): δ 180.1, 51.6, 34.2, 28.9, 26.6, 24.6. 
Assignment 
1H NMR: δ 3.20 (CH2N3), 2.25 (CH2CO2), 1.55 (CH2), 1.40 (CH2). 
Assignment 
13C NMR: δ 180.1 (RCO2H), 51.6 (CH2N3), 34.2 (CH2CO2H), 28.9, 
26.6 & 24.6 (CH2). 6. Experimental 
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6.21 Synthesis of 6-azidohexanoic acid NHS-ester (77) 
 
N,N′-Dicyclohexylcarbodiimide  (DCC)  (0.89  g,  4.3  mmol)  was  added  to  a 
suspension  of  6-azidohexanoic  acid  (0.555  g,  3.5  mmol)  and  NHS  (0.49  g,  4.3 
mmol) in DCM (20 mL). The reaction was stirred for 4 hours with monitoring by 
TLC (eluent; DCM/MeOH 49:1). The mixture was partitioned between a saturated 
solution of potassium chloride (10 mL) and DCM (10 mL), the aqueous phase was 
washed  using  DCM  (10  mL)  and  the  organic  fractions  were  combined,  dried 
(anhydrous magnesium sulphate) and the solvent removed in vacuo. The product was 
purified  by  column  chromatography  (eluent;  DCM/MeOH  99:1)  to  yield  6-
azidohexanoic acid NHS-ester (0.482 g, 1.9 mmol, 54%). 
Physical state: colourless oil; 
MS  (m/z):  calcd  for  C10H14N4O4,  277.09  [M+Na]
+;  found,  277;  calcd  293.07 
[M+K]
+; found, 294 (20%); 
1H NMR (300 MHz, CDCl3): δ 3.32 (t, 2H), 2.82, (s, 4H)  2.62 (t, 2H), 1.79 (m, 
2H), 1.65 (m, 2H), 1.53 (m, 2H). 
13C NMR (75 MHz, CDCl3): δ 168.4, 51.1, 30.8, 28.4, 25.9, 25.6, 24.1. 
Assignment 
1H NMR: δ 3.32 (CH2N3), 2.82 (CH2C(O)N), 2.62 (CH2CO2), 1.79 
(CH2), 1.65 (CH2), 1.53 (CH2). 
Assignment 
13C  NMR:  δ  168.4  (RCO2R’),  51.1  (RCH2N3),  30.8  (RCH2CO2R’), 
28.4 (RCH2R’), 25.9 (RCH2R’), 25.6 (RCH2C(O)N), 24.1 (RCH2R’). 
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6.22 Synthesis of amino functionalised cyanine-5 fluorescent dye (78) 
 
Cy-5  (4.2  mg,  6.4   mol),  O-(N-succinimidyl)-N,N,N’,N’-bis-(tetramethylene)-
uranium hexafluorophosphate (HSPyU) (11.3 mg, 27.4  mol) and DIPEA (3.2 mg, 
2.5  L, 25  mol) were dissolved in DMF (2.8 mL) and stirred. Reaction had gone to 
completion within forty minutes as monitored by TLC (eluent; CHCl3/MeOH/H2O 
70/30/4, Cy-5 Rf = 0.18, NHS-activated Cy-5 Rf = 0.36). 
The  NHS-activated  Cy-5  solution  was  added  drop  wise  to  a  stirred  solution  of 
ethylenediamine (36.1  mg, 32  L, 600  mol) and DIPEA (38.8 mg,  30  L, 300 
 mol) in DMF (5 mL). The reaction was stirred for one hour and was found to have 
gone to completion by TLC. 
Solvent was removed in vacuo and the crude product was purified by reverse phase 
column  chromatography  (pre-packed  RP-18  gel  column,  1.5  ×  3.5  cm)  (eluent; 
EtOH/n-propanol/H2O/acetic  acid  70/30/10/0.01).  Removal  of  solvent  in  vacuo 
yielded product (4.4 mg, 6.3  mol, 98%). 
Physical state: blue solid; 
Rf = 0.10 (silica gel, 70:30:4 CHCl3:MeOH:acetic acid), 0.40 (NHS-activated Cy-5 
intermediate); 
MS  (m/z):  calcd  for  C33H45N4S2O7,  348.635  [M-2H]
2-;  found,  349  (57%);  calcd, 
698.28 [M-H]
-; found, 698 (61%); 6. Experimental 
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1H NMR (300 MHz, D2O): δ 7.91 (m, 2H), 7.75 (s, 2H), 7.71 (d, 2H), 7.19 (d, 2H), 
6.42 (m, 1H), 6.11 (m, 2H), 3.95 (m, 4H), 3.22 (t, 2H), 2.93 (t, 2H), 2.13 (m, 2H), 
1.75 (m, 2H), 1.52 (s, 12H), 1.50 (m, 2H), 1.24 (t, 3H), 1.22 (m, 2H). 
Assignment 
1H NMR: δ 7.91 (CHCHC), 7.75 (CHCSO3H) 7.71 (CHCHCSO3H), 
7.19  (CHCHCSO3H),  6.42  (CHCHCHC),  6.11  (CHCHCHC),  3.95  (CH2N),  3.22 
(CH2CH2NH2),  2.93  (CH2CH2NH2),  2.13  (CH2C(O)N),  1.75  (CH2),  1.52  (CH3), 
1.50 (CH2), 1.24 (CH2CH3), 1.22 (CH2). 
 
6.23 Synthesis of azide functionalised cyanine-5 fluorescent dye (47) 
 
Amino functionalised Cy-5 (4.0 mg, 5.7  mol) was dissolved in DMF (2.9 mL) with 
6-azidohexanoic acid NHS-ester (7.2 mg, 28.5  mol) and DIPEA (2.6 mg, 1.9  L, 
20  mol). The reaction was stirred under nitrogen for one hour with monitoring by 
TLC and rpTLC (normal phase eluent; CHCl3/MeOH/acetic acid 70/30/4, aminoCy-
5  Rf  =  0.05,  NHS-azide  Rf  =  0.9,  azidoCy-5  Rf  =  0.1.  reverse  phase  eluent 
H2O/EtOH/n-propanol/acetic acid 70/21/9/0.07, aminoCy-5 Rf = 0.8, NHS-azide Rf = 
0.15, azidoCy-5 Rf = 0.55). 
Solvent was removed in vacuo and the crude product dissolved in water (1 mL) and 
purified  by  RP-HPLC  (3  loadings  of  333   L,  150  ×  10  mm  column,  increasing 
MeOH content from 0 to 50% in 0.1 M aqueous ammonium acetate over 15 minutes, 
product eluted after 28 minutes). AzidoCy-5 was concentrated by freeze drying (4.1 
mg, 4.9  mol, 86%). 6. Experimental 
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Physical state: blue solid; 
Rf  =  0.1  (silica  gel,  70:30:4  CHCl3:MeOH:acetic  acid),  0.55  (C18-silica  gel, 
70:21:9:0.07 H2O:EtOH:n-propanol:acetic acid); 
MS  (m/z):  calcd  for  C39H54N7S2O8,  418.175  [M-2H]
2-;  found,  418  (42%);  calcd, 
837.36 [M-H]
-; found, 838 (6%). 
 
6.24 Azide functionalisation of oligonucleotides (80) 
 
3’ amino functionalised oligonucleotide (1  mol) was dissolved in DMF (1 mL) with 
6-azidohexanoic acid NHS-ester (1 mg, 4.0  mol) and DIPEA (0.3 mg, 0.2  L, 2.3 
 mol) and the reaction was stirred under nitrogen for one hour. 
Solvent was removed in vacuo and the crude product dissolved in water (200  L) 
and purified by RP-HPLC. 
 
6.25 Synthesis of 3-azidopropan-1-ol (82) 
 
3-bromopropan-1-ol (1.02 mL, 1.64 g, 11.8 mmol) was added to DCM (50 mL). 
Sodium azide (1.63 g, 25 mmol) and potassium carbonate (2.59 g, 18.8 mmol) were 
added and the suspension stirred for 18 hours at 50 °C with monitoring by TLC 
(eluent;  hexane/EtOAc  60:40).  Solvent  was  removed  in  vacuo  and  the  product 
purified  by  column  chromatography  (eluent;  hexane/EtOAc  60:40)  to  yield  3-
azidopropan-1-ol (0.60 g, 5.9 mmol, 50%). 6. Experimental 
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Physical state: colourless oil; 
MS (m/z): Unable to characterise (ESI +ve, ESI –ve & EI) 
1H NMR (300 MHz, CDCl3): δ 3.78 (t, 2H), 3.48 (t, 2H), 1.82 (m, 2H). 
13C NMR (75 MHz, CDCl3): δ 59.9, 48.5, 31.43. 
Assignment 
1H NMR: δ 3.78 (CH2OH), 3.48 (CH2N3), 1.82 (CH2). 
Assignment 
13C NMR: δ 59.9 (CH2OH), 48.5 (CH2N3), 31.43 (CH2). 
 
6.26 Synthesis of Tris-triazole Cu(I) stabilising ligand (48)
269,270 
 
Tripropargyl  amine  (0.13  mL,  0.12  g,  0.92  mmol)  was  added  to  MeCN  (2  mL) 
cooled over ice. Sequentially added were 3-azidopropan-1-ol (0.422 g, 4.2 mmol), 
2,6-lutigine (0.11 mL, 0.1 g, 0.92 mmol) and Cu(MeCN)4PF6 (13.4 mg, 36  mol). 
The  reaction  was  cooled  over  ice  for  20  minutes  then  allowed  to  reach  room 
temperature, after stirring in the dark for 3 days the mixture turned a brown colour. 
The reaction was monitored by TLC (eluent; hexane/EtOAc 1:1). 
The reaction mixture was cooled over ice to afford a white precipitate which was 
filtered and washed using cold MeCN (20 mL). The filtrate was concentrated by the 
partial removal of solvent in vacuo and left on ice to afford a second crop of product 
precipitate which was again filtered and washed. The tris-triazole Cu(I) stabalising 
ligand was found to be pure (0.18 g, 0.42 mmol, 46%). 
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Physical state: white fluffy solid; 
MS  (m/z):  calcd  for  C18H30N10O3,  457.24  [M+Na]
+;  found,  457  (100%);  calcd, 
435.26 [M+H]
+; found, 438 (18%); 
1H NMR (300 MHz, D2O): δ 7.82 (s, 3H), 4.41 (t, 6H), 3.63 (s, 6H), 3.49 (t, 6H), 
2.04 (m, 6H). 
13C NMR (75 MHz, D2O): δ 143.3, 125.3, 58.2, 47.5, 47.2, 31.8.  
Assignment 
1H NMR: δ 7.82 (CHN), 4.41 (CH2OH), 3.63 (NCH2C(N)CH), 3.49 
(NCH2CH2), 2.04 (NCH2CH2). 
Assignment 
13C NMR: δ 143.3 (CH2C(N)CH), 125.3 (CHN), 58.2 (CH2OH), 47.5 
(NCH2C(N)CH), 47.2 (NCH2CH2), 31.8 (NCH2CH2).  
 
6.27 Preparation of alkyne functionalised SU-8 particles (Jeffamine ED-900
® 
spacer) (56) 
 
Pent-5-ynoic acid (6 mg, 61  mol) was activated in a solution of DIC (5.2  L, 4.2 
mg, 33  mol), HOBt (4.5 mg, 33 mol) and DIPEA (5.5  L, 3.9 mg, 30  mol) in 
DMF (1 mL) for five minutes. Amino functionalised SU-8 particles (Jeffamine
® ED-
900
®  spacer)  were  suspended  in  the  activated  acid  solution  and  agitated  for  90 
minutes. Particles were washed thoroughly with DMF (2 mL) followed by water (3 
mL).  The  reaction  was  monitored  using  the  Kaiser  test,  which  was  negative  on 
completion. 
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6.28  General  procedure  for  the  immobilisation  of  functionalised  azides  to 
alkyne  functionalised  SU-8  particles  using  Huisgen  1,3-dipolar  cycloaddition 
reactions 
 
Huisgen  1,3-dipolar  cycloadditions  were  used  to  immobilise  azide-functionalised 
oligonucleotide  probes  and  fluorophores  to  alkyne-functionalised  SU-8  particles. 
Alkyne functionalised particles (40  g) were suspended in a click reaction mixture 
consisting of NaCl (0.94 mg, 16  mol), sodium ascorbate (32  g, 160 nmol), Tris-
triazole Cu(I) stabalising ligand (274  g, 640 nmol), copper sulfate (20  g, 80 nmol) 
and functionalised azide (4 nmol) in water (100  L). Particles were agitated for four 
hours before washing in SSPE (5×) buffer with 0.02 % Tween-20
® (3 mL) then in 
0.5 M NaOH(aq) (1 mL). 
 
6.29 Synthesis of monoacetyl hexaethylene glycol (87)
287 
 
Hexaethyleneglycol (HEG) (2.35 g, 8.3 mmol) was diluted in DCM (5.5 mL) and 
pyridine (1.102 mL, 1.077 g, 13.6 mmol). The solution was cooled on ice and acetic 
anhydride (0.55 mL, 0.595 g, 5.83 mmol) added slowly with stirring. The reaction 
was allowed to warm to room temperature and left stirring for 18 hours. Solvent and 
base were removed in vacuo to yield a yellow oil. Products were purified by column 
chromatography (eluent; acetone:DCM 1:3, HEG Rf = 0.0, monoacetyl HEG Rf = 6. Experimental 
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0.25, bisacetyl HEG Rf = 0.65, reagents and products stained with KMnO4) to yield 
purified monoacetyl HEG (0.887 g, 2.74 mmol, 47%). 
Physical state: colourless oil; 
Rf = 0.25 (silica gel, 1:3 acetone:DCM); 
MS (m/z): calcd for C14H28O8, 347.17 [M+Na]
+; found, 347.2; 
1H NMR (300 MHz, CDCl3): δ 4.22 (t, 2H), 3.75-3.6 (m, 22H), 2.65 (bs , 1H), 2.07 
(s, 3H). 
13C NMR (75 MHz, CDCl3): δ 171.1, 72.5, 70.6, 70.3, 69.1, 63.6, 61.7, 20.9. 
Assignment 
1H  NMR:  δ  4.22  (CH2OCOMe),  3.75-3.6  (CH2),  2.65  (OH),  2.07 
(CH3). 
Assignment 
13C NMR: δ 171.1 (CO2Me), 72.5, 70.6, 70.3, 69.1, 63.6 & 61.7 (CH2), 
20.9 (CH3). 
 
  
6.30 Synthesis of acetyl hexaethylene glycol phosphoramidite (51)
 
 
Monoacetyl HEG (392.9 mg, 1.21 mmol) was placed in a clean, dry R.B. flask (50 
mL) with stirrer bar and dried in vacuo overnight. The flask was filled with nitrogen 
gas and DCM (6 mL) and DIPEA (319 mg, 499  L, 3.03 mmol) (both distilled) were 
added via cannula. Chlorophosphitylating reagent (375 mg, 1.58 mmol) was added 
and the reaction stirred under nitrogen at room temperature with monitoring by TLC. 
TLC plates were pre-soaked in 10 % triethylamine (TEA), DCM before thorough 
drying, (eluent; acetone:TEA:DCM 25:1:74, chlorophosphitylating reagent Rf = 0.30, 
monoacetyl HEG Rf = 0.25, product Rf = 0.55, degradation product Rf = 0.05, 2D 
TLC confirmed that the degradation product was forming on the plate and not in the 6. Experimental 
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reaction). After 2 hours the crude mixture was dried in vacuo then re-suspended in 
DCM (20 mL) and partitioned with saturated sodium bicarbonate(aq) (20 mL) under 
nitrogen. Phases were separated and the aqueous washed three times with DCM (45 
mL), organic phases were combined and dried (magnesium sulfate). Solvent was 
removed in vacuo and the crude product purified by column chromatography (solid 
phase; silica, mobile phase; 1% TEA, DCM (dry), column dimensions; 1.5 × 5 cm). 
Fractions 3-6 (5 mL each) (TLC Rf = 0.55) were combined, solvent removed and 
dried under vacuum to yield purified product (387.4 mg, 0.74 mmol, 61%). 
Physical state: colourless oil; 
Rf = 0.55 (silica gel, 25:1:74 acetone:TEA:DCM); 
MS  (m/z):  calcd  for  C23H45N2PO9,  464.17  [Mhydrolysed+Na]
+;  found,  464.2;  calcd, 
547.28 [M+Na]
+; found, 547.3 (25%); calcd, 440.17 [Mhydrolysed-H]
-; found, 440.2; 
1H NMR (300 MHz, DMSO): δ 4.10 (t, 2H), 3.40-3.80 (m, 26H), 2.76 (t, 2H), 2.02 
(s, 3H), 1.14 (d, 12H). 
13C NMR (75 MHz, DMSO): δ 170.3, 119.0, 70.5, 70.4, 69.8, 68.2, 63.1, 62.5, 62.2, 
58.1, 42.4, 24.3, 19.7. 
31P NMR (120 MHz, DMSO): δ = 147.6 
Assignment 
1H  NMR:  δ  4.10  (CH2OCOMe),  3.40-3.80  (CH2O,  CHN),  2.76 
(NCCH2), 2.02 (CO2CH3), 1.14 (CHCH3). 
Assignment 
13C NMR: δ 170.3 (CO2Me), 119.0 (CN), 70.5, 70.4, 69.8 (large), 68.2, 
63.1,  62.5  &  62.2  (CH2O),  58.1  (NCCH2CH2O),  42.4  (NCH(CH3)2),  24.3 
(NCH(CH3)2), 19.7 (NCCH2CH2O). 
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6.31 Synthesis of monopropargyl hexaethylene glycol (88) 
 
HEG (7.54 mL, 8.47 g, 30 mmol) was added to MeCN (70 mL) and stirred under 
nitrogen. Sodium hydride (0.29 g, 12 mmol) was added as a suspension in MeCN 
(10 mL) and the reaction stirred until all evolution of hydrogen gas had ceased. The 
solution was cooled over ice and propargyl bromide (0.95 g, 8 mmol) was added 
dropwise. The solution was allowed to warm to room temperature and the reaction 
was monitored by TLC (eluent; acetone:DCM 1:3, two product spots Rf = 0.2 & 
0.45). After 1 hour, solvent was removed in vacuo and the product mixture dissolved 
in DCM (20 mL) then partitioned with a saturated solution of brine (20 mL). The 
aqueous  phase  was  washed  with  DCM  (3  ×  15  mL)  and  the  organic  phases 
combined, dried (magnesium sulfate) and the solvent removed in vacuo. Products 
were purified by column chromatography (eluent; acetone:DCM, 1:3). The less polar 
product (TLC Rf = 0.45) was  found to be the  bis substituted product (by M.S.). 
monopropargyl hexaethylene glycol was isolated (1.41 g, 4.4 mmol, 55%). 
Physical state: colourless oil; 
Rf = 0.20 (silica gel, 1:3 acetone:DCM); 
MS (m/z): calcd for C15H28O12, 343.17 [M+Na]
+; found, 343.3; 
1H NMR (300 MHz, CDCl3): δ 4.13 (d, 2H), 3.7 – 3.5 (m, 24H), 2.61 (t, <1H), 2.38 
(t, 1H). 
13C NMR (75 MHz, CDCl3): δ 79.7, 74.5, 72.5 – 58.4 (7 discernable peaks). 
Assignment 
1H  NMR:  δ  4.13  (CH2CCH),  3.7  –  3.5  (CH2O),  2.61  (OH),  2.38 
(CCH). 
Assignment 
13C  NMR:  δ  79.7  (CCH),  74.5  (CCH),  72.5  –  58.4  (7  discernable 
peaks, CH2O). 
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6.32 Synthesis of propargyl hexaethylene glycol phosphoramidite (53) 
 
Monopropargyl HEG (480 mg, 1.5 mmol) was placed in a clean, dry 2-necked flask 
and dried in vacuo overnight. Distilled DCM (10 mL) and distilled DIPEA (0.65 mL, 
0.48 g 3.7 mmol) were added via cannula and the solution stirred over ice and under 
nitrogen.  Chlorophosphitylating  reagent  (0.44  g,  1.86  mmol)  was  added  in  one 
portion  via  cannula.  The  reaction  was  monitored  by  TLC  (eluent; 
acetone:TEA:DCM, 25:1:75, silica plates were neutralised by dipping in TEA:DCM, 
1:10 and drying prior to use, single product spot Rf = 0.6). After 40 minutes the 
solution was transferred to a nitrogen filled separating funnel and distilled DCM (10 
mL) added. Degassed saturated KCl solution (20 mL) was added and the products 
partitioned, the organic phase was collected, dried (magnesium sulfate) and solvent 
was removed in vacuo. The product was quickly separated from unreacted reagent 
by column chromatography (eluent; TEA:DCM, 1:99), product containing fractions 
were  combined  and  dried.  Propargyl  hexaethylene  glycol  phosphoramidite  was 
isolated as a clear oil (0.54 g, 1.04 mmol, 69%). 
Physical state: colourless oil; 
Rf = 0.60 (silica gel, 25:1:75 acetone:TEA:DCM); 
MS (m/z): calcd for C24H45N2PO13, 543.28 [M+Na]
+; found, 543.3; 
1H NMR (300 MHz, DMSO): δ 4.13 (d, H), 3.8 – 3.4 (m, 28H), 2.74 (t, 2H), 2.51 (t, 
1H), 1.15 (d, 12H). 
13C NMR (75 MHz, DMSO): δ 119.0, 80.3, 77.0, 70.5 – 57.5 (14 peaks), 42.5, 24.3, 
19.8. 
Assignment 
1H NMR: δ 4.13, (OCH2CCH), 3.8 – 3.4 (OCH2, NCH(CH3)2), 2.74 
(CH2CN), 2.51 (OCH2CCH), 1.15 (NCH(CH3)2). 6. Experimental 
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Assignment 
13C NMR: δ 119.0 (CN), 80.3 (OCH2CCH), 77.0 (OCH2CCH), 70.5 – 
57.5 (CH2), 42.5 (NCH(CH3)2), 24.3 (NCH(CH3)2), 19.8 (CH2CN). 
 
6.33 Solution-phase avidin DN-FP1 association constant, kon, determination  
The protein-FP1 complex was quantified in solution by measuring the fluorescence 
polarisation (anisotropy) of the fluorescence signal from the Cy-5 label on FP1. For 
solution experiments, it was necessary to use an excess of unlabelled biotin in the 
reaction mixture, since solutions containing only FP1 and avidin DN were found to 
undergo  self-quenching  upon  binding,  likely  due  to  the  proximity  of  four 
fluorophores to each other in the protein tetramer.
215 
The  association  of  biotin  and  avidin  was  measured  throughout  a  time  course 
experiment and the resultant data analysed to determine the association rate constant, 
kon. For the solution phase reaction this was achieved with real-time monitoring on a 
Tecan  SafireII  plate  reader.  At  t0  avidin  DN  (2.5  nM)  was  added  to  total  biotin 
(biotin  +  FP1,  10  nM),  mixed  and  anisotropy  measurements  swiftly  initiated. 
Measurements  were  recorded  until  equilibrium  had  been  obtained  (<  30  min). 
Anisotropy  was  converted  to  concentration  of  protein-ligand  complex  on  the 
assumption that there was no complex at t0 and anisotropy at equilibrium represented 
complete complexation (10 nM). 
 
6.34 Solution-phase avidin DN-FP1 dissociation constant, koff, determination 
Dissociation kinetics were obtained by monitoring the decrease in the fluorescence 
anisotropy of avidin DN-FP1 complex (2 nM) in solution in the presence of a large 
excess of free biotin (200 nM) to perturb steady-state dynamics. Controls included 
avidin DN-FP1 complex (2 nM) without free biotin (-ve control) and FP1 (2 nM) 
(+ve control), data were recorded over a period of 19 days. 
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6.35 Conversion from particle fluorescence to concentration of particle-bound 
fluorophore  
In order to determine thermodynamic and kinetic binding constants the 
measurements taken of particle fluorescence require conversion into measurements 
of the concentration of complexed FP1. As fluorescence is proportional to the 
concentration of complexed FP1, these values can be easily interconverted once the 
maximum binding (bmax) of the system is known, this value is the concentration of 
complex once all working active sites have been filled. 
For on-particle measurements bmax can be obtained from the titration of FP1 against 
avidin particles. Plotting particle fluorescence vs [FP1] gives a binding curve (Figure 
82). Taking the tangent of the initial gradient (where [active sites] >> [FP1] and 
essentially all FP1 can be assumed to be bound at equilibrium and fluorescent signal 
is linear with respect to increasing ligand) and projecting this up to the level of 
maximum fluorescence gives the bmax as read as the value at the intercept with the x-
axis ([FP1]). Other examples of the use of this method for the determination of bmax 
have been published.
288,289 
 
Figure 82. A diagram of titration results measuring the fluorescence of immobilized-avidin particles in increasing 
concentrations of FP1 ligand. bmax can be ascertained from this data by determining the intersect between the 
saturation fluorescence (a) and the tangent of the initial gradient (b), the concentration of FP1 at this point (c) is 
equal to bmax.  
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6.36  Particle-immobilised  avidin  DN-FP1  association  constant,  kon, 
determination 
The association of FP1 and immobilised-avidin DN was measured throughout a time 
course experiment and the resultant data analysed to determine the association rate 
constant, kon. Binding of FP1 (2 nM) to a suspension of protein-coated particles (1 
mg mL
-1, 8.06 × 10
5 particles mL
-1, ~ 2 nM dependent on avidin immobilisation 
method used) was terminated at time-points (0-30 min) by the addition of an excess 
of  biotin.  Fluorescence  microscopy  was  used  to  analyse  particle  samples, 
fluorescence values could then be converted to a measure of complexed ligand.  
 
6.37  Particle-immobilised  avidin  DN-FP1  dissociation  constant,  koff, 
determination 
Dissociation kinetics were obtained by monitoring the decrease in fluorescence of 
particles with the complex immobilised when was exposed to an excess of biotin to 
impose  effectively  irreversible  complex  dissociation.  Fluorescence  could  be 
converted into a measure of the proportion of filled binding sites where fluorescence 
at t0 represented site saturation (100% complexation) whereas the fluorescence of 
particles  not  previously  exposed  to  FP1  represented  complete  dissociation  (0%). 
Measurements were recorded over a period of 5 days. 
 
6.38 Particle-immobilised avidin DN-FP1 equilibrium dissociation constant, Kd, 
determination 
By titrating FP1 (range = 0-100 nM) against particle-immobilised avidin DN (with 
working site concentrations of; Type I, 2.5 nM; Type II, 7.75 nM; Type III, 3.5 nM), 
total  binding  (at  equilibrium)  could  be  monitored  as  a  function  of  particle 
fluorescence at equilibrium. Fluorescence values were converted to a concentration 
of  protein-ligand  complex  and  plotted  against  free  ligand  in  order  to  determine 
equilibrium  dissociation  constants,  Kd  (Figures  19  &  34).  These  measured 
equilibrium  dissociation  constants  were  found  to  match  the  expected  values  as 
calculated from the experimentally determined rate constants (Equation 6). 6. Experimental 
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6.39 Optimised multiplex hybridisation protocol 
Assays  involved  suspension  of  oligonucleotide-functionalised  microparticles  in 
solutions  of  fluorescently  labelled  target  DNA  followed  by  quantification  of 
individual particles’ surface fluorescence intensities. Depending on the hybridisation 
conditions employed, wash steps were often found to be unnecessary. 
A  typical  singleplexed  assay  as  used  to  determine  complementary  hybridisation 
efficiency or the level of nonspecific DNA binding at varying surface densities of 
probe and blocking moieties would proceed as follows; probe particles (69) (2 µg) 
were suspended in SSPE (5×) buffer (200 µL) containing either complementary or 
noncomplementary Cy5-labelled target DNA (20 – 100 nM) and gently agitated for 2 
hours  at  room  temperature.  Supernatant  was  removed  and  particles  washed  with 
buffer (2 × 200 µL). Particles were analysed by fluorescence microscopy and the 
fluorescence  intensity  of  individual  particles  quantified  using  image  processing 
software. 
A typical multiplexed assay as used for the identification of target DNA proceeded 
as  follows;  a  hybridisation  array  was  formed  by  the  mixing  of  different 
oligonucleotide probe-encoded microparticle conjugates (where particles of identical 
encoding had been functionalised with probes of the same base sequence, i.e. all type 
1 (encoded) particles being functionalised with oligonucleotide PJ, those with Type 
2  encoding  functionalized  with  PK).  This  mixture  of  particles  was  suspended  in 
SSPE (5×) buffer (200 µL) containing Cy5-labelled target DNA (20 nM) and gently 
agitated for 2 hours at elevated temperature. Supernatant was removed and particles 
resuspended  in  buffer,  omitting  any  washing  steps.  Individual  particles  were 
analysed  by  fluorescence  microscopy  as  previously  and  decoded  using 
instrumentation and software developed in-house. Decoding allowed the identity of 
oligonucleotide  probes  immobilised  on  each  particle  to  be  determined. 
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7.0 Appendices 
 
7.1 Appendix I: Graphical fitting and coefficient of determination for presented 
data, including that of kinetic and thermodynamic studies 
 
Figure  Description of data set  Equation used  R
2 
20a  Biphasic dissociation from Type I particles  Exponential decay, double  0.995 
20a  Biphasic dissociation from Type II particles  Exponential decay, double  0.982 
20a   Biphasic dissociation from Type III particles  Exponential decay, double  0.983 
20b  Dissociation (Ln[complex] vs. time) fast (non-specific) Type 
I 
Polynomial, linear  0.995 
20b  Dissociation (Ln[complex] vs. time) slow (specific) Type I  Polynomial, linear  0.991 
20c  Dissociation (Ln[complex] vs. time) fast (non-specific) Type 
II 
Polynomial, linear  0.999 
20c  Dissociation (Ln[complex] vs. time) slow (specific) Type II  Polynomial, linear  0.799 
20d  Dissociation (Ln[complex] vs. time) fast (non-specific) Type 
III 
Polynomial, linear  0.934 
20d  Dissociation (Ln[complex] vs. time) slow (specific) Type III  Polynomial, linear  0.881 
23  Non-specific FP1 binding vs. [Tween-20 surfactant]  Exponential decay, double  0.999 
23  Specific FP1 binding vs. [Tween-20 surfactant]  Polynomial, linear  0.971 
24  Stability of the specific immobilised complex (fluorescence) 
vs. time 
Polynomial, linear  0.599 
27 & 32  Association ([complex] vs. time) in solution  Exponential rise to maximum, 
single 
0.925 
27 & 32  Association ([uncomplexed]
-1 vs. time) in solution  Polynomial, linear  0.943 
32  Association ([complex] vs. time) on Type I particles  Exponential rise to maximum, 
single 
0.991 
32  Association ([complex] vs. time) on Type II particles  Exponential rise to maximum, 
single 
0.993 
32  Association ([complex] vs. time) on Type III particles  Exponential rise to maximum, 
single 
0.989 
32  Association ([uncomplexed]
-1 vs. time) on Type I particles  Polynomial, linear  0.988 
32  Association ([uncomplexed]
-1 vs. time) on Type II particles  Polynomial, linear  0.987 
32  Association ([uncomplexed]
-1 vs. time) on Type III particles  Polynomial, linear  0.953 
28 & 33  Dissociation (% complex vs. time) in solution  Exponential decay, single  0.955 
33  Dissociation (% complex vs. time) on Type I particles  Exponential decay, single  0.972 7. Appendix 
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Figure  Description of data set  Equation used  R
2 
33  Dissociation (% complex vs. time) on Type II particles  Exponential decay, single  0.939 
33  Dissociation (% complex vs. time) on Type III particles  Exponential decay, single  0.980 
28 & 33  Dissociation (Ln[complex] vs. time) in solution  Polynomial, linear  0.951 
33  Dissociation (Ln[complex] vs. time) on Type I particles  Polynomial, linear  0.956 
33  Dissociation (Ln[complex] vs. time) on Type II particles  Polynomial, linear  0.920 
33  Dissociation (Ln[complex] vs. time) on Type III particles  Polynomial, linear  0.979 
34  Binding titration ([complexed] vs. [free]) on Type I particles  Ligand binding, one site 
saturation 
0.985 
34  Binding titration ([complexed] vs. [free]) on Type II particles  Ligand binding, one site 
saturation 
0.987 
34  Binding titration ([complexed] vs. [free]) on Type III 
particles 
Ligand binding, one site 
saturation 
0.993 
42  Probe migration t = 0 min  Gaussian, multipeaks fit  0.961 
42  Probe migration t = 143 min  Gaussian, multipeaks fit  0.992 
42  Probe migration t = 1114 min  Gaussian, multipeaks fit  0.998 
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7.2 Appendix II: Oligonucleotide sequences 
 
Name  5’ 
modification 
3’ 
modification 
Sequence (5’ to 3’) 
 
       
FP1  Cy-5  biotin  CTA GTT ACT CTT GTT C 
FP2  Cy-5  amine  GAG ATG CAC TCG AGT AAG TCA AGT CG 
O1  -  -  CCA TCG ACT TGA CTT ACT CGA GTG CAT CTC 
T1  Alexa  -  GCA ACT AAA TTC A 
P2  amine  -  GAG ATG CAC TCG AGT AAG TCA AGT CG 
T2  Cy-5  -  CCA TCG ACT TGA CTT ACT CGA GTG CAT CTC 
T3  Cy-5  -  TTT CTT GAT CAC TCC ACT GTT C 
PA  biotin  -  TTG TTA TAG TTC TCT C 
TA  Cy-5  -  GAG AGA ACT ATA ACA A 
PB  biotin  -  CTA GTT ACT CTT GTT C 
TB  Cy-5  -  GAA CAA GAG TAA CTA G 
O2  -  -  TTT CTT GAT CAC TCC ACT GTT C 
PC  biotin  -  AAA AAC TTG GAT CC 
TC  Cy-5  -  GGG ATC CAA GTT TTT T 
PD  biotin  -  AAA AAG TTG GAT CC 
TD  Cy-3  -  GGG ATC CAA CTT TTT T 
PE  biotin  -  CAA CCC CAG CTA ATA TTA TT 
TE  Cy-5  -  AAT AAT ATT AGC TGG GGT TG 
PF  amine  -  AAA AAC TTG GAT CC 
PG  amine  -  AAA AAG TTG GAT CC 
TG  Cy-5  -  GGG ATC CAA CTT TTT T 
PH  amine  -  CAA CCC CAG TTA ATA TTA TT 
TH  Cy-5  -  AAT AAT ATT AAC TGG GGT TG 
PI  amine  -  CAA CCC CAG GTA ATA TTA TT 
TI  Cy-5  -  AAT AAT ATT ACC TGG GGT TG 
PJ  azide  -  AAA AAG TTG GAT CC 
PK  azide  -  CAA CCC CAG TTA ATA TTA TT 
PL  azide  -  CAA CCC CAG GTA ATA TTA TT 
PM  azide  -  GAG ATG CAC TCG AGT AAG TCA AGT CG 
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7.3 Appendix III: Buffer solutions 
 
Buffer  Constituents   
 
     
imidazole 
 
Imidazole (0.1 M)   
SSPE (20×) 
 
NaCl (3.0 M), NaH2PO4 (200 mM), EDTA (20 mM)   
SSPE (5×) 
 
NaCl (0.75 M), NaH2PO4 (50 mM), EDTA (5 mM)   
MES 
 
MES (0.1 M), NaCl (0.5 M)   
PBS  NaCl (0.14 M), KCl (2.7 mM), Na2HPO4 (10 mM), KH2PO4 (2 mM)     
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